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Enterolobin, a 55 KBa haemolytic protein from 
Enterolobium contortisiliquum seeds, was purified and further 
characterized. Its partial amino acid sequence was determined by using 
both manual and automatic methods of sequence determination. A 
number of 271 residues could be placed by means of overlaps. A 
computational search of these overlapped peptides against the PER. 
database revealed that some residues of one peptide had short sequence 
matches to the bacterial pore-forming aerolysins from Aeromonas 
hydrophyla and Aeromonas sobria and to colicin lb from Escherichia 
coli. A subsequent search for similar sequence patterns stored in the 
PROSITE database showed that the predicted cytolytic site of 
enterolobin and the aerolysins have similarities to the pattern of the 
tortB-dependent receptors of bacteria. This pattern occurs not only in 
these membrane receptor proteins, but also in calkins and other pore-
formers and transport proteins. Hydropathy profile analyses made for 
aerolysins and the predicted cytolytic sites demonstrated their overall 
hydrophilic character with some short stretches of hydrophobic regions. 
Studies on the kinetics of haemolysis of normal red cells by 
enterolobin in the presence of possible effectors such as Ca 2 + , E D T A , 
galactose, choline, phosphatidylcholine, cholesterol, ricin and with 
trypsinised erythrocytes were performed. These analyses indicated that 
the membrane receptor for enterolobin was probably a protein, perhaps 
the band 3 anion-exchanger protein. Optical and electron microscopic 
observations of the effects of enterolobin and gold-enterolobin on the 
membranes of red cell and cancer cells were carried out, and revealed 
severely damaged membranes after contact with the cytolysin. Gold-
enterolobin had a random distribution around holes on the red cell 
membrane. Bioassays showed that enterolobin was toxic to larvae of the 
insect Callosobruchus maculatus but not to those of Spodoptera 
litorallis. Assays of in vitro proteolysis using larval gut enzymes showed 
that only S. litorallis proteases could digest enterolobin. The mechanism 
of toxicity of enterolobin did not involve any damage to the microvillar 
membranes of the epithelial gut cells of C. maculatus as shown by 
electron microscopy. 
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1 D introduction 
U Concepts 
The disruption of the organization of the cytoplasmic 
membrane with leakage of intracellular material leading to a loss of 
morphological and/or functional integrity of a cell is called cytolysis. 
Lysis is a more general term that can be applied to the disorganization 
of the cellular membrane, but also to types of membranes other than the 
cytoplasmic one. Haemolysis is the lysis of erythrocytes, or, as more 
commonly known, red blood cells. 
A large number of substances with the capacity to cause cell 
lysis is known. The chemical nature of these compounds is very 
diversified, and includes saponins, lysophospholipids, ionic and non-
ionic detergents, antibiotics, etc. (Assa et al.9 1973; Thelestan and 
Mollby, 1979; Zalavsky et al., 1978). Besides these low molecular 
weight substances, there are also many cytolytic peptides and proteins 
produced by living organisms as it wil l be shown in this introduction. 
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Erythrocytes have long been used to test cytolytic effects. 
Indeed, these cells are very good models because they are easily 
available, contain an internal marker - haemoglobin - and have a well 
characterized membrane. Moreover, haemolysis occurs with almost all 
lytic agents with few exceptions (Alouf, 1976). 
The aim of this introduction is to give an outline of the 
cytolytic proteins and peptides found in biological systems, focusing 
attention in particular on the novel group of plant cytolytic proteins 
(phytocytolysins), and especially enterolobin (Sousa, 1988; Sousa and 
Morhy, 1989), the first haemolytic/cytolytic protein to be isolated from 
plants. 
1,2 Occurrence of Cytolytic Proteins 
and Peptides 
Although cytolytic peptides and proteins seem to have an 
ubiquitous distribution among living organisms, they have been more 
often studied in bacteria, fungi, stinging arthropods, stinging marine 
invertebrates, poisonous reptiles, and mammals. Some examples of each 
group are described below. 
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1.2.1 Bacteria 
A number of reviews have appeared on several aspects of 
the bacterial cytolytic proteins and peptides (reviews in Alouf, 1976; 
Bernheimer, 1970, 1974 and 1983; Bernheimer and Rudy, 1986; Sousa 
et ai, 1990). A complete issue of Methods in Enzymology was dedicated 
to the purification, assays and applications of microbial toxins including 
cytolysins (Harshman, 1988). 
The most studied cytolytic proteins and peptides from 
bacteria are those from the genera Streptococcus, Staphylococcus, 
Clostridium and Bacillus. They also occur in Vibrio, Pseudomonas, 
Listeria, Aeromonas, Escherichia and many others. For example, Keen 
and Hoffman (1989) reported a Legionella pneumophila extracellular 
protease exhibiting haemolytic and other cytotoxic activities. Even the 
soil bacterium Rhizobium leguminosarum has a nodulation gene (nodO) 
that encodes a protein that is similar to E coli haemolysin (Economou et 
al, 1990) 
The bacterial cytolysins are generally classified in two 
groups, the thiol-activated cytolysins and other cytolysins. The 
cytolysins of the former group lose their cytolytic activity in the 
oxidized state and are activated by thiol compounds. Their site of 
interaction in the membrane is known to be cholesterol. They show 
close relationship to each other (Table 1). The second group is formed 
by cytolysins which are not activated by thiol compounds (Table 2). The 
cytolysins of this second group exhibit many differences to each other. 
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Table Is 
e§ ol sins' 
Species CytoEysim 
Streptococcus 
Bacillus 
Clostridium 
Listeria 
pyogenes 
pneumoniae 
cereus 
thuringiensis 
alvei 
laterosporus 
bifermentans 
botulinum 
histolyticum 
novyi type A 
(oedematiens) 
perfringens 
septicum 
tetani 
chauvoei 
monocytogenes 
streptolysin O 
pneumolysin 
cereolysin 
thuringiolysin O 
alveolysin 
laterosporolysin 
bifermentolysin 
botulinolysin 
histolyticolysin 
(e-toxin) 
oedematolysin O 
(y-toxin) 
perfringolysin O 
(0-toxin) 
septicolysin 
tetanolysin 
chauveolysin 
listerolysin 
(*)From Bernheimer and Rudy (1986). 
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Table 2; 
Examples of bacterial cytolystms mot activated by thiols* 
Genus Specses Cytolysin 
Staphylococcus aureus a-toxin 
P-toxin 
y-toxin 
5-toxin 
leucocidin 
Streptococcus sp. streptolysin S 
Clostridium perfnngens a-toxin 
(phospholipase C) 
hemolyticum lysin 
oedematiens P-toxin 
y-toxin 
septicum a-toxin 
chauvoei a-toxin 
Bacillus subtilis surfactin 
thuringiensis second haemolysin 
cereus phospholipase D 
Pseudomonas aeruginosa haemolysin 
fluoresceins haemolysin 
Aeromonas hydrophyla aerolysin 
sobria haemolysin1 
salmonicida haemolysin2 
Escherichia coli haemolysin 
(*) Adapted from Bernheimer (1974). ^jungh and Wadstrom (1982). 2Titball 
and Munn (1983). 
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1.2.2 Protozoans 
Cytolysins have also been found in protozoa. A 13-14 KDa 
cytolytic protein, probably involved in the pathogenesis of amoebic 
dysentery, is produced by the parasite Entamoeba histolytica (Lynch et 
ai, 1982; Young et al., 1982). These results have been extended to 
another haemolysin-producing protozoan, Naegleria fowled (Lowrey, 
D.M. and Young, J.D.-E., unpublished observations apud Young et aL, 
1988). Also, Trypanosoma cruzi, the causative agent of Chagas' disease, 
secretes a haemolysin of 70-75 KDa that forms lesions of 10 nm on 
target membranes, and resembles perforin and component C9 of the 
human complement (reviewed by Andrews, 1990). 
12.3 Lichens and Fungs 
Cytolytic peptides and proteins have been frequently found 
in fungi. For example, alamethicin, suzukacillin and trichotoxin are 
antibiotic peptides isolated from different strains of the unicellular 
fungus Trichoderma viride (Irmsher and Jung, 1977). Volvatoxin is a 
cardiotoxin with M.W. = 24 000 from the mushroom Volvariela 
volvacea. Pleurotolysin is a 12 050 Da dimeric protein from the edible 
mushroom Pleurotus ostreatus (Bernheimer and Avigad, 1979). 
Phallolysin, a toxin from the poisonous mushroom Amanita phalloides, 
is one of the most studied fungal cytolysins. It has a M.W. = 33 000 and 
pis of 8.06 and 7.49 (Seeger, 1975a,b). This protein is encountered in 
multiple forms and has some similarities with the staphylococcal a-toxin 
(Faulstich et al., 1983). New additions to the group of cytolysin from 
fungi are always appearing in the literature. Recently, a haemolysin of 
6 
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40 KOa has been purified from the poisonous mushroom Rhodophyllus 
rhodophylius (Suzuki et al., 1990a). 
A novel haemolysin from Parmelia pulla, purified by 
Hunaiti et al. (1988), was probably the first protein haemolysin isolated 
from lichens. 1 has a MW of 32 600 composed of two sublimits alpha 
and beta of 18 000 and 14 000 Da respectively. 
Also very recently, a new haemolysin has been discovered 
and purified from the culture filtrate of Streptomyces sp. strain no. A-
6288, a bacterium possesing some characteristics of unicellular fungus, 
isolated from a soil sample (Suzuki et al, 1990b). This cytolytic toxin 
had a molecular weight determined by gel filtration as 45 000. 
1.2.4 Metazoans 
Most of the metazoan phyla, such as porifera, coelenterata, 
anellida, mollusca, arthropoda and echinodermata, posseses cytolysins 
(reviewed by Canicatti, 1990). According to this author, they are 
generally calcium-dependent and heat-labile proteins, and are important 
factors in invertebrate defense, predation and humoral immunity. 
Canicatti (1990) discusses in his review the possibility of the evolution 
of a common ancestral gene which led to both invertebrate and 
vertebrate pore-forming proteins in their immune systems. His 
hypothesis was based on analogies of some invertebrate cytolysins with 
human complement and perforin (see Section 1.2.6). This may be true 
for the particular class of cytolytic proteins reviewed by him. However, 
at least arthropods produce predominantly small peptide cytolysins 
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rather than proteins, which excludes most of them from the above 
mentioned class. 
As marine invertebrates, specially cnidarians (sea 
anemones), and arthropods are the most representative groups of 
cytolysin-containing invertebrates, their cytolytic peptides and proteins 
are described below in greater detail. 
1.2A. 1 Cnidarians and other Marine 
invertebrates 
Among the marine invertebrates, the principal sources of 
cytolysins are the cnidarians (Coelenterates) (Bernheimer and Rudy, 
1986). The toxin from nematocysts of the sea anemone Stoichactis 
helianthus is a basic protein with M.W. = 16 000 (Bernheimer and 
Avigad, 1975). The Atlantic Portuguese man-of-war, Physalia physalis, 
also contains in its nematocysts a lethal and cytolytic glycoprotein of 
high molecular weight (240 000) (Tankun and Hessinger, 1981). Table 
3 lists known sea anemone cytolytic toxins, all of them having molecular 
weights between 10 to 30 KDa and basic pis, except for metridiolysin 
with 80 KDa and pi 5.0 (Bernheimer and Avigad, 1978). 
Besides the cnidarians, many other sea animals produce 
cytolysins (Canicatti, 1990). For example, the mucus secreted from the 
skin of the marine worm Cerebratulus lacteus contains cytotoxins with 
molecular weights around 10 500 Da (Ken and Blumenthal, 1978). 
Also, haemolysins occur in the coelomic fluid of three species of sea 
urchins, Anthocidaris crassipina, Pseudocentrolus depressus and 
Hemicentrolus pulcherrimus (Ryoyama, 1973). A cytolytic, but not 
8 
Mareelo V. Sousa Enteirolobimi Introduction 
haemolytic, glycoprotein (dollabelanin P) has been recently purified 
from the purple fluid of the sea hare Dolabella auricularia (Yamazaki et 
al, 1989) This invertebrate of the class Mollusca discharges a purple 
fluid from the purple gland when disturbed. 
Table 3s 
Cytolytic toxins f rom sea anemones* 
Species 
Actinia cari 
Actinia equina 
Actinia tenebrosa 
Aiptasia pallida 
Anthopleura japonica 
Anthopleura xanthogrammica 
Condylactis gigantea 
Epiactis prolifera 
Metridium senile 
Parasicyonis actinostoloides 
Pseudactinia varia 
Radianthus macrodactylus 
Stoichactis helianthus 
=Stichodactyla helianthus 
Stoichactis kenti 
Tealia lofotensis 
Toxin 
cariotoxin I 
cariotoxin II 
equinatoxin 
equinatoxin I 
equinatoxin II 
equinatoxin III 
tenebrosin A 
tenebrosin B 
tenebrosin C 
fraction DI 
fraction IV 
A. japonica haemolysin 1 
" haemolysin 2 
A. xanthogrammica lysin 
Condylactis toxin 
epiactin A 
epiactin B 
epiactin C 
metridiolysin 
parasitoxin 
variolysin 
R. macrodactylus toxin 
S. helianthus toxin 
Stichodactyla cytolysin I 
cytolysin II 
" cytolysin DI 
cytolysin IV 
kentin 
T. lofotensis lysin 
(*) Compiled by Sencic and Macek (1990). 
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2 A 1 4 rthn d P o s 
Arthropods have long been used as a source for isolation of 
cytolytic peptides and proteins (Iwanaga, 1976; Cavagnol, 1977; 
Schimdt, 1982; Bernheimer and Rudy, 1986). Bees, wasps, ants and 
scorpions, but not spiders, are known to have phospholipase A2 in their 
venoms. Sphingomyelinase D, found in the venom of the spider 
Loxosceles recluse, has a M.W. = 19 000 and causes calcium-dependent 
haemolysis (Forrester et al., 1978). 
Besides these enzymes, arthropod venoms usually contain 
toxic cytolytic peptides. Mellitin from the bee (Apis me I life ra), 
barbatolysin from the red harvester ant (Pogonomyrmex barbatus), 
mastoparan from the wasp (Vespula lewisii), crabolin from the 
European hornet (Vespa crabre) and bambolitin from the bumblebee 
(Megabombus pennsylvanicus) are examples of those peptides 
considered by Bernheimer and Rudy (1986). Recently, some synthetic 
amphiphilic peptides were constructed carrying mellitin-like activity 
(Katsu etal., 1990). 
Gooding (1977) described the presence of a haemolysin in 
the midgut of Glossina morsitans, a hematophagous fly and vector of the 
sleeping disease. Another hematophagous insect, Rhodnius prolixus, the 
vector that transmits Chagas' disease, possesses a haemolytic and 
trypanosomalytic peptide (Azambuja et al., 1989). 
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R 1 ptll Amphihi nd Fi h e a n a 
Not surprisingly, several cytolytic polypeptide fractions 
have been obtained from snake (Elapidae) venoms. Several terms have 
been used to describe them such as: direct lytic factors (DHF) (Aloof-
Hirsh et ai, 1968; Condrea et al. 1964a,b; Yukel'son et al. 1975); 
cobramines (Larsen and Wolff, 1968); cytotoxin P (Braganca et al., 
1965); cardiotoxins (Louw and Visser, 1977); and cytotoxins (Dimari et 
al., 1975). 
These toxins have been classified as belonging to a 
congeneric group of cytolysins, because of their uniform structures and 
modes of action (Bernheimer and Rudy, 1986). Iwanaga (1976) 
described them as similar, strongly basic, peptides with molecular 
weights ranging from 5 700 to 6 700 (52 to 60 amino acid residues). 
Their chemical and pharmacological properties have been reviewed by 
Lee (1972). Phospholipase A2 is also generally present in snake venoms 
in addition to cytolytic peptides. It appears to act synergistically with 
them (Harvey et al, 1983; Yukel'son et al, 1977). 
Amphibians seem to contain cytolysins as well. A 87 000 
Da acidic haemolytic protein was purified from the skin secretion of 
Bombina variegata (Mar and Michl, 1976). Sebben et al. (1989) 
demonstrated the presence of a protein fraction with haemolytic activity 
in the skin secretion of the frog Odontophrynus cultripes. 
Cytolysins from fish are also known. For example, the 
arabian gulf catfish, Arius thalassinus, produces a toxic gelly secretion 
from its epidermis that contains an acidic haemolytic protein of 34 KDa 
with broad specificity (Al-Lahham et al.„ 1987). The secretion of this 
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toxic and haemolytic gel by the fish is induced after a fright or a shock 
as a mechanism of self-defense. 
1.2.6 Humans 
There are some proteins from the human immune system 
which have the ability to lyse cells. The most studied of these proteins 
belongs to the complement system, and have been investigated for a long 
period (reviews in Cooper, 1971; Fearon and Wong, 1983; Frank et al., 
1965; Mayer, 1965; Porter and Reid, 1979; Reid and Porter, 1981). 
Recently, Kipnis and Dias da Silva (1989) reviewed the action of 
complement on Trypanosoma cruzi. Complement causes the lysis of 
both animal cells and infectious agents. It is a system of about 20 distinct 
glycoproteins present in extracellular fluids. Some of these proteins are 
enzymes and cooperate with immunoglobulins in the immune system. 
Besides, Salama et al. (1988) demonstrated that some potent 
haemagglutinating antibodies can cause complement-independent 
haemolysis as well. 
Another group of cytolytic glycoproteins are the 
lymphotoxins from human lymphoid cells. They are glycoproteins, and 
are divided in four groups of molecular weights - 200 KDa, 70-90 KDa, 
30-50 KDa, and 15-20 KDa (Toth and Granger, 1979). 
More recently, a novel cytolytic protein found in cytotoxic 
T lymphocytes and natural killer cells is gaining attention. This protein 
is called pore-forming protein or, simply, perforin (reviewed by 
Tschopp and Nabholz, 1990; Young and Cohn, 1986; Young et al 1988; 
Young, 1989). Perforin exists in a 70 000 Da monomelic form. It can 
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lyse tumor cells and other target cells by a calcium-dependent 
polymerization of the monomers, forming pores through the 
membrane. 
1,3 The siovel group of piant cytolytic 
peptides and proteins 
Surprisingly, only a few plant cytolytic peptides and 
proteins have been studied so far. Only one peptide, the Pyrularia 
pubera thionin (Vernon et. al, 1985) and two proteins, crotin (Banerjee 
and Sen, 1981) and enterolobin (Sousa, 1988; Sousa and Morhy, 1989) 
have been purified. More detailed description of each of them, 
especially enterolobin that is the object of this current work, are given 
below. 
Certainly, many other distinct cytolytic peptides and 
proteins may be found in plants. The increased detection, purification, 
and chemical and biological characterization of these substances wil l 
permit further comprehension of their mechanisms of action, roles in 
the plants and practical applications. 
1.3.1 F^mMm Thionin 
Pyrularia thionin is a 5 280 Da basic peptide with 47 amino 
acid residues purified from the nuts of the fern Pyrularia pubera 
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(Vernon et al., 1985). Pyrularia pubera is a parasitic plant from the 
order Santalaceae, which contains the mistletoes. This thionin is a 
haemolytic, cytolytic and neurotoxic peptide, and has close resemblance 
to the viscotoxins from the mistletoes, to crambin, and to the thionins 
from wheat and barley (Vernon et al., 1985). The peptide has most 
haemolytic activity against red cells from man, followed by rabbit, 
guinea pig and pig. Little or no activity is shown against erythrocytes 
from sheep, horse, cow or mouse. Recently, Bloch and Richardson 
(1991) purified and sequenced three small a-amylase inhibitors from 
sorghum with sequence similarities to the thionins, but no cytolytic 
activity has been found for this thionin-like inhibitor yet. 
The Pyrularia thionin has no phospholipase activity itself , 
but acts synergistically with bee phospholipase A2 (Osorio e Castro et 
al., 1989). It also activates membrane phospholipase A2, which 
promotes the release of free fatty acids, but this release is not totally 
responsible for the haemolysis. 
Thionin and snake venom cardiotoxin seem to have the 
same binding site on the membrane, most likely a protein as concluded 
from kinetic analysis (Osorio e Castro and Vernon, 1989). Subsequent 
changes in the conformation of membrane proteins would result in 
phospholipase A2 activation, enhancing thionin haemolytic activity. 
1.3.2 Crotin 
Crotin is a non-toxic lectin from the seeds of Croton 
tiglium (Euphorbiaceae). Banerjee and Sen (1981) purified and 
characterized this protein. Although it agglutinates erythrocytes of 
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sheep, cow, buffalo and goat, it fails to agglutinate or lyse human (A, B, 
O groups), horse and dog erythrocytes. However, it causes agglutination 
and haemolysis of rabbit erythrocytes. No evidence has been shown in 
the literature of lytic activity of crotin towards cell types other than 
rabbit erythrocytes. 
Crotin has a M.W.= 55 000 by SDS-PAGE but can undergo 
association to form oligomers of 400 000 Da. It is a glycoprotein with 
0.75% of carbohydrate content and consists of two isoforms of pi 5.1 
and 5.4. It contains five cysteine residues with two of them forming a 
disulphide bond. 
Early results (Banerjee and Sen, 1981) suggested that the 
binding site for crotin on rabbit membrane might be a glycopeptide and 
might involve galactose residues. Also, there were indications that there 
might be divergent pathways for hemagglutination and haemolysis 
subsequent to lectin binding. Later experiments (Banerjee and Sen 1983) 
confirmed the previous supposition and suggested a disaccharide 
structure consisting two Gal or GalNAc residues as the binding moiety. 
1.3.3. Enterolohin 
A screening of seeds harvested from plants found in the 
central region of Brazil was carried out in 1986 in order to look for the 
presence of haemolysins in them (Sousa and Morhy, unpublished 
results). In that test, the saline extract of Enterolobium contortisiliquum 
(Veil.) Morong showed haemolytic activity. E. contortisiliquum is a tree 
belonging to the family Leguminosae, subfamily Mimosoideae. This 
plant is commonly known as "orelha-de-macaco", "orelha-de-negro", 
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"tamboril" or "tambouva". It is found in the Brazilian rain forests, 
principally in the Atlantic forest, from the northern state of Ceara to 
Uruguay and Paraguay (Rizzimi and Mors, 1976). It is well adapted to 
the "Cerrado" ecosystem in central Brazil, and is recommended for 
reafforestation (Heringer, 1978). None of the products of E. 
contortisiliquum is used as food for human consumption. The fruit pod 
is toxic to cattle, but the nature of the toxin is not known (Hoehne, 
1939; Santos et al, 1975). 
The haemolytic protein, which was named enterolobin, was 
purified by the following method: extraction with 0.15 M NaCl, 
precipitation with ammonium sulfate (0-33% saturation), batch 
separation with DEAE-cellulose and gel filtration on Sephadex G-100 
or G-150 (Sousa, 1988; Sousa and Morhy, 1989). 
Enterolobin was shown not to possess any phospholipase D 
activity in a chemiluminescence assay (Sousa and Morhy, 1989), despite 
the fact that phospholipase D can be haemolytic (Bernheimer and Rudy, 
1986; Thelestan and Mollby, 1979) and that seeds of legumes are rich 
sources of this enzyme (Galliard, 1980; Heller, 1978). 
Mouse erythrocytes were less susceptible to haemolysis by 
enterolobin than human and rabbit erythrocytes in a microtitration plate 
assay. The haemolytic activity was rapidly lost at temperatures above 55 
°C and at acidic and basic pHs. 
Enterolobin has a molecular weight of 55 000 when 
determined by gradient PAGE-SDS, 59 800 by gel filtration, and 
51 300 by gel filtration in HPLC. Its isoelectric point is 7.0. It contains 
high percentages of Asp(Asx), Phe, Ser and Thr and low percentages of 
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Ala, Cys and Pro in relation to average proportions found in proteins 
(Sousa, 1988; Sousa and Morhy, 1989). 
The characterization of enterolobin by ultraviolet 
spectroscopy (Sousa, 1988; Sousa et al., paper in preparation) showed 
the presence of Trp and Tyr in a molar ratio Tyr/Trp of 1:1. 
Fluorescence studies indicated that Trp is in an environment of medium 
polarity. The quantum yield of enterolobin was similar to that from a 
standard Trp solution, indicating that there was no quenching of the 
fluorescent emission from Trp residues in enterolobin. Data from 
infrared and circular dichroism spectra showed the presence of both 
ordered and unordered secondary structures in enterolobin. 
Additionally, a tight conformation was inferred for enterolobin. 
New studies are underway showing new properties of 
enterolobin (Castro-Faria-Neto et al, in the press; Cordeiro et al, in the 
press). These studies have demonstrated that enterolobin is a very potent 
inducer of paw oedema. Furthermore, enterolobin-induced oedema is 
partially dependent on lipoxygenase metabolites and histamine, while 
PAF-acether (a lipid mediator involved in several physiopathological 
conditions, including inflammation) and prostaglandins do not seem to 
be important in this reaction. Enterolobin also causes pleural exudation 
and cellular infiltration, with a remarkable ability to attract 
polymorphonuclear neutrophils and eosinophils (Castro-Faria-Neto, et 
al., in the press). Cordeiro et al (in the press) have stated that 
enterolobin could be a very useful pharmacological tool to investigate 
some aspects of the inflammatory reaction, since it has the general 
ability to induce oedema, exudation and cellular influx to the inflamed 
area. 
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Sousa et al. (paper in preparation) have found that 
enterolobin is cytolytic to most of the blood cells, except lymphocytes. 
This finding suggests an immediate practical application for enterolobin 
in the purification of lymphocytes. It could also attract groups interested 
in investigating of the molecular mechanism of lymphocyte resistance to 
lysis by enterolobin. 
Cytolytic peptides and proteins can be classified in different 
ways. One of these systems follows the origin of the agent as it was done 
above. A wider classification would be simply microorganism, plant and 
animal cytolysins. 
Cytolytic peptides and proteins from microorganisms are 
the most studied ones. They have been investigated since the beginning 
of this century. Bernheimer (1970) reviewed extensively the research 
done on this class of proteins up to that year. Animal cytolysins also 
have been very much considered as it has been shown above in this 
introduction. The only group that has not yet been significantly 
explored is the plant cytolysins group. 
An early classification of the bacterial cytolytic proteins 
only was made by Bernheimer (1970). As already mentioned above 
(Section 1.2.1), he classified them in two groups: (a) cytolytic toxins 
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activated by SH-compounds (oxygen-labile lysins); and (b) cytolytic 
toxins not activated by SH-compounds. 
SH-dependent cytolysins lose their activity in the oxidized 
state, but are active in the presence of thiol reagents. They form a 
uniform group in some characteristics. All of them come from gram-
positive bacteria, and have the same receptor on the target cells -
cholesterol (Bernheimer, 1974, 1983). They have molecular weights 
ranging from 47 000 to 68 000 Da, and can form dimeric and 
oligomeric forms (Alouf, 1976). The other cytolytic bacterial proteins 
show no close relationship among them and are not activated by thiols, 
thus are classified in the separate group of SH-independent cytolysins. 
Their physical-chemical and biological properties are very diverse. 
Thelestam and Mollby (1979), by means of methodical 
experiments, classified cytolytic agents (micro- and macromolecules) by 
the type of leakage caused to target cells by them. Five groups were 
identified: (a) detergent-like agents which cause non-specific 
solubilization of membrane constituents, e.g. Pseudomonas haemolysin; 
(b) molecules interacting only with certain constituents of the membrane 
and causing solubilization or degradation, e.g. phospholipase C from 
Bacillus cereus and mellitin; (c) cytolysins interacting with specific 
receptors on the cell membrane and giving rise to lesions of limited 
size, e.g. aerolysin, 5-toxin, cereolysin, 0-toxin, listeriolysin, 
streptolysin O, vibriolysin and direct lytic factors of snakes; (d) agents 
which induce small channels of defined size, e.g. nystatin, amphotericin 
B and a-toxin; and (e) proteins producing only a very limited increase 
in the permeabeality of the plasma membrane, e.g. phospholipase D 
from Corynebacterium ovis, phospholipase C from 5. aureus, y-toxin 
and streptolysin S. 
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More recently, two other more extensive classifications of 
the cytolytic peptides and protein have been made. (Bemheimer and 
Rudy, 1986; Bhakdi and Tranum-Jensen, 1987). These new 
classification systems are amalgamations of the previous ones with the 
introduction of new data derived from electron microscopy, protein 
chemistry, kinetics of cytolysis and other biochemical and biophysical 
techniques such as use of cytolysins labelled with fluorescent probes. 
Bernheimer and Rudy (1986) introduced the general 
conceptual classification of cytolytic polypeptides producing actual or 
postulated discrete membrane lesions, and polypeptides not known to 
produce discrete lesions. They also subdivided each group into 
"congeneric" and "individualistic" agents, the former meaning those 
with similar physico-chemical characteristics and/or mechanisms of 
action, while the latter exhibits a high degree of individuality in their 
properties. This classification system is shown in Scheme 1. 
Bhakdi and Tranum-Jensen (1987) suggested a way of 
classification also based on the type of pore: (a) cytolysins forming 
pores with recognizable ultrastructure, e.g. Staphylococcal a-toxin, 
streptolysin O, complement and perforin; and (b) cytolysins generating 
pores with no recognizable ultrastructure, e.g. cytolysin from gram-
negative bacteria (such as E.coli haemolysin, Pseudomonas aeruginosa 
cytotoxin, Aeromonas hydrophila aerolysin and gramicidin A) and 
other pore-forming proteins (from sea anemone, fungi and amoeba). 
The authors define pores with recognizable structure as those that can 
be detected by electron microscopy. 
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Sclheme 1 
Classnfacatiosa of Cytolytic Peptides amd Proteims 
I. Polypeptides produncimg actual or postulated discrete membranie lesions 
A. Congeneric agents B. Individualistic agents 
• SH-activated lysins ° a-Toxin 
- Mellitin and other arthropods lysins 
• Alamethicin 
• Gramicidin 
° Various sea anemone lysins 
• 6-Toxin 
EL Polypeptides mot known to prodrace discrete memlbrame lesions 
A. Congeneric agents B. Individualistic agents 
• Carditoxic peptides from snakes • Aerolysin 
° Phospholipase A2 • Vibrio cytolysins 
° Phospholipase C • Physalia toxin 
• Phospholiapse D • Phallolysin 
° Streptolysin S 0 EMamphotoxin 
*Bernheimer and Rudy (1986) 
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f f f 1 h t t n u y 
It has been shown in this introduction that biomolecules 
from different organisms, with distinct physical and chemical 
properties, and diverse mechanisms of action, can act as cytolysins. 
Such variety stimulates studies aimed at characterizing and 
understanding these molecules to know about their biological and 
medical significance; relations between their structures, mechanisms of 
action and functions; and potentialities as biochemical, pharmaceutical 
and biotechnological tools. 
The medical and pharmacological importance of cytolysins 
is clear since many of them are cytotoxins, neurotoxins and/or 
cardiotoxins. They can be harmful to man following microbial 
infection, ingestion of toxic mushrooms and plants, and inoculation of 
animal venoms. A deep knowledge of these cytolysins is therefore 
important for the development of appropriate medical treatment and 
control. On the other hand they could be exploited as medicines, if their 
activities are capable of being controlled and modified by protein 
engineering. Again, the same is obviously true for the human cytolysins, 
such as proteins of complement, lymphotoxins, perforin and tumor 
necrosis factors. Their study will lead to a better comprehension of the 
immunological system, and to their intelligent use in the prevention and 
treatment of pathological conditions. 
Besides the importance of learning about the structure, 
mechanisms of action and function of cytolysins, a number of potential 
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applications of these substances has recently become evident. In a 
previous section of this introduction, it was observed, for example, that 
some fungal cytolytic peptides are antibiotics. Aiso, some cytolysins 
from snake venoms selectively lyse neoplastic cells when compared to 
other types of cells, thus being potential anti-tumor agents (Braganca et 
ai, 1965; Dimari et ai, 1975). 
The diversity of cell lysis mechanisms mediated by 
cytolytic peptides and proteins makes them useful for the study of the 
ultrastructure of membranes and their role in cellular processes. As an 
example, Iwashita (1989) constructed a cholesterol-specific membrane 
probe deprived of cytolytic effect by chemical modification of a 
microbial cytolysin. 
A concrete application of cytolysins was obtained through 
the construction of an immunocytolysin against neoplasic cells (Avila et 
ai, 1987). This immunocytolysin was built by coupling the cytolysin 
from the sea anemone (Stoichactis helianthus) to an anti-cancer cell 
immunoglobulin. The construction of cytolytic immunotoxins allows the 
destruction of specific cells such as tumor cells or pathogenic 
organisms. 
The use of cytolytic peptides and proteins as biological 
tools is still in its infancy. New applications will certainly emerge with 
the development of research in this area. 
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As it has been shown in this introduction, peptides and 
proteins with cytolytic activity are present in a variety of living forms 
as evolutionary diverse as microorganisms and man, including bacteria, 
fungi, sea anemones, stinging insects and snakes for example. Other 
groups of plant peptide and protein cytolysins have not been so 
thoroughly investigated. Because of their medical, pharmacological, 
biochemical and biotechnological importance, new efforts for the 
research on cytolytic peptides and proteins, principally on the new 
groups (e.g. from higher plants) should be stimulated. 
The objectives of this present work were the determination, 
as far as possible, of the amino acid sequence of enterolobin; indication 
of the chemical nature of its binding site on the membrane; visualization 
of the pattern of the perforations on the membrane; and the 
demonstration of new biological properties towards other cells types 
and insect larvae. 
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2.1.1 Seeds 
The seeds of Enterolobium contortisiliquum (Veil.) 
Morong were collected from trees in Brasilia, Brazil. Prior to use, the 
seeds were kept in a cold room at 4 °C. Voucher specimens of parts of 
E. contortisiliquum trees are conserved at the herbarium of the 
University of Brasilia. Chick pea (Cicer arietinum) seeds were bought 
locally in Durham. 
Human erythrocytes of different blood group types were 
obtained from the Hemocenter of Brasilia (blood bank), Brasilia, Brazil. 
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These erythrocytes were provided in 50 mM EDTA in 150 mM NaCl 
solution and kept at 4 °C for up to one week. In Durham, red cells were 
collected from M.V. Sousa at the Student Health Centre and maintained 
under the same conditions of conservation as above. Before being used, 
the sample was washed four times in 150 mM NaCl solution. 
2.1.3 Cancer Ceils 
Cancer cells of strains L929 (murine fibroblast-like cell) 
and MRC5 (human lung fibroblast) were cell lines maintained at the 
Laboratory of Immunology of the Department of Biological Sciences, 
University of Durham. The culture medium for the cells was RPMX-
1640, plus penicillin and streptomycin at 50 U/ml and 50 ug/ml 
respectively, 50 mM glutamine and 10 % foetal calf serum. All of the 
above products were tissue culture grade, and purchased from Gibco. 
2.1A Insects 
Cultures of Callosobruchus maculatus, originally from 
Campinas, Brazil, were maintained and reared in an insectary at 27 °C 
and 70% rh. Cultures of Spodoptera littoralis were supplied by Rhone 
Poulenc, being maintained and reared at 24 °C with a controlled day 
length of 16 h. 
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£ 1.4 Enzymes and other Proteins 
Only the highest quality enzymes and proteins were utilized 
in this work. Trypsin (TPCK-treated), chymotrypsin and elastase were 
from Sigma; 5. aureus V-8 protease was from ICN ImmunoBiologicals; 
and pyroglutamate aminopeptidase, from Boehringer Mannhein. 
Ovalbumin and bovine y-casein were purchased from 
Sigma. TNF-a was obtained from NIBSC (National Institute of 
Biological Standard and Control). Ricin and BTCI (Black-eyed bean 
Trypsin and Chymotrypsin Inhibitor) were kindly provided in a pure 
state by Prof. L. Morhy from the Dept. of Cellular Biology of the 
University of Brasilia, Brazil. 
2.1.5 Reagents and Solvents 
The reagents and solvents used for protein sequencing were 
all of sequencing grade. DABITC was from either Sigma or Fluka. 
PITC, TFA and pyridine were supplied by Rathburn or Applied 
Biosystems. The acetonitrile used for HPLC peptide separations was of 
HPLC grade from Rathburn. The solvents n-heptane, n-hexane, butyl-
acetate and ethyl-actetae were products from BDH. Buffers and all other 
chemicals were of analytical grade from several suppliers. 
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The purification of enterolobin was performed according 
to Sousa and Horny (1989). Decorticated E. contortisiliquum seeds 
were ground in an electric mill and 80 g of seed flour was extracted 
with 640 ml of 150 mM NaCl solution for 1 h, under agitation and at 4 
°C. The extract was filtered through muslin and centrifuged at 16 300 x 
g, for 1 h, at 4 °C. The supernatant was then adjusted to 33 % saturation 
with ammonium sulphate . After 20 mini, it was centrifuged at 7 000 x 
g, for 30 min, at 4 °C. The sediment was resuspended in 27 ml of saline 
solution, dialysed against distilled water (4 x 10 1) for 24 h and, then, 
centrifuged in a bench centrifuge for 10 min at room temperature. The 
supernatant was freeze-dried and this fraction was called F-l. 
The following step was a DEAE-cellulose batch separation. 
In this adsorption process, 200 mg of fraction F-l was added to 220 ml 
of activated DEAE-cellulose resin suspended in 220 ml of 50 mM Tris-
HC1 pH 8.0 buffer. After 1 h of equilibration at room temperature with 
sporadic gentle agitation, the resin was filtered through filter paper 
under vacuum. The non-adsorbed material in the filtrate was 
concentrated by freeze-drying down to 20 % of its original volume, 
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dialysed against distilled water ( 3 x 5 1) for 24 h, at 4 °C and, finally, 
fully freeze-dried (fraction F-2). 
Subsequently, fraction F-2 was submitted to gel filtration 
on a column (1.9 x 40 cm) of Sephadex G-150 equilibrated in 50 mJVl 
tris-HCl pH 8.0. The sample was loaded as a solution of 30 mg in 2 ml 
of the equilibration buffer. The flow rate was kept at 15 ml/h. Fractions 
of 3 ml were collected and their absorbances, automatically read at 280 
nm. The material from the peak containing enterolobin was dialysed 
against distilled water (3 x 2.5 1) for 24 h at 4 °C and freeze-dried as 
fraction F-3. 
2.2.1.2 Fyrther Pypifieati@ni ®f Ent@r@I@bi§n 
In order to have a suitable purity for sequencing, 
enterolobin was further purified by anion-exchange chromatography on 
DEAE-Sepharose. The column of gel (2.5 x 15 cm) was equilibrated in 
50 mM tris-HCl pH 8.5. The sample (20 mg of fraction F-3) was 
dissolved in 3 ml of equilibration buffer and applied to the column, 
which was then washed with 100 ml of the buffer. A linear gradient of 
0 to 0.25 M NaCl in the equilibration buffer (400 ml total) was used for 
the elution step. The flow rate was 37.5 ml/h. Fractions of 2.5 ml were 
collected, and their absorbances read at 280 nm. The haemolytic 
activities present were determined according to the method described in 
the Section 2.2.1.3 below. The haemolytic fractions were pooled, 
dialysed and freeze-dried. This purest fraction (F-4) of enterolobin was 
used subsequently for the determination of the amino acid sequence. A 
fluxogram describing the method of purification of enterolobin is in 
Scheme 2. 
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Enterolobin (fraction F-4) was also submitted to reverse-
phase HPLC on a Vydac 218TP5405 C-18 column (4.6 x 250 mm, 5 urn 
o 
particle size, 300 A pore size) from Technicol fitted to a Varian model 
5000 HPLC chromatographer. One mg of enterolobin in 500 ul of 6 M 
guanidine-HCl in 0.1 % TFA was injected into the column, which was 
eluted with a linear gradient of 0 to 100% acetronitrile (in 0.1% TFA) 
in 60 min. The eluate was monitored at an absorbance of 214 nm. 
A test tube test was previously made, in which filtered 
aliquots of 100 ul enterolobin (1 mg/ml 0.1% TFA) were added to a 
range of different concentrations of acetonitrile (0 to 100% in 10% 
intervals) in 0.1% TFA. The appearance of the resulting mixture was 
observed to detect any sign of protein precipitation. 
2,2J .3 Haemolytie Act iv i ty Assay 
The determination of the haemolytic activity during the 
purification steps was carried out as previously described (Sousa and 
Morhy, 1989). Samples of 50 ul in 150 mM NaCl solution (saline) were 
two-fold serially diluted in saline on immunological microtitration U-
plates at room temperature. To each well, 50 ul of a 3 % (v/v) 
suspension of human red cells (washed four times in saline) were added. 
After 1 hour, the highest dilution showing haemolysis was recorded. 
The inverse of this dilution was called the haemolysis titre. 
3 1 
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(FPLQ) 
A Phannacia FPLC system fitted with an analytical Mono 
Q HR 5/5 column was used for evaluating the purity of enterolobin F-2 
and F-3 fractions. The equilibration buffer was 20 mM tris-HCl pH 8.7. 
The column was eluted with a gradient of NaCl (0-0.1 M for 18 min, 
and 0.1-0.35 M for 1 min) in the same equilibration buffer. The flow 
rate was set to 1.0 ml/min. The absorbance was read on line at 280 nm. 
2.2 .1LS fl9@®0®@Qiril© F@©tyisoDi)(6) 
A method of isoelectric focusing (Wrigley, 1976) was 
employed to assess the state of purity of the further purified enterolobin 
fraction (F-4). The gel was prepared by mixing 4 ml of 
acrylamide/bisacrylamide (30:0.8), 1 ml Ampholine (LKB) (40 %), pH 
6-8, 20 ml distilled water, 1 ml ammonium persulphate (1 %) and 15 ul 
TEMED. After the polymerization of the gel (15.0 x 15.0 x 0.2 cm), 
volumes of 5, 10 and 15 ul of enterolobin at 1 mg/ml in 10 % (w/v) 
sucrose were loaded into the wells. Hemoglobin was used as a marker of 
the focusing. The cathode solution was 0.4 % (v/v) triethylamine and 
the anodic solution, 0.2 % (v/v) sulphuric acid. The run was carried out 
at a voltage of 500 V for 3 h. The protein bands were then stained with 
0.5 % (w/v) Coomassie Blue R-250 in methanol/acetic acid/water 
(45:5:40), and destained with this same mixture without Coomassie. The 
documentation of the results was done by both photography and laser 
densitometry. The laser densitometry scanning was performed in a LKB 
Ultroscan XL according to the manufacturer's recommendations. 
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photography and laser densitometry. The laser densitometry scanning 
was performed in a LKB Ultroscan XL according to the manufacturer's 
recommendations. 
2.2,2.11 R@dy©US©in) smdl S-GariboxymethylatiooD 
The reduction and S-carboxymethylation of enterolobin 
(fraction F-4) was performed as described in Allen (1981). A sample of 
20 to 30 mg of protein was dissolved in 200-300 ul of 6 M guanidine-
HC1 in 0.6 M tris-HCl pH 8.6, followed by the addition of 30 ul of 
2-mercaptoethanol. The mixture was left under a stream of N2 for 2-3 
h, after which time, 300 ul of a freshly prepared solution of iodoacetic 
acid (0.286 g/ml in 1 M NaOH) was added. After 30 min of reaction in 
the dark at room temperature, the material was desalted in the dark by 
tangential dialysis against 10 1 of distilled water. The sample was then 
freeze-dried. 
The enzymatic and chemical methods used for the cleavage 
of enterolobin into smaller peptide fragments were largely as described 
in Croft (1980), Allen (1981) and Aitken et al (1988). 
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a) Trypsin (EC 3.4.21.4) 
Trypsin is a proteolytic enzyme specific for the hydrolysis 
of lysyl and arginyl peptide bonds, except for lys-pro and arg-pro 
bonds. Occasionally, some cleavages occur at the carboxyl side of 
hydrophobic residues, due to chymotrypsin or vj/-trypsin contamination 
(Allen, 1981; Aitken etal. 1988). 
The reduced and S-carboxymethylated protein (20 mg) was 
dissolved in 1 ml of 0.2 M N-ethylmorpholine-HCl pH 8.5 buffer.. 
Trypsin, dissolved in the NEM-buffer above, was added to yield a 2 % 
(w/w) enzyme/substrate ratio. After 3 h, at 37 °C, under agitation, the 
digest was submitted to gel filtration on Biogel P6 (Section 2.2.2.4 a). A 
small amount was used for peptide mapping by HPLC (Section 2.2.2.4 
b). 
b) Ghymotrypsin (EC 3.4.21.1) 
Chymotrypsin cleaves peptides bonds at the carboxyl side 
of tryptophan, tyrosine, phenylalanine, leucine and methionine residues. 
Occasionally, it cleaves at other sites. Cleavage does not occur where 
proline is following one of the above cited residues. The exact action of 
chymotrypsin is difficult to predict completely, and is partially 
dependent on the neighbouring residues (Allen, 1981). 
The conditions of digestion by chymotrypsin were as 
described for trypsin above. 
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cj Elastase (EC 3.4.23.36) 
Elastase, a serine protease, cleaves preferentially at small 
non-polar residues such as alanine and serine, but cleavages at glycine, 
valine and leucine have also been noticed (Aitken el al, 1988) 
The reduced and S-carboxymethylated enterolobin was 
dissolved in 750 ul of 0.1 M N H 4 H C O 3 pH 8.1 to give a concentration 
of 30 mg/ml. Elastase was added at a 2% (w/w) enzyme/substrate ratio. 
The hydrolysis reaction took place at 37 °C, for 3 h, under agitation. 
After that, the mixture was applied to a BioGel P6 chromatography. A 
small amount was used for peptide mapping by HPLC. 
d) Staphylococcus aureus V-8 protease (EC 3.4.21.19) 
The extracellular protease from S. aureus strain V-8 is 
specific for glutamyl peptide bonds, although it can cleave at aspartyl 
bonds under certain pH and buffer conditions (Aitken et ai, 1988). 
For cleavage extended to aspartic acid residues, V-8 
protease was added to RC-enterolobin (20 mg) in 1 ml of 0.1 M sodium 
phosphate buffer pH 7.8 containing 4 M urea to make 1% 
enzyme/substrate ratio. The reaction was allowed to occur for 48 h 
(with the addition of another same amount of enzyme after 24 h), at 37 
°C, and under constant agitation. A small part of the mixture was 
applied to HPLC for peptide mapping, and the rest, submitted to gel 
filtration on BioGel P6. 
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e) Cyanogen bromide 
Cyanogen bromide has been employed for many years for 
specific cleavage at the carboxyl side of methionine residues, albeit 
some other aspecific cleavages and side reactions can occur (Croft, 
1980; Allen, 1981; Aitken et al, 1988). Cleavages at tryptophanyl bonds 
have often been observed (Blumenthal et ai, 1975; Sanchez et al., 
1991). 
Twenty mg (5 mg when for direct HPLC separation) of the 
reduced and S-carboxymethylated enterolobin were dissolved in 1 ml 
70% (v/v) formic acid. A 500-fold molar excess of CNBr over 
methionine was added. The mixture was left standing for 36 h, at room 
temperature, in the dark, and under an atmosphere of nitrogen . Then, 
it was diluted in 15 ml of distilled water and freeze-dried twice and 
subjected to a gel-filtration on BioGel P 60 or reverse-phase HPLC 
chromatography. 
2,2e2.3 UnbSeeking treatments 
Two possible methods of unblocking obstructed N-terminal 
amino acids were attempted in order to remove the chemical blockage at 
the N-terminus of enterolobin. The first one was carried out with 
pyroglutamate aminopeptidase (EC 3.4.11.8) for the removal of 
pyrrolidone carboxylic acid (or simply pyroglutamic acid) residues 
from the N-terminal portion of proteins. The second one employed 
anhydrous TFA for unblocking proteins where the N-terminal residue 
has been acetylated. 
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a) Unblocking of pyroglutamyl N4erminal amino acid 
This method was adapted from the one described in Zalut et 
al. (1980). Pyroglutamate aminopeptidase (400 ug) was dissolved in 1 
ml of 0.1 M sodium phosphate pH 8.0 buffer, containing 10 mM EDTA 
and 0.7% (v/v) 2-mercaptoethanol. Half of the volume of the enzyme 
solution was added to 1 mg of enterolobin (fraction F-4) and the other 
half, to 3 mg of y-casein (control). The reactions took place under 
nitrogen, at 4 °C for 24 h and at room temperature for 7 h. Then, the 
mixtures were dialysed and manually sequenced as in Section 2.2.2.5. 
b) Unblocking of acetyl N-terminal amino acid 
This reaction was performed according to a slightly 
modified protocol of Wellner et. al (1990). Two mg of enterolobin 
were dissolved in 50 ul of TFA under nitrogen, and left reacting for 3 
min at 52 °C. The tube was then opened and dried for 5 min, at room 
temperature, under nitrogen, and for another 5 min at 52 °C. The tube 
was closed and left under nitrogen, for 40 h, at 52 °C. The protein was 
sequenced by the manual method (Section 2.2.2.5). 
2.2.2A Separation of peptides 
a) Gel filtration on BioGel 
For the separation of groups of peptides produced by 
enzymatic cleavages a long column (1 x 200 cm) of BioGel P 6 was 
utilized. The equilibration and elution buffer was 50 mM NH4HCO3 pH 
8.1. The flow rate was normally 10 ml/h, and the volume of each 
collected fraction was about 1.0 ml. The absorbances were read at 230 
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nm. The major peaks were lyophilised and stored for further separation 
by HPLC. 
The larger peptides obtained from the CNBr reaction were 
applied to a column (1.6 cm x 90 cm) of BioGel P 60 in 70 % formic 
acid. The flow rate was 2.2 ml/h and the volume of the fractions was 
1.1 ml. Alternatively, they were used directly for separation by HPLC. 
b) High Performance Liquid Chromatography (HPLC) 
HPLC was employed for peptide mapping and for the 
separation of peptides. A Varian model 5000 HPLC chromatography 
apparatus fitted with a reverse-phase C-18 Vydac 218TP5405 column 
(4.6 x 250 mm) from Technicol was used. Linear gradients of 
acetonitrile in 0.1 % TFA (v/v) were applied with slopes dependent on 
the complexity of the mixture of peptides. The samples were dissolved 
in 6 M guanidine-HCl in 0.1 % TFA for injection. The eluate was 
monitored at 214 nm. 
2.2.2.B Manual S@£gu@OT@iBig 
The DABITC/PrrC double-coupling method (Chang et al. 
1978; Chang, 1983) was routinely used for the sequence determination. 
The method was carried out as following: 
a) Coupling: 
The sample (at nmol level) was dissolved in 80 ul of 50 % 
aqueous pyridine solution (v/v) in a small pyrex tube (0.6 cm x 5 cm). 
After that, 40 ul (400 nmol) of DABITC (2.8 mg/ml in pyridine) was 
added. The mixture was purged with nitrogen, the tube was sealed, and 
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incubated at 52 °C for 50 min. After that, PFTC (10 ul) was added and 
nitrogen flushed into the tube again. The tube was closed and mixed 
thoroughly (vortexed). The mixture was incubated for a further 20 min 
at 52 °C. 
b) Washing: 
The mixture was washed with heptane:ethyl acetate (2:1) 
(v/v) three times by adding the solvent, vortexing, separating the phases 
by brief centrifugation and aspirating of f and discarding the upper 
(organic) phase. The lower (aqueous) phase was then dried exhaustively 
under vacuum. 
c) Cleavage: 
For peptides, 50 ul (100 ul for proteins) of anhydrous TFA 
was added to the tube which was flushed with N 2 and sealed. After 15 
min at 52 °C, the TFA was removed by vacuum drying. 
d) Extraction: 
n-Butyl acetate (200 ul) and water (50 ul) were added, the 
tube was vortexed and centrifuged briefly. The upper (organic) phase 
was aspirated into a conversion tube. The organic extract and the 
remaining aqueous phase were then dried under vacuum. The dried 
"aqueous phase" was submitted to a further cycle. 
e) Conversion: 
The DABTZ-amino acid dried down from the organic 
extract was converted to the DABTH-amino acid by the addition of 50 
ul of 50 % TFA to the conversion tube, which was sealed and incubated 
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at 80 °C for 10 min. After drying under vacuum, the DABTH-amino 
acid was ready for identification by TLC. 
e) Identification 
The identification of the DABTH-AA was performed by 
bidimensional TLC on 3 x 3 cm polyamide sheets. The sample and the 
marker (OABHC-reacted diethylamine) were spotted at the bottom left 
corner of the sheet about 4 mm diagonally from the edge. The sheet was 
then chromatographed in the first solvent [acetic acid/water (2:1, v/v)] 
in a small covered beaker. After drying in a stream of warm air for 10 
min, the sheet was then run in the second solvent [toluene/n-
hexane/acetic acid (2:1:1, v/v/v)] perpendicularly to the first run. After 
drying the sheets, they were exposed to fumes of concentrated HC1 
making the DABTH-derivatives to become visible as coloured spots 
(red, purple or blue). The identification of the DABTH-AA spots was 
made by comparing them with standards (Fig. 1). 
Ayt©mat@d Sequencing 
An Applied Biosystems 477A automated protein sequencer 
coupled to a 120A analyser on-line was used for automatic sequencing 
of enterolobin and peptides. The sample was dissolved in 50% (v/v) 
TFA and directly loaded onto a glass fiber polybrene-treated membrane 
disc or blotted onto a PVBF membrane. The membrane disc was then 
set into the reaction chamber, and the machine run according to the 
manufacturer's instructions. 
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Figure 1: TLC of standards of DABTH-amino acid derivatives. The standards were 
produced by submitting the respective amino acids to the DABITC/PITC 
double-coupling sequencing method. The first solvent was glacial acetic 
acid:water (1:2 v/v). The second solvent was toluene:n-hexane:glacial 
acetic acid (2:1:1 v/v/v). The DABTH-derivatives are represented by the 
single letter code for amino acids. Photograph reprinted with the kind 
permission of Dr. A. Yarwood, Department of Biological Sciences, 
University of Durham. 
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1.2=2o7 lM©im@!ra©[l^ tur@ ©f Peptides 
The nomenclature of the peptides reflects both the method 
by which they were generated (first letter) and their order of elution 
during gel filtration (first number) and HPLC (second number). For 
peptides generated by CNBr digestions, only one number is used -
numbers 1 to 4 for peaks obtained from gel filtration, and numbers 5 to 
22 for peaks from HPLC separations. 
Sequences obtained by overlapping of peptides are 
represented by the letters Ov followed by a number, as Ov-1, Ov-2, etc. 
The number refers exclusively to the chronological order in which the 
overlaps were found, having nothing to do with their position in the 
sequence of the protein. 
Enzymes: Trypsin 
Chymotrypsin 
Elastase 
T 
C 
E 
Staphylococcus aureus 
V-8 strain protease - V 
Chemical: Cyanogen Bromide CN 
For example, E-1.9 was a peptide obtained from the 
elastase digestion which appeared in peak 1 of the gel filtration and was 
eluted as peak 9 during HPLC. 
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For the CNBr digests, CN-1 to CN-11 are the peaks in the 
chromatogram originating from the gel filtration separation. The CNBr 
fragments separated by HPLC were called CN.H peptides. Thus the 
first peak was CN.H-1, the second, CN.H-2, and so on. 
2.2.3 Computational Searches and 
Analyses of Peptide Sequences 
2.2.3.1 Search @f Maf@hing S©qju©ne@s 
The sequenced regions of enterolobin obtained by the 
overlapped peptides (Ov) were searched for matches against the amino 
acid sequences of proteins deposited in the database PER (Protein 
Identification Resource) databank release 26.0 (NBRF, National 
Biomedical Research Foundation, Washington, USA) by using the 
program FASTA version 1.4x (Pearson and Lipman, 1988). The 
program was run on an Apple Macintosh SE/30 microcomputer. 
The program FASTA is a improved version of the 
program FASTP (Lipman and Pearson, 1985). FASTA is faster and 
more sensitive than its predecessor in making sequence searches through 
large databanks. 
The search algorithm uses four steps for the determination 
of a score for pair-wise similarity between sequences. In the first step 
all identities or groups of identities between two DNA or protein 
sequences are located. Then, the ten best matched regions are used in the 
second step, which consists of rescoring these ten regions by means of a 
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previously determined scoring matrix as PAM250 (Dayhoff et al, 
1978) that allows for contributions such as conservative replacements. 
For each of these regions, a subregion with maximal score - initial 
region - is selected. The third step is the checking to see i f several initial 
regions may be joined together, and the optimal alignment of initial 
regions as a combination of compatible regions with maximal score. 
The resulting score is used by the program to rank the library of 
sequences. In the last step, a final comparison considers all possible 
alignments of the query and library sequence that fall within a band 
centred around the highest scoring initial region. The result of this 
alignment is reported as the optimized score. 
Other programs from the FASTA package were used. 
FINDP was used for finding sequences by key words in the PIR bank, 
and EXTRACT? was employed for downloading the sequences to the 
computer memory as readable files. 
2.2.3.2 PatteDTffl Seereh 
Additionally, the overlapped peptides of enterolobin were 
searched against PROSITE version 6.10, February 1991, a database of 
known motifs or patterns identified in protein sequences (Bairoch, 
1990) . The program used for the search was MACPATTERN (Fuchs, 
1991) written for running on Apple Macintosh microcomputers. The 
hardware used was an Apple Macintosh SE/30. 
The algorithm utilized by the program for detecting 
patterns is based on the set-membership matrix concept (Cockwell and 
Giles, 1989), adopted for the pattern definition syntax of PROSITE. 
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Initially an index file must be created from the database to allow that the 
search be done faster. Then, after reading the index file, the program 
compares the query sequence to the patterns described in the database 
aiming to find any possible pattern in the sequence. The results are 
displayed in a separate window showing the patterns to which the 
sequence is related. 
2.2.3.3 AlifpGUiifitnift ©If Sequences 
The alignment of the amino acid sequences of the 
aerolysins was performed by using the program CLUSTAL (Higgins 
and Sharp, 1989) running on a Apple Macintosh SE/30 microcomputer. 
Then, the peptides of enterolobin were manually aligned to the 
aerolysins sequences. 
Firstly, the program calculates a matrix of similarity scores 
between all pairs of sequence to be aligned by the fast but approximate 
two-sequence alignment method of Wilbur and Lipman (1983). By 
using this matrix, it produces a hypothetical phylogenetic tree from the 
sequences by the UPGMA method (Sneath and Sokal, 1973). Then, the 
sequences are optimally aligned in groups corresponding to the 
branching order of the tree. The optimal alignments are carried out 
using the method of Myers and Miller (1988). The use of Myers and 
Miller's method made it possible to run a multiple alignment program, 
as CLUSTAL, on a microcomputer. With this method, the memory 
usage is a linear function of the length of the sequence, thus allowing it 
to be used in microcomputers, where there are limitations of memory 
space. The percentage of similarity between the aligned sequences was 
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calculated by the program ALIGN from the FASTA package. This 
program also uses the algorithm described in Myers and Miller (1988). 
The programs PLOT.A/HYD5, PLOT.A/H3 and 
PLOT.A/HYD from the compiled version of the MACPROT package 
(Markiewicz, 1990) were used for the analyses of the hydropathies of 
the amino acid sequences of aerolysins and the predicted cytolytic sites. 
This program calculates and plots the hydropathy profile of a sequence 
on the basis of given published hydropathy scales. An Apple Macintosh 
SE/30 was utilized for running the program. 
The first scale used was a "consensus" scale (Eisenberg et 
al., 1984) based on: (a) a theoretical scale to describe the energetic 
effects of the transfer of amino acids side chains to a hydrophobic from 
a hydrophilic phase; (b) the fraction of each type of residue that is 
found buried in globular proteins; (c) the distribution of residues 
between the interior and the exterior in the protein; (d) the free transfer 
energy from the aqueous phase to vapour. This consensus scale is 
normalized to the mean of 0.0 for 20 amino acids going from -2.53 
(most hydrophilic) to 1.38 (most hydrophobic). 
The other scale was that of Argos et al. (1982). This scale 
was the resultant from several sets of characteristics of amino acids as 
well as the previous scale: (a) the distribution of residues between the 
interior and exterior in the protein; (b) the estimated standard free 
energies of transfer for a residue in a helix in water to a helix in the 
non-aqueous phase; (c) the conformational propensity parameters for 
residues for the reverse turn configuration; (d) the bulkiness of 
residues; (e) the polarity of residues. The authors list the values 
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normalized to a mean of 0.0 for the above properties and use the added 
values in their analysis. For the current program, the scale goes from -
4.92 (most hydrophilic) to 4.1 (most hydrophobic). 
2.2A Kinetics of haemolysis 
A continuous haemolytic assay was developed for the 
analysis of the kinetics of lysis of human red blood cell by enterolobin 
(fraction F-3). 
A Berkm-Elms" model 554 <knMs&&m spectrophotometer was 
employed in this method. The wavelength was set to 680 nm, the slit 
aperture was 2.0 and the recorder speed, 0.5 cm/min. A l l the 
experiments were performed at room temperature. 
Four times washed RBC were daily prepared in 150 mM 
NaCl in 10 mM tris-HCl pH 7.4 (tris-buffered saline) to give a % T 
around 10.0. From this suspension, a haemolysed preparation (100% T) 
was made by lysing the red cells with water. Two 1 cm pathlength 
cuvettes were filled as follow. The control cuvette had 2.5 ml of the 
haemolysed RBC and 100 ul of the haemolytic sample (enterolobin 
fraction F-3 at 5 mg/ml). The control transmittance was then adjusted to 
100%, corresponding to 100% haemolysis. The sample cuvette took 2.5 
ml of RBC suspension and 100 ul of the enterolobin solution. This was 
quickly added and followed by rapid agitation with a Pasteur pipette to 
start the process. At this moment, the recorder was switched on. The 
transmittance was both automatically and manually (every 30 s) 
recorded. 
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Possible effectors such as Ca 2 + , EDTA, galactose, choline, 
phosphatidylcholine, cholesterol and ricin were tested. Prior to the 
kinetic assays, suspensions of red cells (3% v/v) were prepared in 150 
mM NaCl in 10 mM tris-HCl pH 7.4 containing the above effector 
substance (concentrations precisely specified in the legends of the 
figures in Section 3.7 of Results and Discussion). Enterolobin was also 
prepared in the same tris-buffered saline as the red cells, and kept in ice 
prior to use. 
Trypsinised RBC were also used. They were produced by 
treating a 3% (v/v) suspension of red cells with 250 ug of trypsin from 
bovine pancreas (type 3H, Sigma) in 2.5 ml of tris-buffered saline for 
30 min, at 37 °C, under gentle agitation. Then the suspension of red 
cells was washed five times with tris-buffered saline, and prepared as 
described in the above paragraphs. The cells were also, in an 
experiment, incubated in the presence of BTCI (1 mg), a trypsin and 
chymotrypsin inhibitor (Morhy and Ventura, 1987), to inhibit any 
remaining active trypsin after the trypsinisation. 
2.2.5 Microscopic Observations of Enterolobin-
and Gold-Enterolobin-treated Membranes 
2.2.S..1 Optical Microscopic Observation of 
Haemolysis by Enterolobin 
One drop of enterolobin (fraction F-3) at 1 mg/ml was 
mixed on a glass slide with one drop of 3% (v/v) suspension of 
erythrocytes, and immediately placed on the plate of a Nikon 
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microscope fitted with differential interference contrast filter 
(Nomarski optics). The haemolysis process was recorded on video-tape 
and photographed every 1 min until completion. 
© M 
Colloidal gold with average particle size of 12 ran (goldl2) 
was prepared by reduction of HAuCU with sodium ascorbate as 
described in Slot and Geuze (1984). Distilled water (5 ml), 1% HAuCU 
(1 ml) and Na2CO>3 pH 7.5 (1 ml) were put together at 0 °C. While 
mixing, 1 ml of 0.7% sodium ascorbate was added. A purple red colour 
formed in the solution. Then, the volume was adjusted to 100 ml with 
distilled water, heated to boiling, and left standing until cool. 
The lowest protein concentration required to stabilize the 
colloidal gold (maintenance of its red colour) was pre-determined in a 
microtitration assay by following the guidelines of Hodges et al. (1984). 
In an immunological microtitration plate, 50 ul of enterolobin (fraction 
F-3) at a initial concentration of 1.0 mg/ml was two-fold serially 
diluted. To each well, 50 ul of gold colloid was added and the plate 
agitated by tapping. After 15 min, 10 ul of 10% NaCl was added to 
make a final concentration of 0.9% NaCl. The plate was agitated and, 5 
min later, the stabilization point was read. This was the lowest 
enterolobin concentration in which the colour of the solution remained 
red. The controls were enterolobin plus gold plus water instead of NaCl 
solution (control 1) and water instead enterolobin plus gold plus NaCl 
solution (control 2). 
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The final protocol for gold labelling of enterolobin was 
then developed so that the final solution remained stable (red) at isotonic 
NaCl concentration, enterolobin kept its haemolytic acdvitity in a 
haemolytic concentration. In this way, 1 ml of colloidal gold was mixed 
with enterolobin F-3 (2.2 mg/ml in water), and 200 ul of 10% NaCl was 
added under agitation. The final mixture was gold-enterolobin (1.0 
mg/ml) in 0.9% NaCl in 450 nM Na 2 C0 3 pH 7.5. Gold-ovalbumin was 
also prepared in the same way to be used as a control. 
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A 1 ml sample of enterolobin (F-3) at 1 mg/ml was mixed 
with 1 ml of a 3% RBC suspension. At 2, 15 and 30 min of reaction, 
aliquots of 0.4 ml were removed. The control was RBC plus the same 
volume of saline. After the given times, the samples were washed 3 
times in saline, and fixed by 0.5 ml 1% glutaraldehyde for 30 min. 
They were then washed 3 times with water, centrifuged, resuspended in 
a small volume, and mounted on Formvar-coated 20© mesh copper EM 
grids. After 5 min, any excess liquid was removed by blotting with 
filter paper. When dry, the samples were examined in a Phillips 400 
electron microscope. Photomicrographs were taken using the automatic 
exposure setting. 
The reaction of haemolysis by gold-enterolobin and the 
sample preparations were also carried out as above. Gold-ovalbumin 
was used as a control. 
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£ £ 8 Cytotoxicity of Entemlobin to Cancer 
Cells 
The cytotoxicity effect of enterolobin was tested on the 
standard and commonly used L929 and MRC5 fibroblast-like cell lines 
following a slightly modified method of Matthews and Neale (1987) as 
below. 
Volumes of 100 ul of cell suspension (5 x 105 cells/ml of 
culture medium) were dispensed into the wells of a 96-well flat-bottom 
microtitration plate, leaving one row of eight wells without cells as a 
blank. A two-fold serial dilution of the protein sample was made in 
culture medium containing 2 ug/ml of actinomycin D, and 100 ul of 
each dilution was added in duplicate to the cells. Enterolobin fractions 
F-2 and F-3 were used at initial concentrations of 2 mg/ml and 500 
ug/ml respectively. TNF-a, Tumor Necrosis Factor-a (from NBBSC), at 
an initial concentration of 100 U/ml (1 U = quantity of TNF that causes 
50% death of L929 cells in standard assay), was the positive control. 
The negative control was tissue culture medium alone. 
Then, the microtitre plate was incubated at 37 °C in a 
gassed incubator (5% CO2 in air). After 3 days of incubation the assay 
was terminated by washing the plate with PBS, fixing for 15 min with 
formalin acetate fixative (90 ml 9% acetic acid, 8.2 g of 0.1 M sodium 
acetate, 100 ml 10% formalin and 1 1 of water), staining for 30 min 
with Amido Black stain (same solution as the fixative less formalin plus 
0.5 g of Amido Black) and drying it at 37 °C. After adding 100 ul of 
0.38% NaOH to each well, the litres of cytotoxicity (inverse of the 
highest dilution of protein causing death to the cells) were recorded, and 
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the absorbances were read at 620 nm in a microplate reader. These 
assays were made in duplicate. 
Videorecords and photographs of the effects of enterolobin 
and TNF-a on L929 cells were taken in a Nikon microscope using 
differential interference contrast (Nomarski optics). 
L929 cells (5 x 1Q5 cells/ml of culture medium) were 
incubated with TNF (100 U/ml) and enterolobin (500 ug/ml). At 0, 2 
and 24 h of incubation, shots were taken in order to document the 
cytotoxic effects of these two proteins on the cells. 
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The effects of enterolobin on the survival and development 
of insect larvae were assessed by feeding them with artificial diets in 
which the protein had been incorporated. The two species used were the 
bruchid Callosobmchus maculatus (Coleoptera) and cotton worm 
Spodoptera littoralis (Lepidoptera). 
The C. maculatus assays were performed using artificial 
seeds as in Gatehouse and Boulter (1983). The concentrations (% wt of 
sample/dry wt of diet) of enterolobin were 0.25%, 0.5%, 1.0%, 2.5%, 
5.0%, 7.5% and 10% for fraction F - l , and 0.01%, 0.025%, 0.05%, 
0.1%, 0.25% for fraction F-2. The control seeds contained no 
enterolobin . The required amount of enterolobin solution for a given 
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given concentrarion was added to 25 g of sieved chickpea meal followed 
by 24 ml of distilled water. The mixture suspension was homogenized 
and freeze-dried. 
When dry, a small amount of water was added to the 
mixture, and five artificial seeds prepared for each concentration of 
protein. The artificial seeds were then dried over silica gel and 
equilibrated for seven days at 27 QC, 70% rh. After that, they were 
individually covered with thin PVC plastic f i lm and left in a C. 
maculatus colony for oviposition for 24 h and placed in individual glass 
vials closed by a filter paper stopper. The numbers of emerged adult 
insects were recorded daily. Forty two days after initial oviposition, the 
assays were terminated and the numbers of surviving larvae and pupae 
inside each pellet were also recorded. 
For the S. littoralis trials, 300 ul of enterolobin solution 
were applied to a communion wafer to make a final concentration of 
5% (w/w) for fraction F-l and 0.1% (w/w) for fraction F-2. The wetted 
wafer was then offered to a third stage larva as the only food source. 
The wafer was replaced when totally consumed. Ten replicas (one 
larva/replica) were used for F- l and six for F-2. Controls consisted of 
wafers wetted by water with no protein. The number of surviving 
larvae was recorded daily. 
2.2.7.2 Assays of Enteroiobira Digestion in Vitro 
In vitro digestion assays of enterolobin by larval gut 
extracts were performed according to Gatehouse et al. (1990). The 
digestive tracts of late ins tar C. maculatus and third instar S. littoralis 
larvae were dissected at 0 °C in 1 mM DTT for C. maculatus (33 
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guts/100 ul), or water for 5. littoralis (4 guts/ml). The guts were 
homogenized, centrifuged, and held on ice until required. For the C. 
maculatus assays, 40 ul of the larval gut extract were added to 80 ul of 
enterolobie (2 mg/ml in Mclvane's 0.2 M citrate-phosphate buffer pH 
5.4) and 100 ul of the same buffer. For S. littoralis, the assay was 
carried out in the same way, but in 0.2 M glycine buffer pH 9.5. The 
mixtures were incubated at 33 2 C for time periods of 0, 1, 2, 4, 8, 24 
and 48 h. 
At the given time intervals, the reactions were stopped by 
the addition of an equal volume of SDS sample buffer [0.4 M tris-HCl 
pH 6.8, 4% (w/v) SDS, 20% (w/v) sucrose] and boiled for 2 min. The 
controls comprised enterolobin without gut extracts incubated at both 
pH values in the same conditions as above for 48 h. The samples were 
analysed by SDS-PAGE on mini-slab gels, pH 8.8, in the presence of 
1% (v/v) 2-mercaptoethanol, followed by staining with Coomassie Blue 
R-250 (Laemmli, 1970). The proteolytic activities of the gut extracts 
were ascertained by using myoglobin as substrate under the same assay 
conditions of reaction as above. 
2.2.7.3 Electron Microscopy Observation of 
Larval Guts 
The ultrastructure of C. maculatus larvae gut cells was 
examined by transmission electron microscopy to evaluate any damage 
that could have been caused by enterolobin. 
In a small volume beaker, 2 mg of enterolobin F-2 was 
mixed with 2 g of sieved chickpea meal to give 0.1% (w/w) protein. 
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The mixture was homogenized in 5 ml of water, freeze-dried, and left 
for 7 days for equilibration in an insectary at 27 °C, 70% r.h.. The 
control meal was devoid of enterolobin. The larvae were placed in 
contact with the meals for 6, 12, 24 and 48 h in the insectary. After 
each of these times, 6 larvae were removed and the insect digestive 
tracts were dissected into Karnovsky fixative (Karnovsky, 1965). The 
samples were fixed according to Karnovsky (Karnovsky, 1965) as 
follows. 
The fixative was composed of two solutions. Solution A is 
made of 2 g of paraformaldehyde in 40 ml of warm water plus 2-6 
drops of 1 N NaOH. Solution B was prepared with 10 ml of 25% 
gluteraldehyde and 50 ml of 0.2 M sodium cacodylate buffer pH 7.3. 
The solutions were kept separate and at 4 °C until just before use, when 
they are mixed well. The specimen was fixed in Karnovsky fixative for 
1-1.5 h at 4 °C, and post-fixed in 1% buffered osmium tetroxide (2% 
osmium tetroxide mixed with an equal volume of 0.2 M sodium 
cacodylate pH 7.3). The sample was then dehydrated by three changes of 
5 min in 70% and 95% ethanol and three of 10 min in 100% ethanol; 
infiltrated with three changes of 10 min in an intermediate solution of 
100% ethanol/propylene oxide (1:1) and in propylene oxide only; 
infiltrated at 45 °C with propylene oxide/araldite (1:1) for 30 min and 
pure araldite for another 30 min. The sample was orientated and 
embedded in a suitable mould, covered with araldite and left 
polymerizing for 12 h at 45 °C and 24 h at 60 °C. Afterwards, the 
specimen was sectioned using an ultramicrotome, mounted on copper 
grids covered by Formvar film, and stained with lead citrate and uranyl 
acetate. A Philips 400 electron microscope was used for the examination 
of the samples. 
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Enterolobin was purified by performing a slightly modified 
method based on Sousa and Morhy (1989). The method involved 
extraction in 0.15 M NaCl, fractionation with ammonium sulphate 
between 0 to 33% saturation, batch separation by adsorption on OEAE-
celullose and gel filtration chromatography on a column of Sephadex G-
150 (Fig. 2). The haemolytic activity was found in the larger peak of 
the chromatogram. 
The pooled and freeze-dried material from this peak 
normally yielded a product after Sephadex gel filtration (fraction F-3) 
which was homogeneous (i.e., single band) when examined by gel 
electrophoresis under both non-denaturing and denaturing conditions, 
and stained by either Coomassie Blue or silver nitrate (Sousa, 1988; 
Sousa and Morhy, 1989). 
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Figure 2: Gel filtration of enterolobin F-2 on Sephadex G-150. The column of 
Sephadex (1.9 x 40 cm) was equilibrated and eluted with 50 mM Tris-
HC1 pH 8.0. The sample was 30 mg of enterolobin (fraction F-2) 
dissolved in 1.5 ml of the same Tris-HCl buffer. The flow rate was 15 
ml/h, and the volume of each fraction was 3 ml. ( ) refers to A28O, 
and the peak with haemolvtic activity is indicated in the figure with its titre 
of haemolysis. The peak with activity was collected and freeze-dried as 
enterolobin fraction F-3. 
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However, on some occasions, when the fraction F-3 was 
analysed by FPLC on a MonoQ column, it was found to contain some 
minor contaminants (Fig. 3). One should observe that the level of 
contamination was already extremely low in comparison with the peak 
carrying the haemolytic activity. The automatic integration of the peak 
carried out by the FPLC chromatographer computer demonstrated that 
the haemolytic peak was responsible for 91% of the total area. 
Due to the very low level of the impurities, their detection 
by the sequencing methods used would be negligible and would not 
interfere with the correct interpretation of the results. A blind test 
performed concomitantly with several protein sequencing laboratories 
came to demonstrate that, on average, a 20% molar contamination in a 
sample represents no problem for making accurate assignments of the 
residues (Speicher et al., 1990). 
Nevertheless, since the aim was to obtain enterolobin as 
pure as possible for the work of determination of the sequence of 
enterolobin, and in order to avoid any doubt during the interpretation 
of the results, the protein was submitted to an additional step of 
purification. It consisted of a further anion-exchange chromatography 
on a DEAE-Sepharose column (Fig. 4). The peak containing the 
haemolytic activity was the larger one, and was eluted between 0.06 M 
and 0.09 M NaCl. 
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Figure 3: FPLC chromatography of enterolobin F-3. An aliquot (25 ul) from the 
pooled sample from the gel filtration chromatography was applied to a 
Mono Q HR 5/5 column equilibrated with 20 mM tris-HCl pH 8.7, and 
eluted with a gradient of NaCl ((H). 1 M in 18 min and 0.1-0,35 in 1 rain). 
The flow rate was 1.0 ml/min, and the absorbance was recorded 
continuously at 280 ran at AUS 0.05. 
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Figure 4? DEAE-Sepharose chromatography of enterolobin F-3. The pooled sample 
(20 mg dissolved in 3 ml of equilibration buffer) from the gel filtration 
chromatography was applied to a column (2.5 x 15 cm) equilibrated with 
50 mM tris-HCl pH 8.5, and eluted with a linear gradient (—) of NaCl 
(0-0.25 M) at a flow rate of 37.5 ml/h. The absorbance ( ) of the 
fractions was read at 280 nm. The haemolytic activity ( -o - -a - ) was 
determined in a microtitration plate assay. The active peak was pooled and 
freeze-dried as enterolobin fraction F-4. 
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A sample from the pooled and freeze-dried haemolytic 
peak (no.l) from the DEAE-Sepharose chromatography was subjected 
to isoelectric focusing in a narrow range of pHs (6 to 8) (Fig. 5). 
Enterolobin has a pl=7.0 (Sousa and Morhy, 1989), and this 
characteristic was once more confirmed here. Only a single strong band 
was detected on the gel after staining with Coomassie Blue. The 
resulting stained gel was then scanned by a LKB laser densitometer 
(Fig. 6) in order to provide further evidence for the homogeneous state 
of enterolobin. This pure condition was thoroughly confirmed by the 
laser scanning, as long as just a single peak was detected by this rigorous 
analytical method. Enterolobin was then proved to be in a highly pure 
state suitable for initiating the sequencing work. 
An attempt was made to use reverse-phase HPLC (Vydac 
C-18 column eluted with a gradient of 0 to 100% acetronitrile in 0.1% 
TFA) for the purification of enterolobin. However, no peaks were 
eluted from the column even at the higher acetonitrile concentrations. In 
fact, it was later shown in a quick test tube experiment, in which 
aliquots of enterolobin (in aqueous solution) were added to a range of 
increasing concentrations of acetonitrile (0 to 100% in 10% intervals) 
in 0.1% TFA, that enterolobin precipitates at acetonitrile concentrations 
as low as 20%. 
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Figure 5: Isoelectric focusing of enterolobin F-4. The gel was a 7.5% acrylamide 
gel with a pH gradient from 6.0 to 8.0. Volumes of 5 (lane a), 10 (lane b) 
and 15 ul (lane c) of enterolobin F-4 (from the DEAE-Sepharose 
chromatography) at 1 mg/ml in 10 % sucrose were applied. Hemoglobin 
was used as marker of the focusing. The cathode solution was 0.4 % 
triethylamine and the anodic solution, 0.2 % sulphuric acid. The run was 
carried out at a voltage of 500 V for 3 h. The gel was stained with 
Coomassie Blue R-250, and was scanned by a LKB laser scanner.. 
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Figure 6: Densitometric scanning profile of isoelectric focusing gel of enterolobin 
F-4. The gel was scanned by a LKB Ultroscan XL after being stained 
with Coomassie Blue R-250. The figure represent the densitometric 
profile of lane c (15 ug of enterolobin F-4) from the gel in Figure 5. The 
absorbance (—) was read at 633 nm. 
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It was not unexpected that enterolobin would interact 
strongly with the Vydac C-18 hydrophobic adsorbent. Enterolobin is a 
high molecular weight protein (55 KDa by SDS-PAGE) (Sousa and 
Morhy, 1989), and such firm interactions of proteins with hydrophobic 
coatings can commonly occur, especially when C-18 packings are used 
in the columns (Roe, 1989), and has actually been observed for large 
proteins on several occasions in the Laboratories of Protein Chemistry 
of the Universities of Durham and Brasilia. Also, enterolobin could 
have suffered denaturation and precipitation inside the column when the 
concentration of acetonitrile reached 20% during the application of the 
eluting gradient. 
The amino acid composition (Table 4) of enterolobin 
(Sousa and Morhy, 1989) shows that there is a higher percentage of 
hydrophilic amino acid residues than hydrophobic ones. Besides, 
enterolobin has always been soluble in aqueous solutions. It suggests that 
enterolobin is a hydrophilic protein overall. Thus the precipitation 
caused by 20% acetonitrile is not surprising. 
3*2 Peptide Maps 
A series of preliminary experiments were carried out to 
determine which were the most suitable enzymatic and chemical 
methods for cleaving enterolobin to generate peptides applicable for 
amino acid sequencing. Small samples (1 mg) in the appropriate buffers 
were digested separately for the required times with 2% (w/w) of 
trypsin, chymotrypsin, V-8 protease (amount of protease doubled at 24 h 
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Table 4; 
Ammo AcM Composattomi off EmftefloroEoMim* 
Amnmo AcM Percentage (%) 
Ala 6.0 
Arg 4.3 
Asx 14.4 
Cys 1.2 
Glx 9.2 
Gly 6.3 
His 1.7 
He 3.2 
Leu 6.9 
Lys 6.9 
Met 0.9 
Phe 4.9 
Pro 3.4 
Ser 9.5 
Thr 8.9 
Tip 3.4 
Tyr 3.7 
Val 5.2 
* Sousa and Morhy (1989) 
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of digestion) and elastase. Enterolobin samples were also subjected to 
cleavages with a 500-fold excess of CNBr. The products of these 
cleavages were analysed by reverse-phase HPLC on an analytical C-18 
Vydac column with gradients from 0 to 70 % acetronitrile in 0.1 % 
UFA. The peptide maps obtained are shown in Figs. 7 to 11. 
The largest number of peaks (58 peaks) was produced by 
digestion with chymotrypsin (Fig. 7). This was expected since the amino 
acid composition analysis of enterolobin (Table 4) indicated that the 
molecule contains a elevated percentage of residues where chymotryptic 
cleavage can occur such as leucyl, tryptophanyl, tyrosyl and 
phenylalanyl Chymotrypsin is well known as a proteolytic enzyme that 
is specific for cleaving on the C-terminal side of hydrophobic residues, 
especially phenylalanine, tryptophan, tyrosine, and leucine in order of 
reducing susceptibility (Aitken et aL, 1989). 
Likewise, plausible figures for the number of peaks from 
the cleavages with elastase (49 peaks) (Fig. 8) and trypsin (34 peaks) 
(Fig. 9) were recorded. It is also in agreement with the amino acid 
composition of the cytolytic protein (Table 4) and the possible sites for 
cleavage by these enzymes. Hie amino acid analysis shows that there are 
a high percentage of residues that would be suitable sites for digestion 
with trypsin (mainly at Arg and Lys residues) and elastase (mainly at 
Ala and Ser residues) (Aitken et aL, 1989). 
Not such expected results were obtained with the V-8 
protease (Fig. 10). The enzyme, which is specific for glutamyl and 
aspartyl bonds (Aitken et a/, 1989), yielded only 9 peaks during the 
peptide mapping. This is not in accord with the amino acid composition 
(Table 4) which shows aspartic and glutamic acid residues at a high 
66 
Mareot© V. Seuao Roaiallfla and Doseuoaioira 
percentage in the protein. The availability of these residues was further 
confirmed by the amino acid sequence of the several peptides from 
enterolobin (Section 3.4). Consequently, a large number of peptides was 
to be expected from the incubation of enterolobin with the V-8 protease. 
However, there are reports in the literature stating that V-8 protease 
does not always attack all acidic residues even after prolonged 
incubation (Vandekerckhove and van Montagu, 1977), suggesting that 
the local amino acid environment may exert some influence on the 
efficiency of the hydrolytic reaction by V-8 protease. Additionally, the 
experience gathered at the Laboratories of Protein Chemistry of the 
University of Durham and the University of Brasilia reinforce these 
observations on the V-8 protease. 
From the chemical digestion with cyanogen bromide 
(CNBr), one should expect four peptides if the reaction had been 
completely specific for only the three Met residues found in the amino 
acid composition of enterolobin (Sousa and Morhy, 1989). However, the 
peptide map of the mixture of peptides obtained from the CNBr 
digestion of enterolobin showed at least 18 peaks in its profile (Fig. 11). 
It is known that CNBr can also cleave polypeptides at sites other than 
Met especially when large excesses of this reagent are used as was the 
case for the cleavage of enterolobin. These cleavages have been 
observed principally at Trp sites of some proteins (Blumenthal et al., 
1975; Sanchez et ai, 1991), and could have happened for enterolobin as 
well. Also the strongly acid conditions of the reaction can cause 
cleavages at Tyr and Trp residues occasionally (Aitken et aL, 1989). 
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Figure 7: HPLC peptide map of enterolobin digested by chymotrypsin. RC-
enterolobin F-4 was digested by chymotrypsin as described in Material 
and Methods. An aliquot of 500 ji l (dissolved in 6 M guanidine-HCl in 
0.1 % TFA) was injected to a reverse-phase C-18 Vydac column (4.6 x 
250 mm) equilibrated with 0.1 % TFA. A linear gradient from 0 to 40 % 
acetronitrile in 0.1 % TFA (v/v) for 100 min was used to elute the 
peptides.The flow rate was 1.0 ml/min. The eluate was monitored at 214 
run at AUS - 0.5. 
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Figure 8: HPLC peptide map of enterolobin digested by elastase. RC-enterolobin F-
4 was digested by elastase as described in Material and Methods. An 
aliquot of 500 ul (dissolved in 6 M guanidine-HCl in 0.1 % TFA) was 
injected to a reverse-phase C-18 Vydac column (4.6 x 250 mm) 
equilibrated with 0.1 % TFA. A linear gradient from 0 to 40 % 
acetronitrile in 0.1 % TFA (v/v) for 90 min was used to elute the peptides. 
The flow rate was 1.0 ml/min. The eluate was monitored at 214 ran at 
AUS = 0.5. 
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FSgMire 5>: HPLC peptide map of enterolobm digested by trypsin. RC-enterolobin F-
4 was digested by trypsin as described in Material and Methods. An 
aliquot of 500 fil (dissolved in 6 M guanidine-HCl in 0.1 % TFA) was 
injected to a reverse-phase C-18 Vydac column (4.6 x 250 mm) 
equilibrated with 0.1 % TFA. A linear gradient from 0 to 40 % 
acetronitrile in 0.1 % TFA (v/v) for 90 rain was used to elute the peptides. 
The flow rate was 1.0 ml/min. The eluate was monitored at 214 nm at 
AUS = 0.5. 
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Figure 1©: HPLC peptide map of enterolobin digested by S. aureus V-8 protease. 
RC-enterolobin F-4 was digested by V-8 5. aureus protease as described 
in Material and Methods. An aliquot of 500 p.1 (dissolved in 6 M 
guanidine-HCl in 0.1 % TFA) was injected to a reverse-phase C-18 
Vydac column (4.6 x 250 mm) equilibrated with 0.1 % TFA. A linear 
gradient from 0 to 40 % acetronitrile in 0.1 % TFA (v/v) for 90 min was 
used to elute the peptides. The flow rate was 1.0 ml/min. The eluate was 
monitored at 214 nm at AUS = 0.5. 
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Figure 11: HPLC peptide map of enterolobin digested by CNBr. RC-enterolobin F-
4 was digested by V-8 CNBr as described in Material and Methods. The 
sample (dissolved in 6 M guanidine-HCl in 0.1 % TFA) was injected to a 
reverse-phase C-18 Vydac column (4.6 x 250 mm) equilibrated with 0.1 
% TFA. A gradient from 0 to 50 % acetronitrile in 0.1 % TFA (v/v) for 
210 min and 50 to 100 % in 40 min was used to elute the peptides. The 
flow rate was 1.0 ml/min. The eluate was monitored at 214 nm at AUS = 
1.0. 
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The peptides obtained by the digestions of larger amounts 
of enterolobin (20-30 mg) with chymotrypsin, elastase, trypsin and S. 
aureus V-8 protease were initially fractionated by gel filtration on a 
column (1 x 200 cm) of Biogel P 6 (Figs. 12 to 15). Each of the 
fractions from the gel filtration was collected as indicated in the figures, 
freeze-dried, and then subjected to reverse-phase HPLC on a Vydac C18 
column (some typical chromatograms are shown in Figs 16 to 19). The 
main peaks from the HPLC chromatographies were manually collected, 
freeze-dried, and submitted to sequence determination by the double-
coupling BABITC-PITC manual method. The results of the manual 
sequencing are in Section 3.4.1. Some of these peptides were chosen for 
automatic sequence determination (Section 3.4.2). 
Peptides produced by the CNBr digestion method were 
applied to a column (1.6 x 90 cm) of BioGel P 60 (Fig. 20). The peaks 
were collected, freeze-dried and submitted to sequence determination by 
the DABITC/PITC manual method. Four initial larger peaks were 
detected. Most probably, they correspond to the four peptides that were 
expected to be generated by cleavages at the three methionine residues 
of enterolobin. Lower molecular weight peptides were also produced by 
the reaction with CNBr (peaks 5 to 11) as previewed by the peptide 
mapping. Seemingly, they were the result of non-especific peptide 
cleavages that can occur with CNBr.(Blumenthal etaL, 1975; Aitken et 
al., 1989; Sanchez etaL, 1991) 
Alternatively, the CNBr peptides were directly applied to 
the reverse phase HPLC column. The HPLC chromatographer was 
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programmed to provide a low slope acetonitrile gradient (0 to 50 % 
acetronitrile in 0.1 % TFA (v/v) for 200 min and 50 to 100 % in 85 
min) in order to allow an optimum separation of the fragments. The 
results of this chromatography are represented in Fig. 21. The peaks 
were carefully collected by hand, to avoid contamination from 
neighbouring peaks, and freeze-dried. Only well separated and defined 
peaks were selected to be sequenced automatically. 
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Figure 12: Gel filtration of the chymotryptic digest of enterolobin. RC-enterolobin 
F-4 was digested by chymotrypsin as described in Material and Methods. 
The digest was dissolved in 50 raM NH4HCO3 pH 8.1 and applied to a 
column (1 x 200 cm) of BioGel P 6 equilibrated with the same buffer. 
The absorbance (—) was read at 230 ran. The flow rate was 10 ml/h, 
and the volume of each fraction was 1.0 ml. The peaks were pooled as 
indicated in the figure by the bars and freeze-dried as peaks C-l to C-13.. 
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Figure 13: Gel filtration of the elastase digest of enterolobin. RC-enterolobin F-4 
was digested by elastase as described in Material and Methods. The 
digest was dissolved in 50 raM NH4HCO3 pH 8.1 and applied to a 
column (1 x 200 cm) of BioGel P 6 equilibrated with the same buffer. 
The absorbance (—) was read at 230 nm. The flow rate was 10 ml/h, 
and the volume of each fraction was 1.0 ml. The peaks were pooled as 
indicated in the figure by the bars and freeze-dried as E-l to E-7. 
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Figure 14: Gel filtration of the trypsin digest of enterolobin. RC-enterolobin F-4 
was digested by trypsin as described in Material and Methods. The digest 
was dissolved in 50 mM NH4HCO3 pH 8.1 and applied to a column (1 x 
200 cm) of BioGel P 6 equilibrated with the same buffer. The absorbance 
(:—) was read at 230 nm. The flow rate was 10 ml/h, and the volume of 
each fraction was 1.0 ml. The peaks were pooled as indicated in the 
figure by the bars and freeze-dried as T-l to T-8. 
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Figure 15: Gel filtration of the 5. aureus V-8 protease digest of enterolobin. RC-
enterolobin F-4 was digested by S. aureus V-8 protease as described in 
Material and Methods. The digest was dissolved in 50 raM NH4HCO3 
pH 8.1 and applied to a column (1 x 200 cm) equilibrated with the same 
buffer. The absorbance (—) was read at 230 nm. The flow rate was 10 
ml/h, and the volume of each fraction was 1.0 ml. The peaks were 
pooled as indicated in the figure by the bars and freeze-dried as V-l to V-
8. 
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Figure 16: HPLC separation of fraction 1 from the gel filtration of the chymotryptic 
digest. Fraction 1 from the gel filtration of the chymotryptic digest of 
RC-enterolobin was dissolved in 6 M guanidine-HCl in 0.1 % TFA, and 
injected to a reverse-phase C-18 Vydac column (4.6 x 250 mm) 
equilibrated with 0.1 % TFA. A linear gradient (dashed line) from 0 to 
50 % acetronitrile in 0.1 % TFA (v/v) for 150 min was used to elute the 
peptides.The flow rate was 10 ml/min. The eluate was monitored at 214 
nm at AUS = 1.0. The peaks were manually collected and freeze dried as 
C-l.X, where X is the order of elution of the relevant peak. 
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Figure 17: HPLC separation of fraction 1 from the gel filtration of the tryptic digest. 
Fraction 1 from the gel filtration of the tryptic digest of RC-enterolobin 
was dissolved in 6 M guanidine-HCl in 0.1 % TFA, and injected to a 
reverse-phase C-18 Vydac column (4.6 x 250 mm)) equilibrated with 0.1 
% TFA. A linear gradient (dashed line) from 0 to 50 % acetronitrile in 
0.1 % TFA (v/v) for 100 min was used to elute the peptides.The flow 
rate was 10 ml/min. The eluate was monitored at 214 nm at AUS = 1.0. 
The peaks were manually collected and freeze dried as T-l.X, where X is 
the order of elution of the relevant peak. 
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Figure 18: HPLC separation of fraction 1 from the gel filtration of the elastase 
digest. Fraction 1 from the gel filtration of the elastase digest of RC-
enterolobin was dissolved in 6 M guanidine-HCl in 0.1 % TFA, and 
injected to a reverse-phase C-18 Vydac column (4.6 x 250 mm) 
equilibrated with 0.1 % TFA. A linear gradient (dashed line) from 0 to 50 
% acetronitriie in 0.1 % TFA (v/v) for 100 min was used to elute the 
peptides.The flow rate was 10 rnl/min. The eluate was monitored at 214 
nra at AUS = 1.0. The peaks were manually collected and freeze dried as 
E-l.X, where X is the order of elution of the relevant peak. 
80 
(WareoH® V . Setsso EnfteirelQ&iirD 
ii 
50% AN ex 
10 mln 
Figure 19: HPLC separation of fraction 1 from the gel filtration of the V-8 S. aureus 
protease digest. Fraction 1 from the gel filtration of the V-8 S. aureus 
protease digest of RC-enterolobin was dissolved in 6 M guanichne-HQ 
in 0.1 % TFA, and injected to a reverse-phase C-18 Vydac column (4.6 x 
250 mm) equilibrated with 0.1 % TFA. A linear gradient (dashed line) 
from 0 to 50 % acetronitrile in 0.1 % TFA (v/v) for 100 min was used to 
elute the peptides.The flow rate was 10 ml/min. The eluate was 
monitored at 214 nm at AUS = 1.0. The peaks were manually collected 
and freeze dried as V-l.X, where X is the order of elution of the relevant 
peak. 
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Bgure 2®: Gel filtration of the CNBr digest of enterolobin. RC-enterolobin F-4 was 
digested by CNBr as described in Material and Methods. The digest was 
dissolved in 70 % formic acid and applied to a column (1.6 cm x 90 cm) 
of BioGel P 60 equilibrated with the same solution. The absorbance (—) 
was read at 230 ran. The flow rate was 2.2 ml/h, and the volume of each 
fraction was 1.1 ml. The peaks were pooled as indicated in the figure by 
the bars and freeze-dried as CN-1 to CN-11 
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Fngsnir© 21: HFLC separation of the CNBr digest The freeze-dried CNBr digest of 
RC-enterolobin F-4 was dissolved in 6 M guanidiae-HCl in 0.1 % TFA, 
and injected to a reverse-phase C-18 Vydac column (4.6 x 25© mm) 
equilibrated with 0.1 % TFA. A gradient from 0 to 50 % aceteonitrile in 
0.1 % TFA (v/V) for 210 min and 50 to 100 % in 40 min was used to 
elute the peptides.The flow rate was 1.0 ml/min. The eluate was 
monitored at 214 nm at AUS = 1.0. The peaks were manually collected 
and freeze dried as CN.H-1.X, where X is the order of elution of the 
relevant peak. 
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The amino acid sequences of peptides obtained by the 
enzymatic cleavage methods were determined by the manual 
DABITC/PITC double-coupling method. The results are shown in 
Tables 5 to 8. 
The amino acid residues are represented by the standard 
single letter code (see Abbreviations). Only the most prominent residue 
found in each sequencing cycle is shown. The minor contaminants which 
were occasionally detected are ignored, since the significant sequence 
can be inferred from the dominant residues. 
The peptides produced by the CNBr cleavage method and 
purified by gel filtration provided no useful sequence information and 
are not shown. Attempts to sequence them manually generated very 
weak spots on T L C or none at all. 
It is not possible to differentiate leucine (L) from isoleucine 
(I) by the manual DABITC/PITC sequencing method used. These 
residues are then represented as L / I (leucine or isoleucine). A X was 
used when no residue was identified, or when it was uncertain. The 
concentrations (v/v) of acetonitrile, in which the peptides were eluted 
during HPLC, are given in percentage (%). 
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Table Ss 
Amimo Acid Sequnemce off Clhymottirypliic PepMdes (C) 
P e p t i d e A c e t o n i t r i l e S e q u e n c e 
(%) 
C - l . 3 15 TDGRS 
C-1. 4 20 L/IVAGSD 
C-1. 5 20 TQRDTL/I 
C-l. 6 20 TQRDTL/IT 
C-1.10 22 EARDAGH 
C-l.11 23 ASNDAGPT 
C-1.12 24 AKEL/IGPG 
C-1.13 25 • WL/IVATG 
C-l.14 25 QFAWN 
C-1.16 26 RSFNHGEG 
C-1.17 27 SPNKL/IT 
C-l.18 27 L/IQFAWNSFGDPTVR 
C-1.19 28 TQNHSWGFA 
C-1.20 28 TQNHL/I 
C-1. 22 29 L/ISTN 
C-l.23 31 NPTDL/I 
C-l.25 31 GSPG 
C-1. 26 32 VPTG 
C-l.30 36 ADH 
C- 1.31 36 TSD 
C-2 . 2 20 ASDKNPDKDS 
C-2 .4 23 TNVQQVTYT 
C-2 . 8 25 ATDGFTDT 
C-2 . 9 28 L/IADTGTGV 
C-2.12 28 RAPP 
C-2.13 31 RSP 
C-2.14 31 L/IDNH 
C-2.16 31 RRSP 
C-2.17 32 RSP 
C-2.18 38 SPN 
C-3 .2 16 ASDKNPD 
C- 3 . 3 17 ASD 
C-3 . 4 18 AGG 
C- 3 . 5 19 YL/IQ 
C- 3 .7 19 TQRDTL/IT 
C-3 . 8 20 TQRDTL/IT 
C-3.11 21 TSTRV 
C-3.14 23 ATTG 
C-3.16 24 DSC 
C-3.17 24 DSC 
C-3.18 25 L/IKGE 
C-3 . 20 27 L/IGXV 
C- 3 . 21 27 L/IPV 
C- 3 . 22 28 RRSPNP 
C-3.23 30 TV L / I 
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C-3.24 31 L/IVNG 
C- 3.25 31 TL/IVDNEL/I 
C- 3.28 33 TL/IVDNEL/I 
C- 3 . 29 37 TL/IVDNEL/I 
C-4 . 3 18 KGDRGG 
C-4 . 4 18 SGGEWSPG 
C-4 . 5 19 RYL/IQEDVQV 
C-4.6 19 TGRDTVTG 
C-4.10 22 L/IRVQL/IGHG 
C-4 . 11 22 ATTGT 
C-4 . 12 24 L/IRVQL/IGHG 
C-4.14 25 ATTGTL/I 
C-4 . 20 30 WL/IL/IDFDN 
C-4.21 31 RL/IL/IDA 
C-4.21 32 RL/IAAPFDSC 
C-4 . 23 33 FYXPL/I 
C-5 . 1 11 KGDY 
C- 5 . 2 14 ETKEP 
C-5.3 15 SDHRV 
C- 5 . 6 16 TDRN 
C- 5 . 9 17 AKFEVXE 
C- 5.10 18 KPL/IYCAD 
C-5.13 19 TQRDTL/IT 
C-5 . 14 19 TQRDTL/IT 
C - 5 . 17 22 RTXQADN 
C- 5.18 23 FKXPTL/IVNA 
C-5.20 24 DVYTTNP 
C- 5.21 25 SVTTEP 
C- 5.22 26 KL/IYVPPRTTL/IV 
C- 5.24 28 TGP 
C- 5 . 27 33 FVTL/IL/IVDN 
C-6 .2 10 KVTNG 
C-6 . 3 13 TVTDGSL/IRT 
C-6 .4 14 L/IWPRQ 
C-6 . 5 15 SYDDDRL/I 
C-6 .6 15 TTHD 
C-6 .7 16 VEKQQV 
C-6 . 8 16 TERDH 
C-6 .9 17 QRSDHF 
C-6 .11 17 NATV 
C-6.12 18 KSGDNGQ 
C-6.15 19 TYAEVN 
C-6.18 22 NTGL/INSTHV 
C-6.19 22 QTG 
C-6.20 23 L/IVYP 
C-6.24 27 ACL/IHQY 
C-6 . 26 27 TFFTH 
C-6 .27 27 VKSD 
C-6 .28 27 TGL/IQ 
C-6 . 29 30 WPL/IKVDNNNVV 
C-6 . 30 32 TL/IVG 
C-6 . 32 33 FWPL/IKVDNNNW 
C-7 . 1 9 SGAL/I 
C-7 . 2 15 QVG 
C-7 . 3 15 QL/IAPG 
C-7 . 4 16 DYRTTQ 
C-7 . 8 19 NL/IGNNN 
C-7 . 9 19 KPVYVDAL/I 
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C-7.11 20 NFKYET 
C-7.12 21 DHFG 
C-7.15 24 KL/IVQ 
C-7.16 25 KPVYVDADAATVR 
C-7.18 28 K L / I L / I 
C-7.19 30 GFVQ 
C- 8 . 2 9 SGP 
c - a . 7 15 L / I L / I R P 
C- 8 . 8 15 L / I L / IRPGSVRWL/ I T 
C- 8 . 9 16 TQNHG 
C-8.10 17 DSR 
C-8.11 17 DAR 
C-8.12 19 WVEKHQV 
C - 8 . 15 26 AWG 
C-8.16 27 SDHFG 
C-9 . 5 15 NAGVSTVSRT 
C-9 . 6 16 SST 
C-9 .7 20 VGQGL/IVH 
C-9.10 27 SDHFG 
C-10 . 1 9 TVSG 
C- 10 . 2 17 NFKYET 
C- 10 . 3 17 GVTRY 
C-10 . 5 18 RNL/IGN 
C-10 . 6 18 RNGL/INNN 
C-10 .7 23 RL/IAAP 
C-10 . 9 25 TVRD 
C-10.10 26 TQNHF 
C-10.11 27 VKSDHRF 
C-10.12 31 SPN 
C- 11. 2 7 KSNY 
C- 11.3 9 AL/INR 
C-11.5 11 NHKY 
C-11 . 6 14 AKT 
C-11.7 16 KSS 
C- 11 . 9 18 RNL/IGNNN 
C-11.11 19 TVRR 
C-11.14 24 GAF 
C-13 . 3 17 SAR 
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Table <&% 
Aminno AcM Seqeennce of TryptSc PepftMes (T) 
P e p t i d e A c e t o n i t r i l e S e q u e n c e 
(%) 
T - l . 5 12 TQEPNT 
T-1. 8 16 L/ITA 
T -1. 9 17 SPN 
T-1.10 17 YL/IQ 
T-1.11 20 SFN 
T-1.12 21 HQYL/IQF 
T-1.13 22 ATT 
T-l. 1 4 22 DTL/ITNGXQT 
T-1.15 24 DTL/I 
T-1.16 25 VGDPT 
T -1. 17 25 DTL/I 
T-1.18 26 L/IPN 
T-1.19 26 L/IPN 
T-1.20 26 SPNPL/IGTD 
T- 1.21 26 SPNPL/IGT 
T-1.23 27 HQYL/IQ 
T-1. 24 27 DTL/ITNGAQ 
T-1.27 29 NNSDTL/I 
T-1.28 30 SDTL/IF 
T-1.35 34 SPNPL/IXT 
T-1.38 36 NPDKDSYDVYT 
T-1.40 37 NPD 
T-2 . 3 15 TQKPN 
T-2.16 27 L/IAAPFD 
T-2.18 30 WWWWS 
T-3 .2 13 CCY 
T - 3 . 4 17 TSTL/INAG 
T- 3 . 6 19 TST 
T- 3 .7 20 TSTL/INAG 
T-3 .8 20 TXCQTG 
T-4 .1 11 L / I T F T T 
T-4 . 3 16 L / I S Y 
T-4 . 4 17 VDNGCYL/I 
T-4 . 5 18 NL/IGNNNF 
T-4 .6 19 GDNNWA 
T-5.1 13 SDHFG 
T - 5 . 3 16 GDNGQ 
T - 5 . 4 16 L/IL/IDAH 
T - 5 . 6 17 GDNGQYL/ISAR 
T- 5 . 8 18 NL/IGNNNFC 
T-6 . 2 6 YETN 
T-6 . 3 7 YETN 
T-6 . 4 11 SDHFG 
T-6 . 5 11 SDHFG 
T-6 . 9 15 GL/INGQYL/ISAR 
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T-6.10 19 L/IDTMAGVLNR 
T-7.5 15 WL/IEG 
T-8.8 10 L/IYQH 
T-8.12 10 SGVQV 
T-8.13 14 HVAFS 
T-8.16 17 SSTCN 
T-8.17 2 0 F W 
T-8 . 18 21 SSTCN 
Table 7 
Amino Acid Sequence off Elastasle Peptides (E) 
P e p t i d e A c e t o n i t r i l e 
(%) 
Sequence 
E-1.2 17 DSDDTTNNNSDT 
E-1.4 18 SSPNPDD 
E-1.5 18 SSPNPDT 
E-1.9 20 WADSDDTTNNNSD 
E-1.11 23 SSNPDTASS 
E-1.14 36 SSNPD 
E-1.15 27 SSNPDKDGXDVY 
E-1.16 27 SSNPD 
E-2 .1 13 DADAEPSDT 
E-2 .2 14 SNDVGDXP 
E-2 .4 14 SGGETVN 
E-2.5 16 TL/IPPTTPTNV 
E-2 . 6 16 TL/IPPTTVT 
E-2 .7 17 STTWETR 
E-2 . 8 17 VGNPTT 
E-2 .9 17 TQRDTL/IT 
E-2.10 17 TQRDTL/IT 
E-2.11 18 YVDADAATVR 
E-2.12 18 TYNVDGVL/IYT 
E-2.13 19 TYNVDGV 
89 
ftflareat© V. Sous© Results and Diseussiess 
E-2.14 19 TYNVDGVL/IYT 
E-2.15 19 RYL/IQEDVQV 
E-2.17 20 QFSGGET 
E-2.18 21 EGKL/IEFG 
E-2.19 21 RYL/IQEDVQ 
E-2.20 22 TYNVDDTL/IYT 
E-2.21 22 VGNEL/IFVTSG 
E-2.22 22 QFSGGETVSP 
E-2.24 23 STTDTVDV 
E- 2 . 25 24 RL/IDVPFSY 
E-2 . 26 24 NCFG 
E-2.27 28 GVN 
E-2.28 28 APFDSCL/IF 
E-2.29 29 AAPFDSCL/I 
E-2.30 30 APFDSCL/I 
E-2 . 31 31 AAAPFDSC 
E-2 . 32 31 AAAPFDSC 
E-2 . 33 33 T W 
E- 3 .1 11 YTEAT 
E- 3 . 2 12 YTE 
E- 3 . 3 14 NYTQEPNT 
E-3 .4 15 YVD 
E- 3 . 8 16 QFSGG 
E-3.11 17 DL/INVP 
E-3.13 18 GVAT 
E-3.16 19 HDGPL/I 
E-3.17 19 HDGPL/I 
E- 3 . 21 22 FKGDNG 
E- 3 . 22 22 FKGDNG 
E- 3 . 23 22 GTTGDGYL/I 
E- 3 . 25 24 DWFNFKYETKQE 
E-3.26 25 GSDVP 
E-3.27 26 GVP 
E-3 . 28 29 L/IDT 
E-4.6 11 VL/IKR 
E-4 . 8 13 SPY 
E-4 . 9 14 QFYT 
E-4.11 16 SFQTR 
E-4.12 16 VSPYF 
E-4.13 17 YNET 
E-4.15 17 KL/IRRVGN 
E-4.16 18 VL/IGH 
E-4.17 18 KWSC 
E-4.18 18 RWVEKH 
E-4.19 19 RNL/IGNNNFC 
E-4.21 20 NYL/I 
E-4.22 20 NFCHRVT 
E-4.23 21 YQWGET 
E-4.26 23 RGXS 
E-4.29 24 L/IFGPY 
E-4 . 33 26 CL / I G 
E-4 . 36 28 GFL/IQ 
E-4 . 37 29 CL/IWR 
E - 5 . 1 10 HYR 
E- 5 . 2 11 HYR 
E-5 . 3 11 RNL/IGNNN 
E- 5 .7 16 YTVS 
E- 5 . 8 16 HFYT 
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E-5 .9 17 VSP 
E-5.11 17 YNL/IGR 
E-5.12 18 YWQTRNV 
E-5.13 18 RWVEKH 
E- 5.14 19 L/IRNGNV 
E-5.16 20 QYRGN 
E - 5 . 17 20 NYNHKL/IYN 
E-5.18 21 YQXG 
E- 5 . 20 21 YSQH 
E- 5 . 21 22 RNL/I 
E- 5 . 23 23 RNL/IGNNNF 
E-5.26 26 RWVEKH 
E-5.27 25 RCCY 
E-5.28 25 RCCY 
E- 5 . 28 25 NFR 
E-5 . 29 27 NFRR 
E-5 . 31 31 CL/IWR 
E-5 . 33 31 FYP 
E-6 .1 15 KWN 
E-6 .7 24 RSPN 
E-6 . 8 25 • DHFG' 
E-6.11 30 QNH 
E-7 . 4 17 RWT 
E-7.11 25 WRD 
E-7.12 25 WRD 
Table 8: 
Amino Acid Sequence of V=8 Protease Peptides 
P e p t i d e A c e t o n i t r i l e Sequence 
(%) 
V-1.2 28 NVRNFR 
V-1.3 28 NVRNFR 
V-1.5 35 VL/IL/IPVTDR 
V-1.6 36 V L / I L / I P V T 
V-1.7 37 V L / I L / I P V 
V-1.8 40 V L / I 
V-1.9 41 WG 
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V-1 , . 10 42 TVT 
V-2 , 2 16 TVTTAL/ID 
V-2 , . 6 16 YGTGER 
V-2 . 7 17 DL/ID 
V-2 . 8 18 V L / I T 
V-2 , . 9 19 ADTGTR 
V-2 , . 10 19 DVT 
V- 2 , . 11 20 TDT 
V-2 , . 13 21 TDT 
V-2 . 14 22 TDTG 
V-2 . 15 22 DVGY 
V-2 . 16 23 DVGY 
V-2 . 17 24 DYDPD 
V- 2 . 18 24 DTL/I 
V-2 . 19 24 DTL/I 
V-2 . 21 25 DTL/I 
V-2 . 24 28 TQVPG 
V- 3 . 2 15 DYTV 
V- 3 . 3 15 H L / I L / I R 
V- 3 . 5 16 GL/IPA 
3.4.2 Automatically Sequenced Peptides 
Some peptides of enterolobin obtained from the digestion 
with enzymes were chosen for automatic sequencing on an Applied 
Biosystems 477A sequencer on the basis of the following factors: 
a) Purity of the peptide, as determined by its peak 
shape and manually determined sequence. The shape of its peak obtained 
during the HPLC chromatography should preferentially be gaussian 
with no shoulders. Also the manually determined sequence of the 
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peptide should contain no contamination, i.e., single amino acid residues 
should be found especially during the initial cycles of reaction. 
b) Concentration of acetonitrile where the peptide 
was eluted. Assuming that larger peptides would have been eluted at 
higher concentrations of the eluent, peptides eluted at less than 20% 
would not be preferentially selected for automatic sequencing. However, 
peptides eluted at high acetonitrile concentrations were avoided. Less 
hydrophobic peptides were given preference for automatic sequencing, 
because they tend to be less susceptible to be washed out from the 
support at earlier cycles. 
c) Number of hydrophobic residues found in the 
manual sequence. For the same reason as above, very hydrophobic 
peptides were rejected for automatic sequence. 
d) Total number of residues manually sequenced. 
The larger the number of manually sequenced residues, the easier the 
comparative assessments of the automatically sequenced residue for the 
operator of the automatic sequencer. 
e) The presence of prolines. The knowledge of the 
position of proline residues manually sequenced facilitates the 
programming of suitable cycles to deal with these residues. Prolines 
give poorer rates of cleavage during the cleaving step. 
From the cleavage of enterolobin with CNBr, only well 
separated and defined peaks (by HPLC) were selected to be sequenced 
automatically. This way, peaks CN.H-1, 4, 10, 19 and 22 were 
submitted to automated sequencing, but only CN.H-10 produced some 
sequence. The other peaks failed to provide any sequence of amino 
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acids, probably due to chemical blockage at their N-terminus similar to 
the intact protein or derived from some secondary chemical 
modification on amino acid residues. 
Table 9 shows the sequence of the peptides that were 
successfully sequenced by the automatic method. 
Table 9 
Automatically Sequenced Peptides 
P e p t i d e A c e t o n i t r i l e S e q u e n c e 
( % ) 
C-1.19 28 TQNHSWIVAGSDEP 
E-1.9 20 WADSDDTTNNNSDTLF 
T-1.14 22 DTLTNGQGQYNDD 
CN.H-1 44 VALAGHPLAGASNRNDLRV 
3.4.3 Determination of the N-terminus 
Amino Acid 
The automatic sequence determination by an Applied 
Biosystems pulsed-liquid sequencer failed to reveal the N-terminal 
residue of enterolobin. Several cycles were run on the machine, but no 
detectable peak corresponding to an amino acid residue was obtained. 
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This result is in agreement with those from the manual sequence 
determination that did not reveal any N-terminal residue as well, even 
when amounts as large as 2 mg of pure enterolobin were used. 
Also after the two different unblocking treatments to 
remove the supposed blockage, the N-terminus could not be found. 
The first treatment employed pyroglutamate amino-
peptidase for the removal of N-terminal pyroglutamic acid residue 
(Zalut et al., 1980), but no free residue from enterolobin could be 
found in the manual sequencing after this treatment. The treatment 
worked well, however, for the control protein y-casein, which yielded a 
glutamic acid as its N-terminal residue as should be expected 
The second method used anhydrous TFA for unblocking 
proteins with acetylated N-terminal residues, especially acetylated 
serines and threonines (Wellner et. al, 1990). No strong residue could 
be identified by manual sequencing. Instead, some weak spots could be 
seen on the T L C sheets, probably arising from peptides produced by 
internal cleavages of enterolobin by the acid treatment. 
Sousa and Morhy (1989) had previously obtained an 
indication that the N-terminus could be a glutamine. That early 
interpretation was probably an error due to the presence of a minor 
contamination, since they used enterolobin fraction F-3 analysed for 
purity by electrophoresis only. It is known now that enterolobin F-3 
can sometimes contain some contamination, although at low 
concentrations (Section 3.1 above). 
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Twenty four overlaps (Ov-1 to Ov-24) from the 
enterolobin peptides could be assembled. Peptide Ov-24 resulted from 
the overlap of peptides Ov-4 and Ov-7. A total number of 271 residues 
were placed in overlaps. The sequenced peptides are indicated below the 
overlaps to which they contributed. The notation employed (see Section 
2.2.2.7) constitutes the letters Ov and a number from 1 to 24. 
The assembly of peptide Ov-1 was made only with the 
participation of tryptic and chymotryptic peptides. An unusual cleavage 
after a glutamine residue occurred for the tryptic peptide T - l . 16. 
Leucine could be attributed as the residue at the fourth position of the 
peptide, since a cleavage by chymotrypsin (C-l.14) occurred at the 
carboxyl side of it. So far, chymotrypsin never has been found to cut at 
isoleucyl sites. 
Ov-1 A C L H Q Y L Q F A W N S F G D P T V 
T-1-12 , 
T-1.16 
T-1.23 
C-1.14 
C-1.18 
C-6.24 
Peptide Ov-2 did not show any cleavage in unexpected 
places. However, there seems to be some microheterogeneity as shown 
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by the substitutions which occurred in E-1.15, from D K to S S and S to 
G. No tryptic peptide was found in Table 6 to fit after the second lysine 
residue in the sequence. 
Ov-2 A S D K N P D K D S Y D V Y T T N P 
T-1.35 
C-2.2 . 
C-3.2 
C-3.3^ 
C-5.20 
S S E-1.15 G —=—=—=—=• / 
E-1.18 
In peptide Ov-3, no uncommon cleavages happened. 
Similarly as in Qv-1, the first residue could be assigned as a leucyl 
based on the occurrence of a chymotryptic cleavage after it. As in Ov-2, 
there was no peptide among the tryptic ones in Table 6 that could be 
placed after the arginine residue in the second position of the peptide. 
Ov-3 L R Y L / 1 Q E D V Q V H 
C-4.5 
C-4.K 
E-2.15 
E-2.19 
Some unusual chymotryptic cleavages were found to be 
located after arginine residues in peptide Ov-4. This type of behaviour 
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Some unusual chymotryptic cleavages were found to be 
located after arginine residues in peptide Ov-4. This type of behaviour 
has not frequently been observed for chymotrypsin in the literature. 
Likewise, elastase cleaved after arginine in E-6.7, what is not common. 
Nevertheless, chymotrypsin and elastase are proteolytic enzymes with a 
broad specificity. 
Ov-4 R R S P N P L / I G T D 
T-1.9 
=7 
T-1.20 
T-1.21 
T-1.35 
C-1.17 
T 
C-2.13 
C-2.16 
— / 
C-2.18 
• =? 
C-3.22 ' / 
C-10.12 
/ 
E-6.7 
In Ov-5, peptide T-1.14 was sequenced both manually and 
automatically. There were two differences - G Q was found to be Q T 
in the manual sequencing. In T-1.23, two substitutions were also found. 
As the automated sequencing proved to give the same results as the 
manual one, the final assignment was based on the former method. 
Often, the last cycles in a manual sequencing are not fully reliable, so 
that the automatically assigned residues are given preference. 
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No special comments needs to be made for Ov-6 and Ov-7 
and Ov-8, apart from the microheterogeneity in Ov-7 (L/I changed to 
A) which occurred in peptides E-2.31 and E-2.32. 
Ov-5 T Q R D T L T N G Q G Q V Y N D D 
C-1.5 
C-1.6 
C-3.7 
C-3.8 
T-1.14 Q T 
T-1.23 A Q 
C-5.14 
E-2.9 
E-2.10 
Ov-6 R LVI Ul D A H 
T-5.4 
1 
r 
9 9 
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Ov-7 R L y i A A P F D S C L / I W R R S 
T-2.16 
"7 
C-3.6 
C-4.22 
C-10.7 
=7 
E-2.28 
E-2.29 
E-2.30 
E-2.31 
/ 
A E-2.32 
E-4-37 
Ov-8 Q R S D H F G 
T-9,4 , 
T-9.5 > 
C-6.9 
C-7.12 
C-8.16 
i / 
C-9.10 
C-9.11 
Peptide Ov-9 showed unusual hydrolysis by trypsin at a 
serine residue (T-5.3, T-5.4 and T-6.9). There was a replacement from 
D to L / I in T-6.9. A leucine residue could be identified because of a 
chymotryptic cleavage after it in C-13.3. 
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Ov-9 F K S G D N G Q Y L S A R 
T-5.3 
T-5^6 
L/l T-6.9 
C-6.12 
C-13.3 
E-3.22 
Again, nothing special can be mentioned about peptides Ov-
10, Ov-11, Ov-12 and Ov-13, which had cleavages in expected places 
and no microheterogenic substitutions. 
Ov-10 D Y R T T Q A D N 
_ C-5.17 
C-7.4 
Ov-11 F W P L / I K V D N N N V 
C-6.29 
C-6.32 ~ ~ T 
Ov-12 D W F N F K Y E T K Q E 
T-6.2 
T-6,3 N 
C-7.11 
y 
C-10.2 = = = 7 
V. Seuoo 
Ov-13 R N U I G . N W N F C 
T-4.5 
C-10.6 
C-11.9 
E-4.19 
E-5.3 
E-5.23 
A cleavage after arginine by chymotrypsin occurred for 
C-8.12 in peptide Ov-14 as seen in the examples above. Yet, a 
replacement of H by Q occurred in C-6.7. 
A chymotryptic cleavage (C-9.5) allowed the determination 
of a leucyl in peptide Qv-15. 
Ov-14 R W V E K H Q V 
c-6.7 Q 
-GAUL 
E-4.18 
E-5.13 
E-5.26 
=7 
=7 
Ov-15 T S T L N A G V S T V S R T 
T-3.4 
=7 
T-3.7 
C-9.5 
7 
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In Ov-16, particular observations must be made for the two 
cleavages by trypsin (T-1.27 and T-1.28) in different sites of asparagine 
residues. In this peptide, automatic sequencing confirmed the 
correctness of the manually determined residues. 
No specific commentary can be made for Ov-17, Ov-19, 
Ov-20 and Ov-21, but in Ov-189 there was a microheterogeneity (S to 
N) in peptide E-2.4. 
Ov-16 W A D S D D T T N N N S D T L F 
T-1.27 
= — = = ? 
T-1.28^ 
E-1.2 
E-1.9 
— « f 
E-1.S (automatic! 
Ov-17 K P V Y V D A D A A T V R 
C-7.9 
C-7.16 
=7 
E-2.11 
Ov-18 Q F S G G E T V S P 
7 
E-2.17 
1> 
_EA22_ 
7 
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Ov-19 N Y T Q E P N T 
T-1.5 
T-2.3 
— /• 
E-3.3 
Ov-20 L / I V A G S D V V 
C-1.4 
E-3.26 
Ov-21 R C C Y 
T-3-2, 
E-5.27^ 
E-5-g8 / 
Also in Ov-22, the automated sequence corroborated the 
manual sequence. Some minor substitutions occurred in some peptides. 
Only expected cleavages happened in Ov-22 and Ov-23. 
Ov-22 T Q N H S W I V A G S D E P 
C-1.14 
C - 1 . 1 9 G F 
C - 1 0 . 1 0 G 
E-3.26 
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Ov-23 K S N Y N H K I J Y N 
C-11.2 
E-5.17 
E-11.5 
Ov-24 was an overlap of two previously overlapped 
peptides, Ov-4 and Qv-7. This assembly was based on the overlap of the 
region R R S commonly occurred in both peptides, and also on sequence 
similarities to other two cytolysins as shown in Fig. 27 below. 
Ov-24 R L / I A A P F D S C U I W R R S P N P U I G T D 
Ov-4 
Q\fc7 
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When new sequence information derived from peptides and 
proteins becomes available, it is a general procedure to search a 
database in order to detect any relatedness with sequences previously 
determined. After this initial search is done, other analyses of the 
sequences, such as optimal alignment, pattern search and hydropathy 
profiling, can follow. 
Using this strategy, the Ov peptides from enterolobin were 
used for searching for matching sequences in the PER database by using 
the program FASTA running on an Apple Macintosh SE/30 desktop 
computer. 
Although peptide Ov- l was found to have higher 
similarities scores to some proteins (S-locus-specific glycoprotein S13 
precursor and glucose-transporter protein from yeast), it proved to 
have some correspondence to two functionally related proteins - the 
haemolytic/cytolytic proteins aerolysins from Aeromonas hydrophila 
and Aeromonas sobria. Both provided 45.5% similarity to Ov-l in 11 
amino acid overlaps: 
10 
AC LHQYLQ FAWNS FGD PTV Ov-l 
ILWVGANDYLAYGWNTEQDAKRVRD A. hydrophila aetolysin 
130 140 150 
10 
ACLHQYLQFAWNSFGDPTV Ov-l 
KPTSYLAHYLGYAWVGGNHSQYVGE A. sobria aerolysin 
140 150 160 
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The amino acid sequences of the aerolysins were found in 
the PIR database by the program FINDP, and downloaded as readable 
files by the program EXTRACTP (Figs. 22 and 24). Their amino acid 
composition and molecular weights were calculated from the sequences 
by the program AA.DATA (Figs. 23 and 25). The aerolysin from A. 
hydrophila is a large protein with a molecular weight of 52.5 KDa and 
463 amino acid residues. A. sobria possesses a slightly larger aerolysin 
of 53.2 KDa and 469 residues. 
The alignment of the amino acid sequences of the two 
aerolysins was performed by the program CLUSTAL, and is shown i f 
Fig. 26. They are highly homologous, which proteins what is not 
surprising, since they are from the same genus. The percentage of 
identity between them is 78% as calculated by the program ALIGN. 
Most of the non-identical residues are the result of conservative 
replacements. 
Besides these two haemolysin-producing Aeromonas, other 
species in the genus were found to have cytolytic activities produced by 
them. Aeromonas salmonicida, a nonmotile major pathogen of fish, 
contains a T-lysin with haemolytic acitvity (Titball and Munn, 1983) 
that is secreted as an inactive precursor which is activated by an 
autogenous caseinase (Titball et al. 1985). Also, another extracellular 
haemolytic toxin, salmolysin, has been purified from Aeromonas 
salmonicida (Nomura, et. al, 1988). Aeromonas veronii was found to 
be haemolytic as well. Neves et al. (1990) detected haemolytic activity 
in thirteen out of fourteen strains of A. veronii isolated from fresh and 
salt water in Rio de Janeiro, Brazil. 
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The aerolysin of A. hydrophila has been far more studied 
than those of A. sobria and other Aeromonas species. A hydrophila is 
a gram-negative aquatic and motile bacteria that has been recognized as 
a pathogen to humans and other animals, principally fish (Khardori and 
Fainstein, 1988). In humans, it is able to cause gastrointestinal 
infections, extraintestinal infections, meningitis, osteomyelitis, septic 
arthritis, endocarditis, peritonitis and eye, urinary and other infections 
(Khardori and Fainstein, 1988). A. hydrophila toxins have been 
reviewed elsewhere (Ljungh and Wadstrom, 1982, 1982-3). 
Bernheimer and Avigad (1974) carried out the partial 
purification and characterization of a haemolytic protein from the 
culture filtrates of A. hydrophila. which they named as aerolysin. The 
haemolysin was identified as having a molecular weight of 50-53 KDa 
by SDS-PAGE and gel filtration. Subsequently, Buckley et al. (1981) 
isolated a similar protein, which was also called aerolysin. This protein 
is secreted across the inner bacterial membrane as a preprotoxin that has 
its signal peptide removed cotranslationally (Howard and Buckley, 
1985a). Then it is secreted to be later activated by proteolytic removal 
of a peptide from the C-terminal region (Howard and Buckley, 1985b). 
The similarities between enterolobin and aero lysins are 
remarkable. They are all cytolytic proteins with close molecular weight. 
By gel filtration, enterolobin has a MW = 51 300 Da. By SDS-PAGE, it 
is a 55 000 Da. single chain polypeptide (Sousa and Morhy, 1989). The 
amino acid composition of enterolobin is also very close to those of 
aerolysins, revealing characteristic low level of Cys and high levels of 
Ser and Thr in relation to the average in other proteins. 
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A E P V Y P D Q L R L F S L G Q G V C G D K Y R P V N R E E A Q S V X S N I V G M M G Q W Q I S G L 
A N G W V I M G P G Y N G E I K P G T A S N T W C Y P T N P V T G E I P T L S A L D I P D G D E V D 
VQWRLVHDSANFIKPTSYLAHYLGYAWVGGNHSQYVGEDMDVTRDGDGWV 
I R G N N D G G C D G Y R C G D K T A I K V S N F A Y N L D P D S F K H G D V T Q S D R Q L V K T V 
V G W A V I ^ S D T P Q S G Y D V T L R Y D T A T I S M S K T N T Y G L S E K V T T K N K F K W P L V 
G E T Q L S I E I R A N Q S W A S Q N G G S T T T S L S Q S V R P T V P A R S K I P V K I E L Y K A 
D I S Y P Y E F K A D V S Y D L T L S G F L R W G G N A W Y T H P D N R P N W N H T F V I G P Y K D 
KASSIRYQWDKRYIPGEVKWWDWNOTIQQNGLSTMQNNLARVLRPVRAGI 
T G D F S A E S Q F A G N I E I G A P V P L A A D S K V R R A R S V D G A G Q G L R L E I P L D R E 
E L S G L G F N K S A S A 
Figure 22: Amino acid sequence of aerolysin from A. hydrophila. The amino acid 
sequence (463 residues) was derived from the nucleotide sequence of the 
gene (Howard et aly 1987). The precursor amino acid sequence was 
found in the PIR database by the program FINDP from the FASTA 
package, and extracted by the program E X T R A C T ? from the same 
package. Subsequently, it was edited with the program AA.DATA from 
the MA.CPROT package to have its signal peptide removed. 
Figure 23: Amino acid composition of aerolysin from A hydrophila. The 
composition was calculated from the amino acid sequence of aerolysin in 
figure 22 by the program AA.DATA from MACPROT. The resulting 
molecular weight of the protein was also determined by the program. 
A 30 
C 4 
D 33 
E 18 
F 11 
G 46 
H 6 
I 22 
K 23 
L 29 
M 5 
N 28 
P 25 
Q 20 
R 24 
S 37 
T 29 
V 34 
W 18 
Y 21 
X 0 
RESIDUE NUMBER % 
6.48 
0.86 
7.13 
3.89 
2.38 
9.94 
1.30 
4.75 
4.97 
6.26 
1.08 
6.05 
5.40 
4.32 
5.18 
7.99 
6.26 
7.34 
3.89 
4.54 
0.00 
MOL. WEIGHT: 52532.59 
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A E P I Y P D Q L R L F S L G E D V C G T D Y R P I N R E E A Q S V R N N I V A M M G Q W Q I S G L 
A N N W V I L G P G Y N G E I K P G K A S T T W C Y P T R P A T A E I P V L P A F N I P D G D A V D 
VQWRMVHDSANFIKPVSYLAHYLGYAWVGGDHSQFVGDDMDVIQEGDDWV 
L R G N D G G K C D G Y R C N E K S S I R V S N F A Y T L D P G S F S H G D V T Q S E R T L V H T V 
V G W A T N I S D T P Q S G Y D V T L N Y T T M S N W S K T N T Y G L S E K V S T K N K F K W P L V 
G E T E V S I E I A A N Q S W A S Q M G G A V T T A L S Q S V R P W P A R S R V P V K I E L Y K A 
N I S Y P Y E F K A D M S Y D L T F N G F L R W G G N A W H T H P E D R P T L S H T F A I G P F K D 
KASSIRYQWDKRYLPGEMKWWDWNWAIQQNGLATMQDSLARVLRPVRASI 
T G D F R A E S Q F A G N I E I G T P V P L G S D S K V R R T R S V D G A N T G L K L D I P L D A Q 
E L A E L G F E N V T L S V T P A R N 
Figure 24: Amino acid sequence of aerolysin from A. sobria. The amino acid 
sequence (469 residues) was derived from the nucleotide sequence of the 
gene (Husslein et at., 1988). The precursor amino acid sequence was 
found in the H R database by the program FINDP from the FASTA 
package, and extracted by the program E X T R A C T ? from the same 
package. Subsequently, it was edited with the program AA.DATA from 
the MACPROT package to have its signal peptide removed. 
RESIDUE NUMBER % 1 
A 35 7.46 
C 4 0.85 
D 31 6.61 
E 22 4.69 
F 15 3.20 
G 39 8.32 ! 
H 8 1.71 j 
I 23 4.90 
K 19 4.05 i 
L 30 6.40 
M 3 1.71 
N 27 5.76 
P 27 5.76 
Q 18 3.84 
R 25 5.33 
S 37 7.89 
T 31 6.61 
V 35 7.46 
w 17 3.62 
Y 18 3.84 
X 0 0.00 
MOL. WEIGHT: 53241.49 
—-— 
Figure 25: Amino acid composition of aerolysin from A. sobria. The composition 
was calculated from the amino acid sequence of aerolysin in figure 22 by 
the program AA.DATA from MACPROT. The resulting molecular 
weight of the protein was also determined by the program. 
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5 10 15 20 25 30 35 40 45 50 55 60 
A25976 hydroph AEPVYPDOLRLFSLGQGVCGDKYRPVNREEAQSVKSNIVGMMGOWOISGLAMGWVIMGPG 
S03098 sobr i a AEPIYPDOLRLFSLGEDVCGTDYRPINREEAQSVRNNIVAMMGOWOISGLANNWVILGPG 
120 
A2 597 6 hydroph YNGEIKPGTASNTWCYPTNPVTGEIPTLSALDIPDGDEVDVQWRLVHDSANFIKPTSYLA 
S03098 s o b r i a YNGEIKPGKASTTWCYPTRPATAEIPVLPA.FNIPDGDAVDVQWRMVHDSANFIKPVSYLA 
I S O 
A2 5976 hydroph HYLGYAWGGNHSOYVGEDMDVTRDGDGWVIRGNNDGGCDGYRCGDKTAIKVSNFAYNLD 
S03 098 s o b r i a HYLGYAWVGGDHSOFVGDDMDyiOEGDDWVLRGNDGGKCDGYRCNEKSSIRVSNFAYTLD 
240 
A2 597 6 hydroph PDSFKHGDVTOSDRQLVKTWGWAVNDSDTPOSGYDVTLRYDTATNWSKTNTYGLSEKVT 
S03 098 s o b r i a PGSFSHGDVTOSERTLVHTWGWATNISDTPQSGYDVTLNYTTMSNWSKTNTYGLSEKVS 
300 
A25976 hydroph TKNKFKWPLVGETOLSIEIRANOSWASONGGSTTTSLSOSVRPTVPARSKIPVKIELYKA 
S03 098 s o b r i a TKNKFKWPLVGETEVSIEIAANQSWASQNGGAVTTALSOSVRPVVPARSRVPVKIELYKA, 
360 
A2 5976 hydroph DISYPYEFKADVSYDLTLSGFLRWGGNAWYTHPDNRPNWNHTFVIGPYKDK.ASSIRYOWD 
503098 s o b r i a NISYPYEFKADMSYDLTFNGFLRWGGNAWHTHPEDRPTLSHTFAIGPFKDKASSIRYOWD 
420 
A25976 hydrcph KRYIPGEVKWWDWNWTIQQNGLSTMQNNLARVLRPVRAGITGDFSAESQFAGNIEIGAPV 
SO3098 s o b r i a KRYLPGEMKWWDWNWAIOONGLATMQDSLARVLRPVRASITGDFRAESQFAGNIEIGTPV 
» * * + * * * 4 - * * # * * * * 4 - * * + * * + - » - * * * 4 . + * * * * * * * * * * + * * * * * 4 - * * * * + * * * * » * * + - * 
A25976 hydroph PLAADSKVRRARSVDGAGOGLRLEIPLDREELSGLGFNK SASA 
S03098 s o b r i a PLGSDSKVRRTRSVDGANTGLKLDIPLDAQELAELGFENVTLSVTPARN 
Figure 26: Alignment of amino acid sequences of aerolysins from A. hydrophila and 
A sobria. The figure is an output of the program CLUSTAL which was 
utilized for performing the alignment. The default settings of a fixed gap 
of 10 and a variable gap of 10 were used. A25976 and S03098 are the 
reference number for the aerolysins sequences of A. hydrophila and A 
sobria, respectively, in the PIR database. A * means identical matches 
across the sequences, + represents conservative substitutions, and -, 
non-conservative substitutions. 
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A tentative manual alignment of some enterolobin peptides 
with the automatically aligned sequences of the aerolysins was made 
(Fig. 27). It showed that in some regions there are very promising 
similarities. One of such similar regions is the predicted cytolytic site. 
The prediction of this putative cytolytic site was performed by analysing 
the common characteristics in the hydropathatic profiles, charge density 
distribution and helix amphiphilicities of several cytolytic proteins and 
peptides of reptilian, amphibian, insect and microorganisms (Kini and 
Evans, 1989). 
From these results and considerations, it can be perhaps 
suggested that enterolobin and aerolysins could be homologous proteins, 
or, in other words, they could have evolved from a common ancestral 
gene. It is clear that they share a functional relationship and similarites 
in their amino acid sequences. However, local protein sequence 
similarity does not necessarily imply a structural relationship among 
proteins (Sternberg and Islam, 1990). For this reason, it is not possible 
to state that there is a tertiary structural relationship among these 
proteins, since no complete X-ray crystallography and/or NMR data are 
available for them yet. 
It is known that only some still preliminary spectroscopic 
and X-ray analyses have been done for A. hydrophila aerolysin (Green 
and Buckley, 1990). These data reveal an almost entire hydrophilic p 
structure with no obvious transmembrane helices. The structure seems 
to be analogous to those of the porins from which aerolysin may have 
evolved (Green and Buckley, 1990). Porins are bacterial and 
mitochondrial proteins (30-36 KDa) that form stable aggregates and 
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Figere 27: Possible manual alignment of the sequences of some enteiolobin peptides 
with the sequences of aerolysins. Sequenced and overlapped enterolobin 
peptides (ent) are in the first row of sequences with aerolysin from A. 
hydrophila (hydr) in the second row and aerolysin from A. sobria (sobr) 
in the third one. Leucine (L ) and isoleucine ( i ) in enterolobin are 
assumed to be equal to their correspondent matching i or L in the 
aerolysins, unless they are actually known. Black bold letters indicate 
identical residues, and grey letters are non-identical ones. The regions 
within the box are the cytolytic sites as tentatively predicted by Kini and 
Evans (1989). 
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transmembrane pores through the outer membranes of the bacteria and 
mitochondria to allow the transport of some solutes (Nikaido, 1982). 
Program FASTA also detected similarities between peptide 
Ov-1 and colicin lb, a channel-forming protein from E. coli, at 60% 
identity in 10 amino acid overlaps: 
1 0 
ACLHQYLQFAWNSFGD Ov-1 
IHICLEKYLFFKTIEEQL Colicin lb 
160 170 
Colicins are proteins of a large family of bactericidal pore-
forming proteins consisting of a single polypeptide of 50 000 to 80 000 
Da, which are encoded by genes present in Col plasmids. Each plasmid 
also carries information to provide the colicin-producing bacteria with 
resistance to its own colicin (Luria and Suit, 1982). These proteins have 
specific receptors in the outer membranes of bacteria and are believed 
to be regulators of the transport of molecules into the cell. For a review 
see Neville and Hudson (1986). 
In view of the encouraging results, another analytical 
approach, pattern search, was utilized. Patterns or motifs in proteins are 
distinguished from a set of aligned sequences with the use of pattern-
recognition matrices (discriminators), and are representations of a 
consensus stretch (Fuchs, 1990; Attwood et al, 1991). The use of this 
type of approach to detect unsuspected but meaningful relationship 
among sequences of proteins is becoming rapidly a obligatory step in 
the analysis of sequences. The sequences of the aerolysins, the Ov 
enterolobin peptides and the predicted cytolytic sites of the three 
cytoysins in study were searched by the program MACPATTERN (Fig. 
28) 
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Sequence f i l e : EHTEROLOBIN PREDICTED C Y T O L Y T I C 3 I T B 
P a t t e r n s e t : A l l e n t r i e s 
Sequence 1 (24 r e s i d u e s ) : 
Matching p a t t e r n C K 2 _ P H O S P H O _ S I T E : 
( 2) SGGE 
T o t a l matches: 1 
Matching p a t t e r n t o n S _ D E P E K D E M T _ R E C E P : 
( 1) FSGGETVSPYRLAAPFDSCLWRRS 
T o t a l matches: 1 
429 p a t t e r n s s e a r c h e d i n l sequences , 25 r e s i d u e s . 
2 h i t s i d e n t i f i e d . 
a 
Sequence f i l e : Aeromonaa hydrophila A E R O L Y S I N P R E D I C T E D 
C Y T O L Y T I C S I T E 
P a t t e r n s e t : A l l e n t r i e s 
Sequence 1 (24 r e s i d u e s ) : 
Matching p a t t e r n ConS_DEPEMDENT_RECEP: 
( 1) FAGNIEIGAPVPLAADSKWRARS 
T o t a l matches: 1 
429 p a t t e r n s s e a r c h e d i n 1 sequences , 24 r e s i d u e s . 
l h i t s i d e n t i f i e d . 
. b 
S e q u e n c e f i l e : Aeromonaa aobria A E R O L Y S I N P R E D I C T E D C Y T O L Y T I C 
S I T E 
P a t t e r n s e t : A l l e n t r i e s 
Sequence 1 (24 r e s i d u e s ) : 
Matching p a t t e r n tonf l_DEPENDENT_RECEP: 
( 1) FAGNIEIGTPVP LGSDS KVRRTRS 
T o t a l matches: 1 
429 p a t t e r n s s e a r c h e d i n 1 sequence, 24 r e s i d u e s . 
1 h i t s i d e n t i f i e d . 
C 
Figure 28 a,b,c: Pattern analyses of the predicted cytolytic sites from enterolobin 
and aerolysins. Enterolobin (a), aerolysin of A. hydrophyla (lb) and 
aerolysin of A. sobria (c). The description of the pattern rewb-dependent 
receptor is in (d) next page. The figures are outputs of the program 
MACPATTERN, which was used for carrying out the search of the 
sequences against the database PRO SITE. 
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PS00430; touB_DEPEEIDENT_RECEP} 
{BEGIN} ' 
*torib-dependent r e c e p t o r p r o t e i n s s i g n a t u r e * 
• A * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * 
I n E s c h e r i c h i a c o l i t h e tonB p r o t e i n i n t e r a c t s w i t h outer 
membrane r e c e p t o r p r o t e i n s t h a t c a r r y o u t h i g h - a f f i n i t y 
b i n d i n g and energy dependent uptake i n t o t h e p e r i p l a s m i c 
space of s p e c i f i c s u b s t r a t e s t h a t are p o o r l y permeable 
t h r o u g h t h e p o r i n channels or a r e encountered a t ve r y low 
c o n c e n t r a t i o n s . I n the absence of tonB these r e c e p t o r s b i n d 
t h e i r s u b s t r a t e s but do not c a r r y out a c t i v e t r a n s p o r t . The 
tonB p r o t e i n a l s o i n t e r a c t s w i t h some c o l i c i n s . The 
p r o t e i n s t h a t a r e c u r r e n t l y known t o i n t e r a c t w i t h tonB 
are: 
Gene F u n c t i o n or name. 
btuB..Receptor f o r cobalamin. 
fecA..Receptor f o r i r o n d i c i t r a t e . 
fepA..Receptor f o r f e r r i c e n t e r o c h e l i n . 
fhuA..Receptor f o r f e r r i c h r o m e - i r o n . 
fhuE..Receptor f o r f e r r i c coprogen, f e r r i o x a m i n e B, and 
r h o d o t r u l i c a c i d , 
iutA..Receptor f o r f e r r i c a e r o b a c t i n . 
cir... Receptor f o r c o l i c i n I (exact s u b s t r a t e not known). 
cba...Colicin B, a channel f o r m i n g c o l i c i n . 
cda...Colicin D. 
cma...Colicin M, i n h i b i t o r of murein b i o s y n t h e s i s . 
A l l these p r o t e i n s c o n t a i n s , a t t h e i r N-terminus, a s h o r t 
conserved r e g i o n , c a l l e d t he tonB-box, which i s i n v o l v e d i n 
the i n t e r a c t i o n of the p r o t e i n w i t h t he tonB p r o t e i n . 
-Consensus p a t t e r n : <x(10,60)-[DEF]-T-[LIVMFY]-[LIVST]-V-x-
[AGP] - [SANP] 
-Sequences known t o be l o n g t o t h i s c l a s s d e t e c t e d by t h e 
p a t t e r n : ALL, except c o l i c i n D which has His i n p o s i t i o n 1 
of t h e p a t t e r n . 
-Other sequence(s) d e t e c t e d i n SWISS-PROT: human alpha-2-
m a c r o g l o b u l i n , r a t a l p h a - 1 - i n h i b i t o r I I I , and bovine copper 
superoxide dismutase. 
-Last update: November 19 9 0 / F i r s t e n t r y . 
d 
Figura 28d: Continuation from previous page 
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Interestingly, all the three sequences were shown to have a 
common similarity to the tonB-dependent receptor pattern. The 
cytolytic site of enterolobin also has in addition a phophorylation site 
pattern. However, phosphorylation as well as glycosylation and 
acylation patterns are very commonly found in several proteins 
(Bairoch, 1990). The other Ov peptides proved to have only these 
common patterns (not shown). The two aerolysins also contain short 
sequences with these common patterns, besides naturally their own 
signature. This aerolysin pattern is also shared by the Pseudomonas 
aeruginosa cytotoxin (Bairoch, 1990). 
When the information in Fig 28d is analysed, one can find 
again the presence of colicins, thus strengthening the hypothesis of 
colicin as another pore-forming protein sharing some function and 
sequence relationship to aeroSysins and enterolobin. 
Several receptors for nutrients were also detected in the 
pattern, mainly ferric receptors from bacteria. These receptors need a 
product from the tonB gene to carry out their functions (Bell et al, 
1990). These fonB-dependent transport proteins from E. coli possess 
highly conserved short regions alternated by long variable sequences 
(Nau and Konisky, 1989). The E. coli gene of the tonB protein has been 
sequenced and encodes a 26.1-26.6 Kda hydrophilic protein that is likely 
to be embedded in the inner or outer membrane of E. coli (Postle and 
Good, 1983) 
Also present in the output in Fig. 28d is human a.2-
macroglobulin, which was identified in the SWISS-PROT database as 
belonging to the same pattern. a-Macroglobulins have been conserved 
during evolution, and have been purified from invertebrates, reptiles, 
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birds, and many mammalian organisms The family is composed of high 
molecular weight (subunits of 185 KDa) proteinases inhibitors, such as 
a2-macroglobulin and some components of the complement system, 
such as factors C3, C4 and C5 (Enghild et aL, 1990). Recently, Enghild 
et al (1990) demonstrated that a a-macroglobulin of the ancient 
invertebrate Limulus polyphemus (horsehoe crab) is not only a protease 
inhibitor, but also is a complement-like protein participating in the lytic 
system of the crab. Then Limulus polyphemus a-macroglobulin 
complement-like (limac) could be a link between the two sides of the a-
macroglobulin family - the protease inhibitors and the complement. 
There seem to be a common link among all these pore-
forming protein considered above - enterolobin, aerolysins, porins, 
colicins, transport proteins in E. coli, a-macroglobulins and 
complement factors. The question whether they are evolutionary related 
has not been answered yet. Further analysis must be done using more 
powerful and sensitive software and faster hardware. Package of 
programs and databases such as OWL, SOMAP, ADSP from the 
University of Leeds and UWGCG from the University of Winsconsin, 
USA, running on DEC VAX operating VMS and SUN (or similar 
workstations) operating UNIX could be of great help to the analyses. 
3.6.2 Hydropathy Profiles 
The theoretical approach of analysing the hydropathy 
profiles of sequences has been used for some time for the prediction of 
surface-seeking, antigenic and membrane-interacting regions in proteins 
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(for review Eisenberg, 1984; Heijne, 1988). Being cytolytic proteins, 
enterolobin and aerolysin should somehow interact with the target 
membranes. In order to gain some indication about the regions of these 
proteins that could interact with membranes, analyses of their 
hydropathic characteristics were carried out. 
To perform a hydropathy analysis, one should firstly 
choose an appropriate hydrophobicity scale, i.e., a scale that assigns 
hydrophobicity values to each of the twenty amino acids. Basically, 
there are three types of scales: (a) experimental ones constructed from 
physical-chemical properties of the amino acids; (b) statistical, from the 
knowledge derived from previously determined proteins structures; and 
(c) theoretical consensus that employs several scales to optimize a given 
parameter. 
Although other scales such as Kyte and Doolittle's are more 
frequently used, the hydropathy analyses of aerolysins and enterolobin 
were done by applying the consensus scales of Eisenberg et al. (1984) 
and Argos et al. (1982). These two scales are highly optimized for 
detecting membrane-interacting sequence regions. 
An important parameter that must be set during the analysis 
is the moving window size. This is the number of residues along the 
sequence that will be taken in account each time for the calculation of 
the average hydrophobic value for the first residue in the window. This 
window advances one residue at a time, and has the function of 
smoothing the hydrophobic plot in order to allow a better interpretation 
of the results. For example, windows with short sizes (<5-7 residues) are 
set when the objective is to find turns in the sequence, while long 
windows (18-20 residues) are indicated for investigating membrane-
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spanning stretches, since the width of biological membranes is equal to 
the length of 18-20 residues in average. 
Using both Argos' and Eisenberg's scales with several 
window sizes, it was demonstrated that the two aerolysins are rather 
more hydrophilic than hydrophobic proteins with no region long 
enough to be considered as membrane-spanning (Figs 29 and 30). This 
result is in agreement with the data provided by preliminary 
crystallographic studies, which demonstrates that the aerolysin of A. 
hydrophila is a hydrophilic p-structured protein with no recognizable 
amphiphilic helices (Green and Buckley, 1990). 
There seem to be, however, some regions which could be 
possible turns. More resolved plots were produced with a window size 
of 7 residues to permit a better interpretation of this fact (Figs 31 and 
32). For both scales and both methods, the possible existence of turns 
related to proline residues (at positions 25, 59, 77, 86, 90, 115, 181, 
248, 305, 347, 419, 421) was predicted satisfactorily. Proline is known 
as a turn former, and is not generally found in helices and j3-sheets 
(Richardson and Richardson, 1989). The method did consider the two 
close proline residues (419 and 421) that are located in the predicted 
cytolytic site. 
For the sake of comparison, the hydropathy profiles of the 
two aerolysins were ploted in the same graph (Fig. 33) Similarly to the 
sequence alignment, the hydropathic plots revealed two extremely 
homologous, mostly hydrophilic, proteins, which was absolutely 
expected. It would not be surprising i f enterolobin had a hydrophilic 
profile resembling those of the aerolysins. The complete analysis of the 
hydropathic characteristics of enterolobin will be performed when its 
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complete amino acid sequence is determined. Meanwhile, its predicted 
cytolytic site was compared to the sites of aerolysins (Fig. 34) 
The predicted cytolytic sites of the two aerolysins shared a 
great uniformity in their hydropathy pattern as can be seen in Fig 34. 
The outline of the profile for enterolobin was similar to the others, 
although there were some differences, especially when the scale of 
Argos was used. In the aerolysins, there is a hydrophobic region 
followed by a hydrophilic one. As mentioned above, there are two 
proline residues (PT0419 and PT0421) placed in the predicted cytolytic 
sites and related to possible turns. Enterolobin also has a proline residue 
aligned to Prc>4i9. It is not unreasonable to suppose that these prolines 
could actually form a turn or a distortion in the strucuture. This motif 
would be an 'amphipatic proline finger', which could behave like 
amphipathic helices (e.g. mellitin) in the disruption of membranes. 
However a hypothesis like this must be carefully built, since this concept 
of a common cytolytic region could be wrong for some cases. 
The existence of a common cytolytic region in myotoxins, 
haemolysins, cardiotoxins and antibacterial peptides from several 
sources and diverse physical-chemical and biological characteristics was 
a proposal by Kini and Evans (1989). The authors employed several 
theoretical tools, including analysis of hydropathy. For A. hydrophila 
aerolysin, they described a region between residues P h e 4 i o and Arg422 
shown in Fig. 27. This generalization for the aerolysin has to be taken 
in consideration with care, since recent experiments of site-directed 
mutagenesis revealed the involvement of histidine residues in membrane 
binding and cytolysis by A. hydrophila aerolysin (Green and Buckley, 
1990). These residues are His332 (binding) and His 132 (cytolysis), and 
are distant from the discussed site, at least in the primary structure. 
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Figure 29: Hydropathy profiles of aerolysin A. hydrophila. Program 
PLOT.A/HYD5 was used with the hydropathy scales of Eisenberg (a) 
(Eisenberg et al, 1984) and Argos (b) (Argos et al, 1982). The 
numbers at the right side represent the moving average windows along 
the sequences. The regions above the horizontal lines represent the 
hydrophobic stretches, and below the lines, the hydrophilic ones. 
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FSgure 3©: Hydropathy profiles of aerolysin A. sobria. Program PLOT.A/HYD5 
was used with the hydropathy scales of Eisenberg (a) (Eisenberg et al., 
1984) and Argos (b) (Argos et al., 1982). The numbers at the right side 
represent the moving average windows along the sequences. The regions 
above the horizontal lines represent the hydrophobic stretches, and below 
the lines, the hydrophilic ones. 
123 
Mare©!© V. S o u s a Eifi)$eir©ll@lbQini R©©yOftQ ara3 D B s e u G s o e n 
pho 
phi 
50 00 150 200 350 400 450 250 300 
Residue Number 
a 
4.5 
pho 
>| im|MHf««| l t tq»! l | IMI|INI | int | lM<!IIM|»M t MI. |Mtt^ 
phi . 
-4.5J-" . jMHll l l lhHl l lHt lHt l l imlMl l tM. l lmt l tml lMt^ 200 250 300 350 400 450 
Residue Number 
b 
Figure 31: Detailed hydropathy profiles of aerolysin A. hydrophila. Program 
PLOT.A/HYD was used with the hydropathy scales of Eisenberg (a) 
(Eisenberg et ai, 1984) and Argos (b) (Argos et ai, 1982). A default 
moving average window value of 7 residues was used. 
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Figure 32: Detailed hydropathy profiles of aerolysin A. sobria. Program 
PLOT.A/HYD was used with the hydropathy scales of Eisenberg (a) 
(Eisenberg et al, 1984) and Argos (b) (Argos et ai, 1982). A default 
moving average window value of 7 residues was used. 
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Figure 33: Comparative hydropathy profiles of aerolysins of A. hydrophila and A. 
sobria.. Program PLOT.A/H3 was used with the hydropathy scales of 
Eisenberg (a) (Eisenberg et al., 1984) and Argos (b) (Argos et al., 
1982). A moving average window value of 15 residues was used. 
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Figure 34: Comparative hydropathy profiles of the putative cytolytic sites of 
enterolobin and aerolysins. Program PLOT.A/H3 was used with the 
hydropathy scales of Eisenberg (a) (Eisenberg et al, 1984) and Argos 
(b) (Argos et al., 1982). A default moving average window value of 7 
residues was used. 
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The determination of the kinetic behaviour of haemolysis 
caused by enterolobin was performed by means of a light scattering 
continuous assay. The method was based on the fact that the 
transmittance of a suspension of erythrocytes increased during the 
course of the haemolysis reaction. The increase of the transmittance 
could be conveniently recorded in a spectrophotometer, where the 
wavelength of 680 nm was chosen in order that the difference of 
transmittance before and after haemolysis was the highest possible to 
provide a maximum sensitivity. The method permitted the inhibitory or 
activating effects of various agents on the haemolytic profile to be 
readily observed. 
From the results of the kinetic experiments, it is clear that 
enterolobin can lyse red cells to 100% haemolysis in periods of time 
usually around 15 min (Fig. 35). The release of haemoglobin always 
started after few minutes of incubation (5-6 min). The shape of the 
haemolysis curve was sigmoidal as it is for many other haemolytic 
agents like saponin (Fig. 36), free radicals from hydrogen peroxides 
(McFaul and Everse, 1986; Richards et at, 1988), Prymnesium parvum 
toxin (Martin and Padilla, 1971; Martin et ai9 1973), equinatoxin from 
the sea anemone Actinia equina (Macek and Lebez, 1981), haemolytic 
glycoprotein from the Portuguese Man-of-War venom (Lin and 
Hessinger, 1979), Bombina variegata haemolytic toxin (Mar and Michl, 
1976), crotin (Banerjee and Sen, 1983) and several other cytolytic 
micromolecules and peptides, proteins (Thelestan and , 1979; Bash ford 
et ai, 1986; Menestrina et aL, 1990). 
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Figure 35: Curve of haemolysis by enterolobin. The concentration of enterolobin 
(fraction F-2) was 200 i^g/ml in 10 mM tris-HCl pH 7.4. A 3% (v/v) 
suspension of human red cells (type O+) in the same buffer was used as 
target cells. The percentage of transmittance (%T) was recorded 
continuously at 680 ran at room temperature. 
Figure 36: Curve of haemolysis by saponin. The concentration of saponin was 6 
ug/ml in 10 mM tris-HCl pH 7.4. A 3% (v/v) suspension of human red 
cells (type 0+) in the same buffer was used as target cells. The 
percentage of transmittance (%T) was recorded continuously at 680 ran at 
room temperature. 
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Enterolobin was non-specific for all the erythrocyte types 
tested (groups A, B, AB and O). Minor differences in the periods of 
time needed for the achievement of total haemolysis and shape of the 
curves (while always keeping their sigmoidal characteristic) occurred 
for different blood groups and individuals (figures not shown). It is 
known that factors such as diet can induce modifications on the 
molecular composition of the cell membrane (Kummerow, 1983; 
Holmes and Kummerow, 1985). Similarly, modification of components 
on the erythrocyte membrane can occur in function of age of 
individual. For example, band 3 protein degradation by the protease 
calpain is enhanced in erythrocytes of old people (Meir et al., 1991). 
These and other factors might account for those small changes in the 
time-length of the reaction and the shape of the curve of haemolysis. 
Ca 2 + is a common inhibitor of haemolytic peptides and 
proteins (Cannicati, 1983; Bashford et al.9 1986; Osorio and Castro et 
al. 1989; Menestrina et al. 1990). On the other hand, this cation can be 
an activator or even a co-factor for some haemolytic agents (Mar and 
Michl, 1976; Louw and Visser, 1977; Macek and Lebeg, 1981; Young, 
1989); The cation chelator EDTA generates the expected opposite effect 
of Ca2+. Their mechanisms of inhibition and activation of haemolysins 
are still not completely clear. For enterolobin, in any way, Ca 2 + and 
EDTA had no effect at all as shown in Fig. 37. 
Cholesterol, phospholipids and proteins are well known as 
the main components of the red cell membrane. Gennis (1989) has 
summarized some data: phosphatidylcholine accounts for 25% of the 
total lipids of the erythrocyte membrane; cholesterol forms 25% as 
well; and band 3 and PAS-1 proteins have a lipid/protein (dry weight) 
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Figure 37: Curve of haemolysis by entetolobin in presence of C a 2 + and EDTA. The 
concentration of enterolobin (fraction F-2) was 200 ug/ml in 10 mM tris-
HC1 pH 7.4. A 3% (v/v) suspension of human red cells (type 0+) in the 
same buffer was used as target cells. The concentrations of C a 2 + and 
EDTA were 10 mM. Control was enterolobin alone. The percentage of 
transmittance (%T) was recorded continuously at 680 nm at room 
temperature. 
ratio of 0.75, being the principal proteins on the membrane. Band 3 and 
PAS-1 are common designations (from their positions and staining 
characteristics in electrophoresis gels) of the anion-exchanger protein 
and glycophorin respectively. These proteins have parts of their 
structures located at the external part of the membrane (Marches! et al., 
1976). Also phosphatidylcholine and cholesterol are preferentially 
localized at the external layer of the membrane (Kamp, 1979). 
Thelestan and Mollby (1979) classified most of the 
cytolysins tested in their work as belonging to a group of substances 
interacting with specific receptor molecules in the surface of the cell 
membrane and, then, giving rise to membrane lesions. Proteins like 
aerolysin, S. aureus 5-toxin, cereolysin, listeriolysin, streptolysin O, 
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vibriolysin, direct lytic factor (Naja), etc. fell in this group. Most of the 
cytolysins have either phosphatidylcholine or cholesterol as their 
binding site on the membrane (Bernheimer and Rudy, 1986). However, 
some of them possess glycoprotein receptors. Examples are the 
haemolytic toxin of Physalia physalis (Lin and Hessinger, 1979) and 
aerolysin (Howard and Buckley, 1982). 
In this present work, an attempt was made to find out i f 
enterolobin had any specific binding site on the red cell membrane, and, 
i f so, what the chemical nature of this molecule was. The kinetic 
experiments in the presence of some possible effectors such as galactose, 
choline, phosphatidylcholine, cholesterol, ricin, and with the utilization 
of trypsinised erythrocytes produced results allowing some conclusions 
as discussed below. 
Galactose is a monomeric carbohydrate with properties to 
inhibit erythrocyte agglutination by many lectins and hemi-lectins like 
R C A t and RCAn (ricin) from Ricinus communis for example (Lis and 
Sharon, 1986). It is not surprising since these proteins exhibit galactose-
specific binding to the red cell membrane . This carbohydrate is a major 
constituent of the glycosidic moiety of many membrane glycoproteins 
such as the band 3 protein (Fukuda et al., 1984). Galactose, however, 
was not seen to have any inhibitory effect upon haemolysis by 
enterolobin (Fig. 38). It is possible that a more complex carbohydrate 
or a glycopeptide isolated from the membrane red cell membrane would 
inhibit enterolobin. This is to be tested. 
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Fagmre 38: Curve of haemolysis by enterolobin in presence of galactose and choline. 
The concentration of enterolobin (fraction F-2) was 200 fig/ml in 10 mM 
tris-HCl pH 7.4. A 3% (v/v) suspension of human red cells (type 0+) in 
the same buffer was used as target cells. The concentration of galactose 
was 100 mM (and choline was 10 mM. Control was enterolobin alone. 
The percentage of transmittance (%T) was recorded continuously at 680 
run at room temperature. 
The major lipids that compose biological membranes, 
phosphatidylcholine and cholesterol, are common interactive sites for a 
number of cytolysins (Bernheimer, 1983; Bemheimer and Rudy, 1986). 
However, they do not seem to be the receptors for enterolobin since 
they did not inhibit haemolysis by this protein (Figs. 39 and 40). The 
pattern of inhibition would have to be like the one for saponin, which 
was effectively inhibited by cholesterol (Fig. 41). 
For phosphatidylcholine, an interesting phenomenon 
happened. When in presence of non-sonicated phosphatidylcholine, there 
was a partial decrease in the maximum percentage of haemolysis by 
enterolobin (Fig. 40). It could lead one to conclude prematurely that 
phosphatidylcholine was the site of interaction for the haemolysin. 
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However, sonicated phosphatidylcholine did not produce any inhibition 
(Fig. 40). Similarly, choline, the polar head of phospatidylcholine, 
exerted no effect on the haemolysis. A possible explanation for these 
results is that non-sonicated phosphatidylcholine might be encapsulated 
in micelles either normal or reverse ones. Reverse micelles are 
structures the reverse of normal micelles, with their polar heads turned 
to the core of the micelle and their apolar tails interacting outside with 
other reverse micelles. Reverse micelles have been shown to be hosts of 
a number of proteins (Luisi et aL, 1988). 
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Figure 39: Curve of haemolysis by enterolobin in presence of cholesterol. The 
concentration of enterolobin (fraction F-2) was 200 ^g/ml in 10 mM tris-
HC1 pH 7.4. A 3% (v/v) suspension of human red cells (type 0+) in the 
same buffer was used as target cells. The concentration of cholesterol 
was 10 mM. Cholesterol was previously sonicated in a Bronwill 
Biosonik sonicator. Control was enterolobin alone. The percentage of 
transmittance (%T) was recorded continuously at 680 nm at room 
temperature. 
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Figeme 4(Q>: Curve of haemolysis by enterolobin in presence of sonicated and non-
sonicated phosphatidylcholine. The concentration of enterolobin (fraction 
F-2) was 200 ug/ml in 10 mM tris-HQ pH 7.4. A 3% (v/v) suspension of 
human red cells (type 0+) in the same buffer was used as.target cells. The 
concentration of phosphatidylcholine both sonicated and non-sonicated was 
10 mM. The sonication of PC was done in a Bronwill Biosonik sonicator. 
Control was enterolobin alone. The percentage of transmittance (%T) was 
recorded continuously at 680 nm at room temperature. 
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Figure 41: Curve of haemolysis by saponin in presence of cholesterol. The 
concentration of saponin was 6 ug/ml in 10 mM tris-HCl pH 7.4. A 3% 
(v/v) suspension of human red cells (type 0+) in the same buffer was used 
as target cells. The concentrations of cholesterol was 10 mM. Cholesterol 
was sonicated with a Bronwill Biosonik sonicator. Control was saponin 
alone. The percentage of transmittance (%T) was recorded continuously at 
680 nm at room temperature. 
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Trypsinised red cells were shown to be resistant to 
haemolysis by enterolobin (Fig. 42). There could be a doubt related to 
the possibility of any residual trypsin attacking and inactivating 
enterolobin during the incubation despite the cells having been washed 
several times. To remove this possibility, BTC1, a potent trypsin and 
chymotrypsin inhibitor from cowpea (Morhy and Ventura, 1987), was 
added in excess to the mixture, but the absence of haemolysis was also 
obtained here (Fig. 43). This set of results clearly indicated that a 
peptide or a protein was the receptor site for the haemolytic protein. 
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Figure 42: Curve of lysis of trypsinised red cells by enterolobin. The concentration 
of enterolobin (fraction F-2) was 200 (iig/ml in 10 mM tris-HCl pH 7.4. 
A 3% (v/v) suspension of trypsinised human red cells (type 0+) in the 
same buffer was used as target cells. Control was normal red cells with 
enterolobin. The percentage of transraittance (%T) was recorded 
continuously at 680 ran at room temperature. 
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Fflgur® 43: Curve of lysis of trypsinised red cells by enterolobin in presence of 
tryr«in/chymotrypsin inhibitor. The concentration of enterolobin (fraction 
F-2) was 200 ug/ml in 10 mM tris-HCl pH 7.4. A 3% (v/v) suspension 
of trypsinised human red cells (type 0+) in the same buffer was used as 
target cells. One mg of B T Q , black-eyed bean trypsin and chymotrypsin 
inhibitor (Morhy and Ventura, 1987), was added to the mixture. Control 
was normal red cells with enterolobin. The percentage of transmittance 
(%T) was recorded continuously at 680 run at room temperature. 
Haemolysis was also extensively inhibited by ricin (Fig. 
44). Although ricin could just be causing steric obstruction for the 
approach of enterolobin to the membrane surface, these two proteins 
might actually be competing for the same binding site. In this case it 
would be a glycopeptide or a glycoprotein. There may be the hypothesis 
that band 3 protein is actually this binding site as explained below. 
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Figure 44: Curve of haemolysis by enterolobin in presence of ricin. The 
concentration of enterolobin (fraction F-2) was 200 fig/ml in 10 mM tris-
HC1 pH 7.4. A 3% (v/v) suspension of human red cells (type 0+) in the 
same buffer was used as target cells. One mg of ricin was incubated with 
the mixture. Control was enterolobin alone. The percentage of 
transmittance (%T) was recorded continuously at 680 nm at room 
temperature. 
It is known that band 3 is a binding site on the red cell 
membrane for ricins (Jenkins and Tanner, 1977; Chicken and Sharon, 
1985). While their interactions are directed predominantly to galactose 
residues, the presence of sialic acid substituents on the residues 
markedly reduces or abolishes their association constants for 
glycopeptides (Baenziger and Fiete, 1979). This suggests that ricins do 
not bind to glycophorin, a protein rich in sialic acid groups (Fukuda et 
al, 1984). From these considerations, one can build the hypothesis that 
the binding site of enterolobin could be, as for ricins, the anion-
exchanger band 3. Alternatively, as said above, ricin could just be 
impeding the approach to its real binding site by a steric blockage mode. 
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Some authors consider band 3 as a protein with no tryptic 
cleavage sites in its exofacial region, but only in its cytoplasmic portion 
(Jay and Cantley, 1986; Low, 1986). However, i f the amino acid 
sequence of band 3 is examined, one can see several lysine and arginine 
residues along its outside region. In addition, Jenkins and Tanner (1977) 
have already reported the cleavage of external peptides of this protein. 
So, the hypothesis that band 3 could be the binding site for enterolobin 
is not destroyed by the fact that trypsinised red cells became resistant to 
haemolysis by this haemolysin. 
As demonstrated earlier (Section 3.6), enterolobin seems to 
be similar to aerolysin. Howard and Buckley (1982) also found that 
trypsinised erythrocytes are more resistant to haemolysis by the 
bacterial toxin. They reached the conclusive hypothesis that the binding 
site for aerolysin on the red cell membrane would be glycophorin, 
although this is still to be fully proved. 
Further work is necessary in order that the binding site for 
enterolobin might be precisely discovered. The use of other lectins such 
as ConA, WGA and PHA would help in this determination very much, 
since the first one is known to bind to band 3 and the latter ones bind to 
glycophorin (Grant and Peters, 1984). Likewise, BEDS, a specific 
inhibitor of ions and water transport by band 3 with a binding site on 
the external part of the protein (Jennings, 1985), could be useful, as 
well as antibodies against the anion-exchanger protein. Enterolobin 
could also be marked with colloidal gold or a fluorescent probe such as 
FITC, and used to detect its binding site after the separation of the red 
cell membrane proteins by gel electrophoresis. It could probably be 
done after the transference of the membrane proteins to a blotting 
paper. 
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The observation of haemolysis by enterolobin under optical 
microscopy was carried out in order to provide visual time-course 
information on the morphological transformation that red cells suffer 
during the lytic process. This study generated useful data that were 
photographed at given times and dynamically recorded on video casette. 
It appears that there were three distinct phases. In the first 
one (0 to 2 min) no changes on the red cells could be noted (Figs. 45 a 
and b). Probably, this was the phase.when enterolobin established its 
binding to the cell membrane. 
The second phase (2 to 4 min) clearly showed the swelling 
of the red cells (Fig. 46). Some few cells had already been lysed. It 
seems that water could somehow be entering into the cells during this 
phase, as i f they were suffering an osmotic pressure difference caused 
by their placement in hypotonic solutions. Due to the high elasticity of 
the erythrocyte membranes (Hochmuth and Waugh, 1987; Mosior, 
1988), they were able to resist to this deformation for some minutes. 
The last phase (4 to 8 min) was the lysis of the 
erythrocytes, after which the lysed cells took on a translucid appearance 
due to the loss of the cytoplasmic content (Figs. 47 a and b). After 10 
min of incubation, no cell was left intact (Fig. 48). Control cells did not 
undergo any modification after standing alone for 10 min (Fig 49). 
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Figure 45: Visualization of haemolysis by enterolobin under optical microscopy. 
One drop of enterolobin F-3 at 1 mg/ml was mixed with one drop of red 
cell suspension (3% v/v) in saline solution, and taken for observation 
under differential interference contrast microscopy at a magnification of 
20 times. The incubation periods were of 0 min (a) and 2 min (b). 
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Figure 46: Visualization of haemolysis by enterolobin under optical microscopy. 
One drop of enterolobin F-3 at 1 mg/ml was mixed with one drop of red 
cell suspension (3% v/v) in saline solution, and taken for observation 
under differential interference contrast microscopy at a magnification of 
20 times. The incubation period was of 4 min. 
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Figure 47: Visualization of haemolysis by enterolobin under optical microscopy. 
One drop of enterolobin F-3 at 1 mg/ml was mixed with one drop of red 
cell suspension (3% v/v) in saline solution, and taken for observation 
under differential interference contrast microscopy at a magnification of 
20 times. The incubation periods were of 6 min (a) and 8 min (b). 
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Figure 48: Visualization of haemolysis by enterolobin under optical microscopy. 
One drop of enterolobin F-3 at 1 mg/ml was mixed with one drop of red 
cell suspension (3% v/v) in saline solution, and taken for observation 
under differential interference contrast microscopy at a magnification of 
20 times. The incubation period was of 10 min. 
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Figure 49: Control visualization of red cells under optical microscopy. One drop of 
red cell suspension (3% v/v) in saline solution was observed under 
differential interference contrast microscopy at a magnification of 20 
times after standing undisturbed for 10 min. 
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When the red cell membranes were examined by electron 
microscopy, very few perforations could be seen by 2 min of incubation 
with enterolobin (Fig. 50). After 15 min, the membranes had been 
covered by holes of several sizes ranging from 40-50 nm to 300 nm or 
more (Figs 51 and 52). The control cells did not show any perforation 
on their membranes (Fig. 53). 
Other cytolytic proteins like, for example, staphylococcal 
a-toxin, streptolysin O, perforin and complement produce pores of 
defined and constant sizes as measured by electron microscopy (Bhakdi 
and Tranum-Jensen, 1987). Their general mechanism of cytolysis is by 
means of the formation of oligomers with pore shape that transverse the 
membrane causing the leakage of intracellular material. From the 
results for enterolobin, this appears not to be the case since it coats the 
membrane with pores of several different sizes as i f the cell had been 
burst. 
The understanding of the molecular chemical and physical 
mechanisms that determines the stability/instability of biological 
membranes is fundamental for the comprehension of several important 
biological processes, including haemolysis. 
In many of these biological phenomena, membranes can 
undergo two basic types of instability - (a) rupture, which leads to the 
formation of pores or/and fragmentation of the membrane; and (b) 
buckling, resulting in folding or bending of the membrane (Dimitrov 
and Jain, 1984). 
One of the most typical and best studied examples of 
instability of biological membranes is the lysis of erythrocytes, which 
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can occur under the action of different physical and chemical factors. 
Basically, two kinds of membrane breakage can be observed - (a) 
rupture of local areas on the membrane leading to the formation of 
pores with the release of osmotically active substances; and (b) 
fragmentation of the membrane involving breakage of the 
supramolecular structure of the cytoskeleton, and leading to the loss of 
the membrane integrity (Dimitrov and Jain, 1984). In the first case, the 
rupture is usually reversible and the membrane returns to its original 
state after the cessation of the external stress. The integrity of the 
membrane is kept, with the formation of ghosts for example. 
The results from the electron microscopy observation of 
the red cell membranes treated with enterolobin (Figs 51 and 52), 
showed clearly that there was fragmentation of the membrane, since its 
integrity was not maintained. 
Dimitrov and Jain (1984) summarized the stages through 
which the red cell passes when in contact with lysins such as saponin. 
The three first stages are transformations of the shape of the red cell 
from a biconcave disc to a smooth, glistening sphere. Then the 
glistening of the prolytic sphere is replaced by a uniform duskiness. 
After some time (variable as a function of the lytic agent and physical-
chemical conditions), the prolytic sphere begins to haemolyse, and fade 
from view. The membrane rupture (or fragmentation) occurs in this 
last stage. 
The photographs of the optical microscopy observations of 
the haemolytic process by enterolobin (Figs 45 to 48 above) revealed 
apparently the same set of stages as those described by Dimitrov and 
Jain (1984). The video record of this process showed dynamically all 
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the phases, including the passage from the glistening prolytic sphere to 
the dusky one, and the fading of the cells. 
The erythrocyte membrane possess certain elasticity that 
enables it to tolerate some increment of the cell volume. However, when 
a critical volume is reached during the swelling of the cells, haemolysis 
occurs. 
A mathematical expression for the calculation of the critical 
cell volume, VCi is available (Mosior, 1988): 
vc = ( c p . n / Kh) + b 
where cp is the mean osmotic coefficient of internal solutes, n is the 
amount of internal solutes, nh is the mean osmolality of solutions in 
which haemolysis took place, and b is the osmotically non-active 
volume of the cell. 
Assuming that cp, nh and b remained constant in all the 
haemolytic assays with enterolobin, as they were supposed to be since 
the experiments were done in isoosmotic saline solution, the only 
variable that could change would be n. Consequently, it can be inferred 
that enterolobin induces some changes in the red cell that make it to 
overpass its critical volume, VCf and haemolyse, and these changes are 
related to the variation of the amount of internal solutes. 
3.8.2 Membranes Lysed by Gold-Enterubbin 
Gold-enterolobin was successfully used in this work to 
show the pattern of distribution of the enterolobin on the red cell 
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membrane and the complexation of the protein at sites in the initial 
prolytic stage of the cytolytic process. 
It was demonstrated that some black gold-enterolobin dots 
were already gathered surrounding a site at 2 min (Fig. 54), which 
would probably become a pore afterwards caused by the combined 
action of a number of enterolobin molecules. 
By 15 min, many gold-enterolobin dots could be seen 
scattered around the holes (Fig.55). The pattern of distribution of the 
gold-enterolobin complexes on the membrane was rather more random 
than organized, thus suggesting that this cytolytic protein does not form 
organized pores by polymerization of oligomers as for staphylococcal 
cc-toxin, streptolysin O, perforin and complement for example (Bhakdi 
and Tranurn-Jensen, 1987). This must be further investigated to allow a 
undoubtable conclusion The control of gold-albumin showed no black 
dots characteristic of gold complexes (Fig. 56), indicating that there was 
no non-specific binding of the two moieties, albumin and gold, to the 
membrane surface. 
Colloidal gold has been used frequently for the study of 
interactions of lectins and other proteins to the membrane (Horisberger, 
1984). However, as far as it could be searched in the literature, its 
utilization with cytolytic peptides and proteins had never been exploited 
before. This present study was presumably one of the first ones in this 
direction. Much can be exploited from this technique for the study of 
cytolysin-membrane interactions. 
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Figure 50: EM visualization of membranes of red cell after 2 min in contact with 
enterolobin iF-3.The haemolysis reaction and preparation of the 
specimens were carried out as in Material and Methods (Section 2.2.5.3) 
A Phillips 400 electron microscope was used at a magnification of 
x46 000. The print magnification was of 2 times. 
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Figure 51: EM visualization of membranes of red cell after 15 min in contact with 
enterolobin F-3.The haemolysis reaction and preparation of the 
specimens were carried out as in Material and Methods (Section 2.2.5.3) 
A Phillips 400 electron microscope was used at a magnification of x46 
000. The print magnification was of 2 times. 
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Figure 52: Detailed EM visualization of membranes of red cell after 15 min in 
contact with enterolobin F-3.The haemolysis reaction and preparation of 
the specimens were carried out as in Material and Methods (Section 
2.2.5.3) A Phillips 400 electron microscope was used at a magnification 
of xlOO 000. The print magnification was of 2 times. 
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Figure 53: EM visualization of membranes of control red cell. The preparation of the 
specimens were carried out as in Material and Methods (Section 2.2.5.3) 
A Phillips 400 electron microscope was used at a magnification of x46 
000 to observe the control cell membranes after 15 min of repose. The 
print magnification was of 2 times. 
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Figure 54: EM visualization of membranes of red cell haemolysed by gold-
enterolobin. The preparation of gold-labelled enterolobin, haemolysis 
reaction and preparation of the specimens were carried out as in Material 
and Methods (Section 2.2.5.3) A Phillips 400 electron microscope was 
used at a magnification of x25 000 (a) and x70 000 (b). The incubation 
period of the cells with gold-enterolobin was of 2 min. The dense black 
dots are the gold-enterolobin complexes. The print magnification was of 
2 times. 
154 
Marcelo V. Sousa Entero lobin Results and Discussion 
* 
100 nm 
a 
b 
Figure 55: EM visualization of membranes of red cell haemolysed by gold-
enterolobin. The preparation of gold-labelled enterolobin, haemolysis 
reaction and preparation of the specimens were carried out as in Material 
and Methods (Section 2.2.5.3) A Phillips 400 electron microscope was 
used at a magnification of x55 000 (a) and xl20 000 (b). The incubation 
period of the cells with gold-enterolobin was of 15 min. The dense black 
dots are the gold-enterolobin complexes. The print magnification was of 
2 times. 
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Figure 55: EM visualization of membranes of red cell treated with gold-ovalbumin. 
The preparation of gold-labelled ovalbumin, incubation with the cells and 
preparation of the specimens were carried out as in Material and Methods 
(Section 2.2.5.3) A Phillips 400 electron microscope was used at a 
magnification of x25 000 . The incubation period of the cells with gold-
ovalburnin was of 15 min. The print magnification was of 2 times. 
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It has been shown that many cytolytic agents, including 
several peptides and proteins can induce lysis on culture cells as MRC5 
(Thelestam and Mollby, 1979). If this occurs for a number of cytolytic 
proteins, it could also be true for enterolobin. 
In this study, enterolobin was tested against two cancer cell 
lines, L929 and MRC5, in a in vitro assay on a microtitration plate with 
TNF (for a review see Bonavida and Granger, 1990) as a positive 
control. The TNF- and enterolobin-treated cells were also observed 
under a differential interference contrast microscope in order to 
provide a visual comparison of the pattern of cytotoxicity caused by the 
two proteins. 
Enterolobin proved to be cytotoxic to both cancer cell lines 
tested - L929 and MRC5. Both L929 (Fig. 57) and MRC5 (not shown) 
were killed at an enterolobin concentration as low as 250 ug/ml (titre = 
2) in the microtitration plate assay. However, this concentration of 
enterolobin was much higher than the concentration of TNF that was 
required to kill the cells. TNF was able to cause death to the cells at 
concentrations as low as 1 U/ml (25 pg/ml). 
No damage to the cells could be observed by differential 
interference contrast microscopy at 2 hours of incubation with 
enterolobin and TNF. After 24 h, however, TNF had caused death to 
many of the cells, as they became detached from the plastic surface of 
the petri dish and contracted a round shape (Fig. 58). Enterolobin also 
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had killed the cells by 24 h of incubation, but by inducing lysis to them, 
since cell debris could be seen in profusion in the supernatant (Fig. 59). 
No changes had occurred to the control cells after 24 h. 
It is still early to suggest any mechanism of cytotoxicity of 
enterolobin on the cancer cells. However, it would be probably correct 
to assume that enterolobin and TNF produce the killing of the cells by 
different mechanisms given the above results and the knowledge of their 
physical-chemical characteristics. 
The results demonstrated differences in the toxic 
concentrations and way of killing of these two proteins. It became clear 
that enterolobin caused cell death by a cytolytic mechanism, whereas 
TNF killed them with no apparent lysis. Enterolobin was needed in 
higher concentrations than TNF to induce its cytotoxic effect to the cells 
tested. 
Furthermore, while TNF in its soluble form is a compact 
trimer with 17 KDa per protomer (Old, 1990), enterolobin is a 55 KDa 
protein of only one polypeptide chain (Sousa and Morhy, 1989). TNF is 
relatively stable in acidic and apolar conditions (Aggarwal, 1990), while 
enterolobin is unstable under these conditions. Further investigation 
must be done in order to clarify the mechanism of action of enterolobin 
on cancer cells. An initial line would be to question i f there is a similar 
binding site molecule for enterolobin on the red cell and cancer cell 
membranes, and then if the mechanisms of cytolysis are the same. 
It is worth noting another characteristic in common 
between enterolobin and aerolysin. Aerolysin induces lysis of MRC5 
cells as well (Thelestam and Mollby, 1979). In their study, Thelestam 
and Mollby (1979) suggested that there may be a specific receptor 
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involved in the interaction of aerolysin with the cancer cell, although 
the nature of this receptor could not be deduced from their results. 
Figure 57: Cytotoxic effect of enterolobin on cancer cells. Enterolobin was two-fold 
serially diluted on microtitration plates and incubated with L929 cancer 
cells for 3 days. Experimental details are given in Material and Methods 
(Section 2.2.6). Rows B2 to D9 - enterolobin F-3 (initial concentration 
of 500 ug/ml). Rows E2 to G9 - enterolobin F-2 (initial concentration of 
2 mg/ml). Rows D10/11 and O10/11 - control cells with no enterolobin. 
Rows A and H plus columns 1 and 12 were left empty. The assays were 
done in duplicate; e.g. wells A2/3 are duplicates and so on. The clearer 
wells (A2 to A5 and E2/3) contain dead cells. 
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Figure 58: Visualization of the cytotoxic effect of TNF-a on cancer cells. TNF at 
100 U/ml was incubated with L929 cancer cells for 24 h, and then taken 
for observation under differential interference contrast microscopy at a 
magnification of xlO (a) and x20 (b). 
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Figure 59: Visualization of the cytotoxic effect of enterolobin on cancer cells. 
Enterolobin F-3 at 500 ug/ml was incubated for 24 h with L929 cancer 
cells, and then taken for observation under differential interference 
contrast microscopy at a magnification of xlO (a) and x20 (b). 
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Figure 59: Control visualization of the cancer cells. L929 cancer cells were left 
standing for 24 h, and then taken for observation under differential 
interference contrast microscopy at a magnification of xlO (a) and x20 
(b). 
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Many compounds have been found in plants, especially in 
legume seeds, which exhibit some toxicity to insects. These compounds 
range from micromolecules to proteins (reviewed by Gatehouse et aL, 
1990). Within the group of seed proteins, protease inhibitors (Gatehouse 
et aL, 1979; Gatehouse and Boulter, 1983), lectins (Gatehouse et aL, 
1984; Pratt et aL, 1990; Chrispeels and Raikhel, 1991), lectin-like 
proteins (Osborn et aL, 1988a and b) and ribosome inactivating proteins 
(RIPs) (Gatehouse et aL, 1990) have been shown to possess 
antimetabolic effects against insects. 
Some cytolytic crystal proteins of the soil bacterium 
Bacillus thuringiensis also contain insecticidal activity against a broad 
spectra of insect pests (review by Hofte and Whiteley, 1989). It is 
believed that these crystal proteins are dissolved in the midgut of the 
insects forming pores on the epithelium cells, and that they may 
interfere in the amino acid transport driven by a K + gradient. However, 
complete understanding of their mode of action is still to be elucidated. 
Enterolobin, which is both a seed and a cytolytic protein, 
was tested in order to determine whether it had any toxic effects against 
insect larvae of the coleopteran Callosobruchus maculatus and the 
lepidopteran Spodoptera litorallis. The study also attempted to provide 
a possible explanation for the results obtained in vivo. 
Initially, the effects of a partially purified preparation of 
enterolobin (fraction F- l ) on the development and survival of a 
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coleopteran, Callosobruchus maculatus (cowpea seed weevil), and a 
lepidopteram, Spodoptera littoralis (armyworm) were investigated. Both 
are pests of major economic importance especially in tropical countries. 
The partially purified enterolobin fraction (F-l) was added 
in a range of concentrations to artificial seeds in order to test its effects 
on C. maculatus larvae. The results for survival of the insect to adult 
are shown in Fig. 61 This shows that at a concentration of 0.25% (w/w), 
adult survival was reduced by 95% relative to the controls, and at a 
concentration of 0.5% (w/w), complete mortality was observed. 
Since the partially purified preparation was proved to be 
toxic to C. maculatus, it was further purified (fraction F-2) and shown 
by FPLC to be essentially homogeneous (Fig. 62). This purer sample 
(F-2) was incorporated to the artificial seeds at a range of up to 0.25 % 
(w/w). At a concentration of 0.01%, this sample reduced adult survival 
to 30% (Fig. 63); in this instance, an enterolobin concentration of 
0.025% caused 100% mortality. 
The effects of the partially purified (F-l) and purified (F-
2) enterolobin were also tested against S. littoralis. Both samples failed 
to show any deleterious effects, despite being offered to the larvae at 
concentrations of 5% (F-l) and 0.1% (F-2). After 6 days of feeding, the 
percentage of survival was 83% for both the insects fed with 
enterolobin and the control insects (Fig. 64). 
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Figure 61: Effect of enterolobin F - l on the survival of C. maculatus larvae. 
Enterolobin F - l was incorporated in artificial seeds and disposed to the 
insects for oviposition. After 42 days, the assay was terminated, and the 
number of emerged adults recorded. The concentration of enterolobin is 
given as a percentage (per dry weight) of each artificial seed. Six replicas 
were used for the calculation of the mean of the number of emerged 
adults. 
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Figure 62: FPLC chromatography of enterolobin F-2. An aliquot (500 ul) from a 
solution of enterolobin F-2 (1 mg/ml) was applied to a Mono Q HR 5/5 
column equilibrated with 20 mM tris-HCl pH 8.7, and eluted with a 
gradient (- - -) of NaCl (0-0.1 M in 18 min and 0.1-0.35 in 1 min). The 
flow rate was 1.0 ml/min, and the absorbance ( ) was recorded 
continuously at 280 nm at AUS 0.1. 
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Figure 63: Effect of enterolobin F-2 on the survival of C. maculatus larvae. 
Enterolobin F-2 was incorporated in artificial seeds and disposed to the 
insects for oviposition. After 42 days, the assay was terminated, and the 
number of emerged adults recorded. The concentration of enterolobin is 
given as a percentage (per dry weight) of each artificial seed. Six replicas 
were used for the calculation of the mean of the number of emerged 
adults. 
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Figure 64: Effect of enterolobin F-2 on the survival of S. littoralis larvae. 
Enterolobin F-2 was incorporated in artificial diet at 0.1 % (w/w/), and 
presented to the larvae for feeding. The number of surviving larvae was 
recorded daily for six days. 
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From the results of the feeding trials (Figs. 61, 63 and 64), 
it is evident that enterolobin, the cytolytic protein, has a toxic effect 
against C. maculatus but not against S. littoralis. Similar results have 
also been obtained for the RBPs ricin and saporin (Gatehouse et al., 
1990). Ricin, with a molecular weight of 60 KDa, was found to cause 
100% mortality at a concentration of 0.005% (w/w). Saporin (30 KDa) 
resulted in complete larval mortality at 0.01% (w/w). Enterolobin (55 
KDa) appears to be slightly less toxic than ricin when compared either 
on a weight or on a molar basis. However, enterolobin has 
approximately the same degree of toxicity as saporin when examined on 
a percentage basis, but it is more toxic than this toxin i f a molar relation 
is considered. 
In order to determine how enterolobin was highly toxic to 
the coleopteran but innocuous to the lepidopteran, the stability of the 
protein to digestive proteolysis was investigated in vitro. For each 
insect, a larval gut preparation was incubated with the purer enterolobin 
sample (F-2) for given time intervals up to 48 h, either at pH 5.4 in the 
case of C. maculatus or pH 9.5 for 5. littoralis. Control incubations in 
the absence of larval gut extracts were run concurrently at the two 
different pH values in order to detect any autolysis of the protein. The 
hydrolysis products were then analysed by SDS-PAGE.The results 
clearly show that after an incubation period of only 2 h under optimal 
conditions, the S. littoralis gut enzymes had completely hydrolysed 
enterolobin (Fig. 65). The C. maculatus enzymes, on the other hand, 
were unable to hydrolyse the cytolytic protein in vitro even after 48 h 
of incubation (Fig. 66). 
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Gatehouse et aL (1990) demonstrated, by in vitro digestion, 
that the gut enzymes of 5. littoralis were able to digest both ricin and 
saporin, while the enzymes from C. maculatus were unable to cleave the 
proteins. This could explain the lack of toxicity of these proteins against 
S. littoralis. Likewise, enterolobin was susceptible to hydrolysis by the 
enzymes of the lepidopteran, but was resistant to those of the 
coleopteran (Figs. 65 and 66). The same explanation for the differential 
toxicity of the RXPs to the two species of insects appears to apply to 
enterolobin as well. S. litorallis gut enzymes can digest the toxic 
proteins, and thus rendering them inactive, before they are able to 
exercise their deleterious effects, while the C. maculatus enzymes do not 
possess this capacity. 
The question as to how enterolobin exerts its toxicity to C. 
maculatus still remains to be elucidated. It is well known that this 
protein has haemolytic (Sousa and Morhy, 1989) and other activities, 
such as cytolysis to cancer cells (discussed above) and inflammation to 
rats (Castro-Faria-Neto et al., in the press; Cordeiro et al, in the press). 
Since enterolobin is such a cytolytic and toxic protein, the ultrastructure 
of the epithelial cells of the enterolobin-treated gut of C. maculatus 
larva was worth investigating by electron microscopy. 
There appeared to be no evidence that, between control and 
experimental insects, there were morphological differences caused by 
structural damage in the microvillae membrane of the epithelial cells 
(Fig. 67). Futhermore, there were no apparent differences between the 
internal organelles of the gut epithelial cells from either experimental 
or control insects. Then, the hypothesis that enterolobin might exert its 
toxic effects by causing lysis to the membrane of the epithelium cells 
had to be discarded. 
170 
Marcelo V. Sousa Enterolobin Result* and Discussion 
a b c d e f g h i 
ent. 
myo 
Figure 65: Analysis by PAGE-SDS of the proteolytic effect of S.littoralis larval gut 
enzymes on enterolobin. Enterolobin F-2 (ent.) was incubated with gut 
enzymes from S.littoralis for 0 (a), 1 (b), 2 (c), 4 (d), 8 (e), 24 (f) and 
48 h (g). At each of these times, aliquots were taken for analysis by 
PAGE-SDS slab mini-gel at an acrylamide concentration of 5% . 
Myoglobin (myo.) was treated in the same manner, and samples at 0 (h) 
and 48 h (i) were submitted to SDS-PAGE at an acrylamide concentration 
of 17%. The runs was carried out at constant voltage (100 V) for 1 h. 
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Figure 66: Analysis by PAGE-SDS of the effects of C. maculatus larval gut 
enzymes on enterolobin. Enterolobin F-2 (ent.) was incubated with gut 
enzymes from C. maculatus for 0 (a), 1 (b), 2 (c), 4 (d), 8 (e), 24 (f) 
and 48 h (g). At each of these times, aliquots were taken for analysis by 
PAGE-SDS slab mini-gel at an acrylamide concentration of 5% . 
Myoglobin (myo.) was treated in the same manner, and samples at 0 (h) 
and 48 h (i) were submitted to SDS-PAGE at an acrylamide concentration 
of 17%. The runs was carried out at constant voltage (100 V) for 1 h. 
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Figure 67: Visualization by EM of gut epithelial cells of C. maculatus fed with 
enterolobin. Section of a cell treated with enterolobin (a) and control cell 
(b) showing internal organelles and microvilae at magnifications of x l7 
000 and x46 000 (insert). 
173 
MareoH® M. Samoa Era fie rod ©lb! in) 
The basis of toxicity may reside at the biochemical level. C. 
maculatus larvae do not contain serine proteases as their main 
proteolytic digestive enzymes (Gatehouse et ai, 1985) as do 5. littoralis 
and other lepidopterans (Ahamad et aL, 1980). Instead, they possess 
thiol proteases (Gatehouse et al., 1985). Enterolobium contortisiliquum 
contains a thiol protease inhibitor (Oliva et ai, 1988) which molecular 
weight (60 KDa) was found to be very close to that of enterolobin (55 
KDa). Preliminary results (data not shown) suggested some slight 
inhibition of papain, a thiol protease, by enterolobin. Currently, we are 
investigating whether enterolobin and the thiol protease inhibitor from 
E. contortisiliquum are in fact the same protein.species. I f this were to 
be the case, the toxicity of this protein towards C. maculatus could be 
explained by the inhibition of thiol proteases within the guts of these 
insects. 
On the other hand, the possibility of the presence of a minor 
contamination of a thiol-protease inhibitor in the enterolobin 
preparation cannot be ruled out. However, it would have to be an 
exceptionally potent inhibitor to cause such response at so low a 
concentration since enterolobin was demonstrated to be in a high level 
of purity by analytical FPLC (Fig. 62). The automatic integrator of the 
FPLC apparatus showed that the area of the enterolobin F-2 peak 
accounted for 87% of the total area of the chromatogram. This class of 
inhibitor characteristically does not exhibit such levels of toxicity 
(Gatehouse etal, 1979). 
Another speculative hypothesis is currently being 
investigated. Enterolobin appears to have a glycoprotein binding site on 
the membrane of erythrocytes (Sousa et al, work in progress). There is 
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evidence that this protein is the anion exchanger protein band 3 
(discussed above, Section 3.7). This protein regulates the transport of 
ions (especially CI"), small nonelectrolytes and water through the 
membrane of erythrocytes (Solomon et aL, 1983; Jennings, 1985; Low, 
1986). Enterolobin could also be binding to a similar carrier protein on 
the membrane of the insect gut epithelial cells thus deregulating its 
transport of anions and water. Interestingly, Hofte and White ley (1989), 
in a review on the insecticidal cytolytic proteins of Bacillus 
thuringiensis, observed that one of the proposed mode of actions of 
these toxins is the inhibition of a K -amino acid co-transporter protein. 
The above results and considerations suggested that 
enterolobin in vivo could well be one of the natural defensive proteins 
for E. contortisiliquum. The concentration of the toxic protein that 
began to cause death to the larvae was 0.01 % (w/w), and this is the 
supposed concentration of the protein in the seeds, as calculated from 
typical purification yelds. This plant also contains other proteins and 
small compounds toxic to insects such as, for example, a set of protease 
inhibitors in the seeds (Oliva et al, 1988; and personal communication) 
and saponins in the fruit pod (unpublished results). 
Further work has yet to be carried out in order to 
understand ful ly the mechanism by which enterolobin kills C. 
maculatus. However, a potential application of this cytolytic and toxic 
protein in plant genetic engineering for the control of crop pests can be 
already envisaged. 
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In 1989, Sousa and Morhy published a paper on the 
purification and initial characterization of enterolobin, the first 
haemolytic/cytolytic protein founds in seeds. They showed that this 
large new protein was able to cause haemolysis by a mechanism that did 
not involve any phospholipase D activity. Apart from characteristics 
such as red cell specificities, stability to different pHs and temperature, 
molecular weight, isoelectric point, amino acid composition and some 
spectroscopic properties, nothing else was known about the protein. 
Since that time, more data has been accumulated on this phytocytolysin. 
During the present work, the digestion of enterolobin with 
chymotrypsin, elastase and trypsin generated hundreds of peptides. The 
separation of these peptides by a combination of gel filtration and RP-
HPLC proved to be a lengthy process, and, in some cases, was 
ineffective in providing them in a suitable level of purity for the 
subsequent sequence determination. 
A further obstacle was the finding that the N-terminal 
residue of the protein was chemically blocked. This blockage was 
refractory to two unblocking methods. In addition, during the early 
stages of this study, no other amino acid sequence similar to enterolobin 
was known that could help in the alignment of the peptides. Also, since 
no automated sequencing facilities were available until the later stages of 
this work, only the manual method was extensively employed for the 
sequencing of the peptides. This meant that large amounts of protein 
were always necessary for the hydrolytic digestions. However, despite 
these drawbacks, a considerable amount of the sequence was resolved. 
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The alignment of this partial sequence indicated that 
enterolobin is similar ( i f not homologous, given their functional 
relationship) to the aerolysins of A. hydrophila and A. sobria. The use 
of pattern searching revealed that enterolobin and aerolysins could be 
related to other pore- and channel-forming proteins as well as transport 
proteins from membranes of bacteria. This could be true not only for 
proteins from lower organisms, but also from higher species, as is 
suggested by the finding of the same pattern in a-macroglobulin. 
The results of this investigation pose many new questions. 
Is there an evolutionary line from the transport proteins, porins, 
colicins, and cytolysins from bacteria to the cytolytic proteins of higher 
organisms in which enterolobin could fi t as a link? 
To respond to this and other questions, enterolobin needs to 
have its amino acid sequence completely determined. Although manual 
sequencing alone can be useful for cheaply sequencing small and 
abundant peptides and proteins, it is not sufficient for carrying out the 
determination of primary structure of large and complex proteins such 
as enterolobin. For the accomplishment of this objective, new methods 
and strategies must be employed. 
Needless to say, automatic sequencing would have to be 
available throughout the work. It provides a much higher sensitivity and 
efficiency than the manual method, and frees the researcher for other 
tasks. To exploit the automatic method to its fu l l , some changes in 
strategy should be envisaged. For example, the use of very specific 
enzymes, like the Arg-specific enzyme from mouse sub-maxillary gland 
and the Lys-specific enzyme from Armillaria me lie a, would be 
indicated for generating a smaller number of larger peptides. A parallel 
177 
monitoring of the cleavages by mini-electrophoresis, capillary 
electrophoresis and/or micro-bore HPLC in order to optimize the 
conditions of the reactions would be advisable. The aim would be to 
reach a situation where one would obtain cleavages of small amounts of 
the protein (pmol level) that should produce mainly only long peptides 
ideal for the sequencing machine. 
Likewise, the use of micro-bore HPLC columns and/or two 
dimensional electrophoresis combined with blotting would permit the 
purification of peptides from very low quantities of protein. Also new 
methods and equipment for the separation of peptides and proteins are 
being introduced in the literature and in the market. As an example, a 
high performance preparative column electrophoresis device from 
Applied Biosystems has joined the arsenal of machinery that facilitates 
the work of the protein chemist and wi l l be available for the 
continuation of the work. 
Similarly, amino acid analysis is essential as a complement 
to the determination of amino acid sequences. It can be decisive in cases 
where there are some doubts remaining in the sequence. Another 
potentially useful technique is mass spectrometry for the elucidation of 
the structure of chemical blockages at the N-terminus, as well as for 
determining peptide sequences. The use of molecular biology as an 
auxiliary way of indirectly determining protein sequences has to be 
acknowledged. Some new techniques, such as the polymerase chain 
reaction (PCR), have made remarkable progress, and are becoming still 
more important as a tool for the protein investigator. 
When the complete sequence of enterolobin becomes 
available, the application of computational analytical methods wil l be 
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utilized, this time with more appropriate software and hardware. Even 
though useful data can be produced with a microcomputer, it lacks raw 
power to run programs at high processing speeds. For these programs, 
workstations are indicated, since some of them combine ease of use, 
graphical interface, large memories and high processing speeds. As far 
as possible, workstations running sensitive programs and holding non-
redundant sequence databases will be employed for the comparative 
analyses of the sequence of enterolobin and other related and apparently 
non-related proteins, and for other types of searches and analyses. 
The experiments on the kinetics of haemolysis by 
enterolobin indicated the chemical nature of its binding site on the 
erythrocyte membrane. It is known that many cytolysins have lipids as 
their binding molecules, but enterolobin is not included in this group. It 
was shown that this phytocytolysin could have a protein receptor, with 
the suggestion that it could be perhaps the band 3 anion exchanger 
protein. If this is the case, enterolobin could maybe be interfering 
somehow with the functions of transport of ions and water by the 
exchanger. This could lead to a change in the concentration of internal 
solutes, and cause lysis of erythrocytes by exceeding their critical cell 
volume. However, aerolysin, in its turn, appears to bind to glycophorin, 
which is the most abundant protein on the red cell membrane after band 
3. Further studies will confirm the identity of the receptors for these 
two similar proteins. The extension of the kinetic analysis to red cells 
treated with other enzymes (e.g. chymotrypsin, papain, neuraminidase, 
phospholipases, etc.), agglutinins (e.g. WGA, ConA, PHA, etc.), and 
chemicals (e.g. DEDS) should be further tried, as they might yield clues. 
Methods exploring the labelling of the protein with fluorescent probes 
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or dense markers as colloidal gold could be used to detect the receptor 
after its separation by electrophoresis and blotting. 
The utilization of optical and electron microscopic 
techniques in this work proved to be very helpful in giving a visual idea 
of what occurs during the process of haemolysis by enterolobin. This 
kind of study could be repeated for every type of cell shown to be lysed 
by the protein. This would reveal whether the pattern is similar to that 
which occurs with cancer and red cells (damage to the membrane) or to 
that of insect larvae gut cells (apparent intactness). 
It was demonstrated that enterolobin is toxic against two 
cancer cell lines and one insect species. It would be interesting if other 
species of insect and animals and other cell types could be also tested. 
Besides increasing the volume of information about this protein, it could 
suggest some interesting applications for the phytocytolysin. For 
example, its gene could be cloned and expressed in plants attacked by 
insect pests, possibly confering resistance to the plant. Before that 
however, it is essential to test the degree of toxicity of enterolobin when 
ingested by animals. Currently, experiments are under way to assay its 
effects in the diet of rats. 
However, some basic questions remain. It would be 
interesting to know if the haemolysis, lysis of cancer cells, toxicity to 
insects and inflammatory activity are all related to the same mechanism 
of action, or are exerted through different pathways. An initial point 
for investigation would be to determine whether the receptors in these 
different cells are similar proteins or not. This would open another line 
of research on the recptor(s) for enterolobin. 
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The physiological role(s) of enterolobin in the seeds of 
Enterolobium contortisiliquum remains an intriguing question. 
Enterolobin could be one of the seed storage protein or a natural 
defensive protein against microorganisms, insect pests and animal 
predators. Another hypothesis is that this cytolytic protein (in vitro) 
could be an endogenous porin-like, colicin-like or transport protein in 
the plant cell membranes. When extracted and isolated, this pore-
forming ability would be preserved in the protein. 
The answers are dependent not only on experiments in 
plant physiology, but also on a great effort in membrane biochemistry 
and protein chemistry, and will involve methods from other auxiliary 
areas, such as molecular genetics, immunology, protein crystallography 
and protein modelling. 
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